"AGEGR1","AGEGR1N","AGEGR2","AGEGR2N","REGNGR1","REGNGR1N","REGNGR2","REGNGR2N","STRATA1","STRATA2","ECOG","ECOGGR1","ECOGGR1N","HEIGHT","HGTGR1","HGTGR1N","WEIGHT","WGTGR1","WGTGR1N","BSA","BSAGR1","BSAGR1N","BCA199","BCAGR1","BCAGR1N","TRT01P","TRT01PN","TRT01A","TRT01AN","DSREAS","DSREASN","DSTERM","DTHFL","DEATHDSC","DEATHDY","LASTVDT","LASTCDT","STATUS","STATUSN","RANDDUR","DIAGDUR","DIAGGR1","DIAGGR1N","METDDUR","METDGR1","METDGR1N","DGMTDUR","MEASDFL","METDFL","MLOCN","MLOCGR1","MLOCGR1N","METLIV","METLYM","METPERI","METLUNG","METKIDNY","METOTH","HCGRAD","PTLOC","PTCLAS","RGCLAS","RES10X","R10XGR1","R10XGR1N","TRTP","TRTPN","TRTA","TRTAN","PARAM","PARAMCD","AVAL","ADT","CNSR","EVNTDESC","AVAL.TDTHSEN1","ADT.TDTHSEN1","CNSR.TDTHSEN1","EVNTDESC.TDTHSEN1","AVAL.TDTHSEN2","ADT.TDTHSEN2","CNSR.TDTHSEN2","EVNTDESC.TDTHSEN2","AVAL.TIME2DTH","ADT.TIME2DTH","CNSR.TIME2DTH","EVNTDESC.TIME2DTH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,175.5,">175",6,66,">50-75",2,1.81,">1.75-2.0",4,9420,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",446,427,427,"Died",2,2,1.54414784394251,"<=3",1,1.54414784394251,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","","","Y","","","Unknown","TAIL OF PANCREAS","T3","N0","15","11-20",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",9.59342915811088,291,0,"DOCUMENTED PROGRESSION",14.6858316221766,446,0,"DEATH",14.6858316221766,446,0,"DEATH",14.6858316221766,446,0,"DEATH"
"<=50",1,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,170,">150-175",5,52.5,">50-75",2,1.59,">1.50-1.75",3,422,">10xULN-20xULN",5,"Gemcitabine",2,"Gemcitabine",2,"WITHDRAWAL BY SUBJECT",5,"WITHDREW CONSENT","Y","DISEASE PROGRESSION",255,248,248,"Died",2,1,2.82546201232033,"<=3",1,1.80698151950719,"<=3",1,1.05133470225873,"Y","Y",2,"2",2,"Y","","Y","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T4","N0","5","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",8.37782340862423,254,0,"DEATH",8.37782340862423,254,0,"DEATH",8.37782340862423,254,0,"DEATH",8.37782340862423,254,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,169,">150-175",5,69.2,">50-75",2,1.79,">1.75-2.0",4,508,">10xULN-20xULN",5,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,479,479,"Alive",1,1,24.1478439425051,">24",5,1.44558521560575,"<=3",1,22.735112936345,"Y","Y",3,"3",3,"","Y","Y","","","Y","G1 - Well differentiated","HEAD OF PANCREAS","T3","N0","10","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.64271047227926,49,0,"DOCUMENTED PROGRESSION",15.7700205338809,479,1,"CENSORED AT TIME OF LAST FOLLOW-UP",15.7700205338809,479,1,"CENSORED AT TIME OF LAST FOLLOW-UP",15.7700205338809,479,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,172,">150-175",5,59.2,">50-75",2,1.7,">1.50-1.75",3,732,">10xULN-20xULN",5,"Gemcitabine",2,"Gemcitabine",2,"DEATH",2,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",7,0,NA,"Died",2,1,16.5256673511294,">12-24",4,1.60985626283368,"<=3",1,14.9486652977413,"Y","Y",1,"1",1,"Y","","","","","","Unknown","HEAD OF PANCREAS","T2","N0","10","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",0.229979466119097,6,0,"DEATH",0.229979466119097,6,0,"DEATH",0.229979466119097,6,0,"DEATH",0.229979466119097,6,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,NA,"",NA,NA,"",NA,NA,"",NA,NA,"",NA,"Gemcitabine",2,"",NA,"WITHDRAWAL BY SUBJECT",5,"WITHDREW CONSENT","Y","DISEASE PROGRESSION",NA,108,108,"Died",2,NA,2.10266940451745,"<=3",1,0.887063655030801,"<=3",1,1.24845995893224,"N","Y",1,"1",1,"Y","","","","","","Unknown","HEAD OF PANCREAS","T4","Unknown","30","21-30",3,"Gemcitabine",2,"",NA,"Progression Free Survival (months)","PFS",4.07392197125257,123,0,"DEATH",4.07392197125257,123,0,"DEATH",4.07392197125257,123,0,"DEATH",4.07392197125257,123,0,"DEATH"
"61-70",3,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,172,">150-175",5,74,">50-75",2,1.87,">1.75-2.0",4,12800,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",267,252,252,"Died",2,1,1.70841889117043,"<=3",1,1.64271047227926,"<=3",1,0.0985626283367557,"Y","Y",2,"2",2,"Y","Y","","","","","G1 - Well differentiated","BODY OF PANCREAS","T2","N1","20","11-20",2,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",7.12936344969199,216,0,"DOCUMENTED PROGRESSION",8.77207392197125,266,0,"DEATH",8.77207392197125,266,0,"DEATH",8.77207392197125,266,0,"DEATH"
"61-70",3,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,169,">150-175",5,56,">50-75",2,1.62,">1.50-1.75",3,41900,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",392,356,391,"Died",2,1,1.28131416837782,"<=3",1,1.28131416837782,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","Unknown","HEAD OF PANCREAS","Unknown","Unknown","30","21-30",3,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",7.98357289527721,242,0,"DOCUMENTED PROGRESSION",12.8788501026694,391,0,"DEATH",12.8788501026694,391,0,"DEATH",12.8788501026694,391,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,155,">150-175",5,48,"<=50",1,1.43,">1.25-1.50",2,2630,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"WITHDRAWAL BY SUBJECT",5,"WITHDREW CONSENT","Y","DISEASE PROGRESSION",257,224,224,"Died",2,9,48.5585215605749,">24",5,41.5934291581109,">24",5,6.99794661190965,"Y","Y",5,">=5",5,"Y","Y","","Y","","Y","G1 - Well differentiated","HEAD OF PANCREAS","T3","Nx","30","21-30",3,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.87268993839836,56,0,"DOCUMENTED PROGRESSION",8.70636550308008,264,0,"DEATH",8.70636550308008,264,0,"DEATH",8.70636550308008,264,0,"DEATH"
"61-70",3,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,160,">150-175",5,52.6,">50-75",2,1.53,">1.50-1.75",3,283,">3xULN-10xULN",4,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",218,212,230,"Died",2,1,1.64271047227926,"<=3",1,0.887063655030801,"<=3",1,0.788501026694045,"Y","Y",2,"2",2,"","Y","Y","","","","Unknown","HEAD OF PANCREAS","T3","N1","5","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.7782340862423,114,0,"DOCUMENTED PROGRESSION",7.16221765913758,217,0,"DEATH",7.16221765913758,217,0,"DEATH",7.16221765913758,217,0,"DEATH"
"61-70",3,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,160,">150-175",5,53,">50-75",2,1.54,">1.50-1.75",3,17600,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",142,134,142,"Died",2,2,0.985626283367556,"<=3",1,0.394250513347023,"<=3",1,0.624229979466119,"Y","Y",4,"4",4,"Y","Y","Y","Y","","","Unknown","TAIL OF PANCREAS","T4","N1","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",4.69815195071869,142,0,"DEATH",4.69815195071869,142,0,"DEATH",4.69815195071869,142,0,"DEATH",4.69815195071869,142,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,160,">150-175",5,43,"<=50",1,1.41,">1.25-1.50",2,8320,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",310,279,279,"Died",2,2,2.72689938398357,"<=3",1,0.427104722792608,"<=3",1,2.33264887063655,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","TAIL OF PANCREAS","T4","N1","2","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.41683778234086,103,0,"DOCUMENTED PROGRESSION",10.217659137577,310,0,"DEATH",10.217659137577,310,0,"DEATH",10.217659137577,310,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,165,">150-175",5,80,">75-100",3,1.87,">1.75-2.0",4,1030000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","Other",52,39,NA,"Died",2,1,1.51129363449692,"<=3",1,0.985626283367556,"<=3",1,0.558521560574949,"Y","Y",1,"1",1,"Y","","","","","","G1 - Well differentiated","TAIL OF PANCREAS","Tx","Nx","2","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.70841889117043,51,0,"DEATH",1.70841889117043,51,0,"DEATH",1.70841889117043,51,0,"DEATH",1.70841889117043,51,0,"DEATH"
"61-70",3,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,178,">175",6,85,">75-100",3,2,">1.75-2.0",4,118,">3xULN-10xULN",4,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",49,39,NA,"Died",2,3,1.83983572895277,"<=3",1,1.83983572895277,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","HEAD OF PANCREAS","T3","N1","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.18275154004107,35,0,"DOCUMENTED PROGRESSION",1.67556468172485,50,0,"DEATH",1.67556468172485,50,0,"DEATH",1.67556468172485,50,0,"DEATH"
"<=50",1,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,185,">175",6,74,">50-75",2,1.95,">1.75-2.0",4,NA,"",NA,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",237,226,226,"Died",2,4,1.08418891170431,"<=3",1,0.919917864476386,"<=3",1,0.197125256673511,"Y","Y",1,"1",1,"Y","","","","","","G1 - Well differentiated","TAIL OF PANCREAS","Tx","Nx","2","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",7.88501026694045,239,0,"DEATH",7.88501026694045,239,0,"DEATH",7.88501026694045,239,0,"DEATH",7.88501026694045,239,0,"DEATH"
"61-70",3,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,196,">175",6,78,">75-100",3,2,">1.75-2.0",4,6690,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,421,421,"Alive",1,2,1.18275154004107,"<=3",1,1.18275154004107,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G2 - Moderately differentiated","BODY OF PANCREAS","Tx","Nx","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",4.92813141683778,149,0,"DOCUMENTED PROGRESSION",13.864476386037,421,1,"CENSORED AT TIME OF LAST FOLLOW-UP",13.864476386037,421,1,"CENSORED AT TIME OF LAST FOLLOW-UP",13.864476386037,421,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"61-70",3,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,182,">175",6,76,">75-100",3,1.96,">1.75-2.0",4,40000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",129,106,NA,"Died",2,1,2.0041067761807,"<=3",1,2.0041067761807,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T2","Nx","15","11-20",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",2.85831622176591,86,0,"DOCUMENTED PROGRESSION",4.23819301848049,128,0,"DEATH",4.23819301848049,128,0,"DEATH",4.23819301848049,128,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,178,">175",6,60,">50-75",2,1.7,">1.50-1.75",3,39600,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",115,93,NA,"Died",2,3,1.08418891170431,"<=3",1,1.08418891170431,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","Unknown","HEAD OF PANCREAS","Unknown","Unknown","30","21-30",3,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.02258726899384,91,0,"DOCUMENTED PROGRESSION",3.84394250513347,116,0,"DEATH",3.84394250513347,116,0,"DEATH",3.84394250513347,116,0,"DEATH"
"51-60",2,"<65",1,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,167.9,">150-175",5,62.1,">50-75",2,1.68,">1.50-1.75",3,12.4,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","DISEASE PROGRESSION",420,418,420,"Died",2,2,3.94250513347023,">3-6",2,1.44558521560575,"<=3",1,2.52977412731006,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","HEAD OF PANCREAS","T3","N1","50","41-50",5,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",13.8316221765914,420,0,"DEATH",13.8316221765914,420,0,"DEATH",13.8316221765914,420,0,"DEATH",13.8316221765914,420,0,"DEATH"
"61-70",3,"<65",1,"North America",1,"US/Western Europe/Australia",1,0,1,0,"0",1,NA,"",NA,NA,"",NA,NA,"",NA,NA,"",NA,"Gemcitabine",2,"",NA,"WITHDRAWAL BY SUBJECT",5,"WITHDREW CONSENT","","",NA,595,595,"Alive",1,NA,1.31416837782341,"<=3",1,1.08418891170431,"<=3",1,0.262833675564682,"N","Y",1,"1",1,"","","","Y","","","Unknown","BODY OF PANCREAS","T4","N0","40","31-40",4,"Gemcitabine",2,"",NA,"Progression Free Survival (months)","PFS",0.0328542094455852,0,1,"CENSORED AT TIME OF RANDOMIZATION",19.5811088295688,595,1,"CENSORED AT TIME OF LAST FOLLOW-UP",19.5811088295688,595,1,"CENSORED AT TIME OF LAST FOLLOW-UP",19.5811088295688,595,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,162,">150-175",5,70.8,">50-75",2,1.76,">1.75-2.0",4,8.1,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"",NA,"","","",NA,727,NA,"",NA,1,2.26694045174538,"<=3",1,0.854209445585216,"<=3",1,1.44558521560575,"Y","Y",2,"2",2,"","Y","Y","","","","Unknown","BODY OF PANCREAS","T2","N1","2","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",21.8809034907598,665,1,"CENSORED AT TIME OF LAST ASSESSMENT",23.917864476386,727,1,"CENSORED AT TIME OF LAST VISIT",23.917864476386,727,1,"CENSORED AT TIME OF LAST VISIT",23.917864476386,727,1,"CENSORED AT TIME OF LAST VISIT"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,172,">150-175",5,60,">50-75",2,1.71,">1.50-1.75",3,406,">10xULN-20xULN",5,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",271,251,251,"Died",2,2,0.624229979466119,"<=3",1,0.624229979466119,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","Unknown","HEAD OF PANCREAS","T2","N1","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.48254620123203,105,0,"DOCUMENTED PROGRESSION",8.93634496919918,271,0,"DEATH",8.93634496919918,271,0,"DEATH",8.93634496919918,271,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,164,">150-175",5,45.3,"<=50",1,1.47,">1.25-1.50",2,622,">10xULN-20xULN",5,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"WITHDRAWAL BY SUBJECT",5,"WITHDREW CONSENT","Y","DISEASE PROGRESSION",200,167,323,"Died",2,2,1.34702258726899,"<=3",1,1.34702258726899,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","BODY OF PANCREAS","T4","N1","60","51-60",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",6.60369609856263,200,0,"DEATH",6.60369609856263,200,0,"DEATH",6.60369609856263,200,0,"DEATH",6.60369609856263,200,0,"DEATH"
"81-90",5,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,166,">150-175",5,61.7,">50-75",2,1.69,">1.50-1.75",3,6950,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",59,43,NA,"Died",2,2,2.56262833675565,"<=3",1,0.854209445585216,"<=3",1,1.74127310061602,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","BODY OF PANCREAS","T2","N1","20","11-20",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.97125256673511,59,0,"DEATH",1.97125256673511,59,0,"DEATH",1.97125256673511,59,0,"DEATH",1.97125256673511,59,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,161,">150-175",5,71.4,">50-75",2,1.75,">1.50-1.75",3,1.4,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,376,376,"Alive",1,1,2.36550308008214,"<=3",1,2.10266940451745,"<=3",1,0.295687885010267,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T3","N1","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.60985626283368,48,0,"DOCUMENTED PROGRESSION",12.3860369609856,376,1,"CENSORED AT TIME OF LAST FOLLOW-UP",12.3860369609856,376,1,"CENSORED AT TIME OF LAST FOLLOW-UP",12.3860369609856,376,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"51-60",2,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,183,">175",6,79,">75-100",3,2,">1.75-2.0",4,11000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,280,280,"Alive",1,2,1.31416837782341,"<=3",1,0.722792607802875,"<=3",1,0.624229979466119,"Y","Y",1,"1",1,"Y","","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T1","N0","15","11-20",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",2.10266940451745,63,0,"DOCUMENTED PROGRESSION",9.23203285420944,280,1,"CENSORED AT TIME OF LAST FOLLOW-UP",9.23203285420944,280,1,"CENSORED AT TIME OF LAST FOLLOW-UP",9.23203285420944,280,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,162,">150-175",5,60,">50-75",2,1.62,">1.50-1.75",3,167,">3xULN-10xULN",4,"Gemcitabine",2,"Gemcitabine",2,"DEATH",2,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",28,9,NA,"Died",2,2,10.611909650924,">6-12",3,1.47843942505133,"<=3",1,9.16632443531828,"Y","Y",4,"4",4,"Y","Y","Y","Y","","","Unknown","BODY OF PANCREAS","Unknown","N0","40","31-40",4,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",0.952772073921971,28,0,"DEATH",0.952772073921971,28,0,"DEATH",0.952772073921971,28,0,"DEATH",0.952772073921971,28,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,176,">175",6,73,">50-75",2,1.89,">1.75-2.0",4,NA,"",NA,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,277,277,"Alive",1,29,1.83983572895277,"<=3",1,1.44558521560575,"<=3",1,0.427104722792608,"Y","Y",2,"2",2,"Y","Y","","","","","GX - Grade cannot be assessed","HEAD OF PANCREAS","Tx","N0","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",8.24640657084189,250,0,"DOCUMENTED PROGRESSION",9.13347022587269,277,1,"CENSORED AT TIME OF LAST FOLLOW-UP",9.13347022587269,277,1,"CENSORED AT TIME OF LAST FOLLOW-UP",9.13347022587269,277,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"51-60",2,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,168,">150-175",5,73,">50-75",2,1.85,">1.75-2.0",4,62300,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"DEATH",2,"TUMOR BLEEDING DUE TO TUMOR INVASION IN DUODENUM","Y","Other",55,49,NA,"Died",2,1,2.92402464065708,"<=3",1,1.21560574948665,"<=3",1,1.74127310061602,"Y","Y",3,"3",3,"Y","Y","","","","Y","Unknown","HEAD OF PANCREAS","Unknown","Unknown","90","81-90",9,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.80698151950719,54,0,"DEATH",1.80698151950719,54,0,"DEATH",1.80698151950719,54,0,"DEATH",1.80698151950719,54,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,172,">150-175",5,82,">75-100",3,1.95,">1.75-2.0",4,3320,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,596,596,"Alive",1,1,1.90554414784394,"<=3",1,1.90554414784394,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","G3 - Poorly differentiated","HEAD OF PANCREAS","Unknown","Unknown","30","21-30",3,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",7.85215605749487,238,0,"DOCUMENTED PROGRESSION",19.6139630390144,596,1,"CENSORED AT TIME OF LAST FOLLOW-UP",19.6139630390144,596,1,"CENSORED AT TIME OF LAST FOLLOW-UP",19.6139630390144,596,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"51-60",2,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,NA,"",NA,NA,"",NA,NA,"",NA,NA,"",NA,"Gemcitabine Elaidate",1,"",NA,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","Other",NA,159,175,"Died",2,NA,0.558521560574949,"<=3",1,0.558521560574949,"<=3",1,0.0328542094455852,"N","Y",1,"1",1,"Y","","","","","","Unknown","TAIL OF PANCREAS","Tx","Nx","40","31-40",4,"Gemcitabine Elaidate",1,"",NA,"Progression Free Survival (months)","PFS",5.782340862423,175,0,"DEATH",5.782340862423,175,0,"DEATH",5.782340862423,175,0,"DEATH",5.782340862423,175,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,163,">150-175",5,79,">75-100",3,1.85,">1.75-2.0",4,6720,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","DISEASE PROGRESSION",177,146,182,"Died",2,2,1.08418891170431,"<=3",1,0.75564681724846,"<=3",1,0.361396303901437,"Y","Y",2,"2",2,"Y","Y","","","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T3","N1","50","41-50",5,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.44969199178645,104,0,"DOCUMENTED PROGRESSION",5.84804928131417,177,0,"DEATH",5.84804928131417,177,0,"DEATH",5.84804928131417,177,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,164,">150-175",5,48,"<=50",1,1.5,">1.25-1.50",2,285,">3xULN-10xULN",4,"Gemcitabine",2,"Gemcitabine",2,"OTHER",8,"DUE TO WRONG RADIOLOGICAL DIAGNOSIS OF PD THE PATIENT WAS TAKEN OFF TRIAL.","Y","DISEASE PROGRESSION",131,118,134,"Died",2,2,0.985626283367556,"<=3",1,0.68993839835729,"<=3",1,0.328542094455852,"Y","Y",2,"2",2,"Y","","","Y","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T4","N0","60","51-60",6,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",4.33675564681725,131,0,"DEATH",4.33675564681725,131,0,"DEATH",4.33675564681725,131,0,"DEATH",4.33675564681725,131,0,"DEATH"
"51-60",2,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,169,">150-175",5,79.8,">75-100",3,1.91,">1.75-2.0",4,2280,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",363,329,329,"Died",2,2,0.952772073921971,"<=3",1,0.525667351129363,"<=3",1,0.459958932238193,"Y","Y",1,"1",1,"","","","Y","","","Unknown","TAIL OF PANCREAS","Unknown","Unknown","10","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.74537987679671,113,0,"DOCUMENTED PROGRESSION",11.958932238193,363,0,"DEATH",11.958932238193,363,0,"DEATH",11.958932238193,363,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,185,">175",6,77,">75-100",3,1.99,">1.75-2.0",4,1130,">20xULN-50xULN",6,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",160,142,142,"Died",2,2,1.34702258726899,"<=3",1,0.887063655030801,"<=3",1,0.492813141683778,"Y","Y",1,"1",1,"Y","","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","Tx","Nx","20","11-20",2,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.93839835728953,58,0,"DOCUMENTED PROGRESSION",5.28952772073922,160,0,"DEATH",5.28952772073922,160,0,"DEATH",5.28952772073922,160,0,"DEATH"
"51-60",2,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,190,">175",6,105.3,">100-125",4,2.36,">2.0",5,138000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",254,230,279,"Died",2,1,1.21560574948665,"<=3",1,0.657084188911704,"<=3",1,0.591375770020534,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","Tx","N1","50","41-50",5,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",2.26694045174538,68,0,"DOCUMENTED PROGRESSION",8.34496919917864,253,0,"DEATH",8.34496919917864,253,0,"DEATH",8.34496919917864,253,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,170,">150-175",5,73.2,">50-75",2,1.86,">1.75-2.0",4,211,">3xULN-10xULN",4,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",260,303,262,"Died",2,2,0.427104722792608,"<=3",1,0.657084188911704,"<=3",1,-0.197125256673511,"Y","Y",2,"2",2,"","Y","","Y","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T3","N1","55","51-60",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",6.04517453798768,183,0,"DOCUMENTED PROGRESSION",8.57494866529774,260,0,"DEATH",8.57494866529774,260,0,"DEATH",8.57494866529774,260,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,184,">175",6,68,">50-75",2,1.92,">1.75-2.0",4,38.8,">ULN-2xULN",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","Other",308,412,531,"Died",2,5,0.558521560574949,"<=3",1,0.558521560574949,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","","Y","","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T4","Nx","40","31-40",4,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",5.48665297741273,166,0,"DOCUMENTED PROGRESSION",10.2505133470226,311,0,"DEATH",10.2505133470226,311,0,"DEATH",10.2505133470226,311,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,178,">175",6,64,">50-75",2,1.8,">1.75-2.0",4,99000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",167,158,NA,"Died",2,1,0.591375770020534,"<=3",1,0.591375770020534,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","OTHER","T2","N1","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.05954825462012,153,0,"DOCUMENTED PROGRESSION",5.48665297741273,166,0,"DEATH",5.48665297741273,166,0,"DEATH",5.48665297741273,166,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,174,">150-175",5,103,">100-125",4,2.2,">2.0",5,8810,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"DEATH",2,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",154,147,NA,"Died",2,1,0.525667351129363,"<=3",1,0.525667351129363,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","","","Y","G2 - Moderately differentiated","TAIL OF PANCREAS","T3","N0","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",5.05954825462012,153,0,"DEATH",5.05954825462012,153,0,"DEATH",5.05954825462012,153,0,"DEATH",5.05954825462012,153,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,178,">175",6,85,">75-100",3,2.04,">2.0",5,6.5,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"",NA,"","","",NA,532,NA,"",NA,2,0.68993839835729,"<=3",1,0.68993839835729,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"","Y","Y","","","","G2 - Moderately differentiated","BODY OF PANCREAS","T4","Nx","55","51-60",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.58110882956879,108,1,"CENSORED AT TIME OF LAST ASSESSMENT",17.5112936344969,532,1,"CENSORED AT TIME OF LAST VISIT",17.5112936344969,532,1,"CENSORED AT TIME OF LAST VISIT",17.5112936344969,532,1,"CENSORED AT TIME OF LAST VISIT"
"61-70",3,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,175,">150-175",5,74,">50-75",2,1.91,">1.75-2.0",4,130,">3xULN-10xULN",4,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,474,474,"Alive",1,2,0.591375770020534,"<=3",1,0.591375770020534,"<=3",1,0.0328542094455852,"Y","Y",4,"4",4,"Y","","","","","Y","Unknown","BODY OF PANCREAS","T1","Nx","60","51-60",6,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.67556468172485,50,1,"CENSORED AT TIME OF LAST ASSESSMENT",15.605749486653,474,1,"CENSORED AT TIME OF LAST FOLLOW-UP",15.605749486653,474,1,"CENSORED AT TIME OF LAST FOLLOW-UP",15.605749486653,474,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"<=50",1,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,176,">175",6,71.1,">50-75",2,1.85,">1.75-2.0",4,1.4,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",159,155,155,"Died",2,2,1.08418891170431,"<=3",1,0.624229979466119,"<=3",1,0.492813141683778,"Y","Y",3,"3",3,"Y","Y","","Y","","","G3 - Poorly differentiated","BODY OF PANCREAS","T4","N1","5","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.90554414784394,57,0,"DOCUMENTED PROGRESSION",5.25667351129363,159,0,"DEATH",5.25667351129363,159,0,"DEATH",5.25667351129363,159,0,"DEATH"
"61-70",3,"<65",1,"Australia/South America",4,"US/Western Europe/Australia",1,1,1,1,"1",2,168,">150-175",5,43.6,"<=50",1,1.44,">1.25-1.50",2,43900,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",93,93,NA,"Died",2,2,2.59548254620123,"<=3",1,0.952772073921971,"<=3",1,1.67556468172485,"N","Y",1,"1",1,"Y","","","","","","G3 - Poorly differentiated","BODY OF PANCREAS","T4","N1","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.08829568788501,93,0,"DEATH",3.08829568788501,93,0,"DEATH",3.08829568788501,93,0,"DEATH",3.08829568788501,93,0,"DEATH"
"51-60",2,"<65",1,"Australia/South America",4,"US/Western Europe/Australia",1,1,1,1,"1",2,NA,"",NA,NA,"",NA,NA,"",NA,NA,"",NA,"Gemcitabine Elaidate",1,"",NA,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","DISEASE PROGRESSION",NA,2,NA,"Died",2,NA,18.8911704312115,">12-24",4,3.74537987679671,">3-6",2,15.1786447638604,"N","Y",5,">=5",5,"Y","Y","Y","Y","","Y","G1 - Well differentiated","HEAD OF PANCREAS","T2","N1","50","41-50",5,"Gemcitabine Elaidate",1,"",NA,"Progression Free Survival (months)","PFS",0.427104722792608,12,0,"DEATH",0.427104722792608,12,0,"DEATH",0.427104722792608,12,0,"DEATH",0.427104722792608,12,0,"DEATH"
"61-70",3,"<65",1,"Australia/South America",4,"US/Western Europe/Australia",1,1,1,2,">=2",3,169,">150-175",5,53.4,">50-75",2,1.57,">1.50-1.75",3,172000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","DISEASE PROGRESSION",12,8,NA,"Died",2,2,0.788501026694045,"<=3",1,0.68993839835729,"<=3",1,0.131416837782341,"Y","Y",2,"2",2,"Y","","","Y","","","G1 - Well differentiated","HEAD OF PANCREAS","Tx","Nx","50","41-50",5,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",0.427104722792608,12,0,"DEATH",0.427104722792608,12,0,"DEATH",0.427104722792608,12,0,"DEATH",0.427104722792608,12,0,"DEATH"
"71-80",4,">=65",2,"Australia/South America",4,"US/Western Europe/Australia",1,1,1,1,"1",2,158,">150-175",5,73.2,">50-75",2,1.76,">1.75-2.0",4,94200,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",191,148,148,"Died",2,2,1.64271047227926,"<=3",1,1.64271047227926,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","","","Y","G4 - Undifferentiated","HEAD OF PANCREAS","T2","N1","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.7782340862423,114,0,"DOCUMENTED PROGRESSION",6.30800821355236,191,0,"DEATH",6.30800821355236,191,0,"DEATH",6.30800821355236,191,0,"DEATH"
"71-80",4,">=65",2,"Australia/South America",4,"US/Western Europe/Australia",1,1,1,1,"1",2,164,">150-175",5,71.4,">50-75",2,1.77,">1.75-2.0",4,171000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","DISEASE PROGRESSION",27,8,NA,"Died",2,2,1.14989733059548,"<=3",1,1.14989733059548,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","Unknown","HEAD OF PANCREAS","T2","Unknown","N/A","",NA,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",0.919917864476386,27,0,"DEATH",0.919917864476386,27,0,"DEATH",0.919917864476386,27,0,"DEATH",0.919917864476386,27,0,"DEATH"
"61-70",3,">=65",2,"Australia/South America",4,"US/Western Europe/Australia",1,1,1,1,"1",2,NA,"",NA,NA,"",NA,NA,"",NA,NA,"",NA,"Gemcitabine",2,"",NA,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",NA,2,NA,"Died",2,NA,1.08418891170431,"<=3",1,1.08418891170431,"<=3",1,0.0328542094455852,"N","Y",2,"2",2,"Y","","","Y","","","Unknown","HEAD OF PANCREAS","Unknown","Unknown","20","11-20",2,"Gemcitabine",2,"",NA,"Progression Free Survival (months)","PFS",0.328542094455852,9,0,"DEATH",0.328542094455852,9,0,"DEATH",0.328542094455852,9,0,"DEATH",0.328542094455852,9,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,171.5,">150-175",5,71,">50-75",2,1.83,">1.75-2.0",4,70800,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","Other",98,79,98,"Died",2,2,2.13552361396304,"<=3",1,0.459958932238193,"<=3",1,1.70841889117043,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","BODY OF PANCREAS","T2","Nx","80","71-80",8,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",2.62833675564682,79,0,"DOCUMENTED PROGRESSION",3.25256673511294,98,0,"DEATH",3.25256673511294,98,0,"DEATH",3.25256673511294,98,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,180.5,">175",6,80.1,">75-100",3,2,">1.75-2.0",4,1.4,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"ADVERSE EVENT",3,"ADVERSE EVENT","","",NA,211,NA,"",NA,2,1.34702258726899,"<=3",1,0.657084188911704,"<=3",1,0.722792607802875,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","TAIL OF PANCREAS","T3","N1","70","61-70",7,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.35523613963039,162,1,"CENSORED AT TIME OF LAST ASSESSMENT",6.96509240246407,211,1,"CENSORED AT TIME OF LAST VISIT",6.96509240246407,211,1,"CENSORED AT TIME OF LAST VISIT",6.96509240246407,211,1,"CENSORED AT TIME OF LAST VISIT"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,NA,"",NA,NA,"",NA,NA,"",NA,1.7,"<=ULN",1,"Gemcitabine",2,"",NA,"OTHER",8,"ECOG 3","Y","DISEASE PROGRESSION",NA,38,38,"Died",2,NA,1.51129363449692,"<=3",1,1.51129363449692,"<=3",1,0.0328542094455852,"N","Y",5,">=5",5,"Y","","Y","Y","","Y","Unknown","TAIL OF PANCREAS","T4","Unknown","90","81-90",9,"Gemcitabine",2,"",NA,"Progression Free Survival (months)","PFS",2.16837782340862,65,0,"DEATH",2.16837782340862,65,0,"DEATH",2.16837782340862,65,0,"DEATH",2.16837782340862,65,0,"DEATH"
"61-70",3,">=65",2,"Australia/South America",4,"South America",3,0,3,0,"0",1,169,">150-175",5,75,">50-75",2,1.85,">1.75-2.0",4,385,">10xULN-20xULN",5,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",413,393,421,"Died",2,2,1.34702258726899,"<=3",1,1.34702258726899,"<=3",1,0.0328542094455852,"Y","Y",4,"4",4,"","Y","Y","Y","","Y","G2 - Moderately differentiated","BODY OF PANCREAS","T4","N1","80","71-80",8,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",5.35523613963039,162,0,"DOCUMENTED PROGRESSION",13.6016427104723,413,0,"DEATH",13.6016427104723,413,0,"DEATH",13.6016427104723,413,0,"DEATH"
"71-80",4,">=65",2,"Australia/South America",4,"South America",3,1,3,1,"1",2,173,">150-175",5,80,">75-100",3,1.94,">1.75-2.0",4,1930,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",51,45,NA,"Died",2,3,1.57700205338809,"<=3",1,1.57700205338809,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"","","","Y","","Y","G4 - Undifferentiated","OTHER","Unknown","Unknown","25","21-30",3,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.74127310061602,52,0,"DEATH",1.74127310061602,52,0,"DEATH",1.74127310061602,52,0,"DEATH",1.74127310061602,52,0,"DEATH"
"<=50",1,"<65",1,"Australia/South America",4,"South America",3,0,3,0,"0",1,162,">150-175",5,87,">75-100",3,1.98,">1.75-2.0",4,83.2,">2xULN-3xULN",3,"Gemcitabine",2,"Gemcitabine",2,"WITHDRAWAL BY SUBJECT",5,"WITHDREW CONSENT","","",NA,386,386,"Alive",1,2,1.08418891170431,"<=3",1,1.08418891170431,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"","","","","","Y","Unknown","OTHER","Tx","Nx","55","51-60",6,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.84804928131417,177,1,"CENSORED AT TIME OF LAST ASSESSMENT",12.7145790554415,386,1,"CENSORED AT TIME OF LAST FOLLOW-UP",12.7145790554415,386,1,"CENSORED AT TIME OF LAST FOLLOW-UP",12.7145790554415,386,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"<=50",1,"<65",1,"Australia/South America",4,"South America",3,1,3,1,"1",2,164,">150-175",5,70.5,">50-75",2,1.77,">1.75-2.0",4,298000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",290,275,275,"Died",2,1,2.0041067761807,"<=3",1,2.0041067761807,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","Unknown","TAIL OF PANCREAS","Unknown","Unknown","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",9.52772073921971,289,0,"DEATH",9.52772073921971,289,0,"DEATH",9.52772073921971,289,0,"DEATH",9.52772073921971,289,0,"DEATH"
"51-60",2,"<65",1,"Australia/South America",4,"South America",3,0,3,0,"0",1,158,">150-175",5,70.5,">50-75",2,1.72,">1.50-1.75",3,9420,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",142,140,140,"Died",2,1,1.05133470225873,"<=3",1,1.05133470225873,"<=3",1,0.0328542094455852,"Y","Y",4,"4",4,"Y","","","Y","Y","Y","G2 - Moderately differentiated","BODY OF PANCREAS","T4","N0","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.5482546201232,107,0,"DOCUMENTED PROGRESSION",4.6652977412731,141,0,"DEATH",4.6652977412731,141,0,"DEATH",4.6652977412731,141,0,"DEATH"
"51-60",2,"<65",1,"Australia/South America",4,"South America",3,1,3,1,"1",2,155,">150-175",5,57,">50-75",2,1.55,">1.50-1.75",3,669,">10xULN-20xULN",5,"Gemcitabine",2,"Gemcitabine",2,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","Other",266,252,NA,"Died",2,2,1.01848049281314,"<=3",1,1.01848049281314,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","Y","","","G1 - Well differentiated","HEAD OF PANCREAS","T4","N1","60","51-60",6,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",8.77207392197125,266,0,"DEATH",8.77207392197125,266,0,"DEATH",8.77207392197125,266,0,"DEATH",8.77207392197125,266,0,"DEATH"
"<=50",1,"<65",1,"Australia/South America",4,"South America",3,1,3,1,"1",2,157,">150-175",5,57,">50-75",2,1.57,">1.50-1.75",3,250000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",104,76,NA,"Died",2,4,1.01848049281314,"<=3",1,1.01848049281314,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","Unknown","Unknown","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",2.26694045174538,68,0,"DOCUMENTED PROGRESSION",3.51540041067762,106,0,"DEATH",3.51540041067762,106,0,"DEATH",3.51540041067762,106,0,"DEATH"
"71-80",4,">=65",2,"Australia/South America",4,"South America",3,1,3,1,"1",2,156,">150-175",5,38.8,"<=50",1,1.3,">1.25-1.50",2,311000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"DEATH",2,"RESPIRATORY INSUFFICIENCE","Y","Other",35,29,NA,"Died",2,2,0.624229979466119,"<=3",1,0.624229979466119,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","Unknown","OTHER","T3","Nx","15","11-20",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.18275154004107,35,0,"DEATH",1.18275154004107,35,0,"DEATH",1.18275154004107,35,0,"DEATH",1.18275154004107,35,0,"DEATH"
"<=50",1,"<65",1,"Australia/South America",4,"South America",3,0,3,0,"0",1,159,">150-175",5,52.1,">50-75",2,1.52,">1.50-1.75",3,98900,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"DEATH",2,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",23,15,NA,"Died",2,2,0.657084188911704,"<=3",1,0.657084188911704,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","","","Y","","","G2 - Moderately differentiated","OTHER","T3","Nx","70","61-70",7,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",0.788501026694045,23,0,"DEATH",0.788501026694045,23,0,"DEATH",0.788501026694045,23,0,"DEATH",0.788501026694045,23,0,"DEATH"
"71-80",4,">=65",2,"Australia/South America",4,"South America",3,1,3,1,"1",2,157,">150-175",5,58.7,">50-75",2,1.6,">1.50-1.75",3,111,">2xULN-3xULN",3,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"WITHDRAWAL BY SUBJECT",5,"WITHDREW CONSENT","","",NA,9,NA,"Lost to Follow-up",3,3,1.34702258726899,"<=3",1,1.1170431211499,"<=3",1,0.262833675564682,"Y","Y",1,"1",1,"","","","Y","","","Unknown","HEAD OF PANCREAS","T4","Nx","50","41-50",5,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",0.0328542094455852,0,1,"CENSORED AT TIME OF RANDOMIZATION",0.328542094455852,9,1,"CENSORED AT TIME OF LAST VISIT",0.328542094455852,9,1,"CENSORED AT TIME OF LAST VISIT",0.328542094455852,9,1,"CENSORED AT TIME OF LAST VISIT"
"71-80",4,">=65",2,"Australia/South America",4,"South America",3,0,3,0,"0",1,155,">150-175",5,46,"<=50",1,1.37,">1.25-1.50",2,59000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",166,142,142,"Died",2,3,1.01848049281314,"<=3",1,1.01848049281314,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","Y","","","Unknown","HEAD OF PANCREAS","Tx","Nx","40","31-40",4,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.97125256673511,59,0,"DOCUMENTED PROGRESSION",5.51950718685832,167,0,"DEATH",5.51950718685832,167,0,"DEATH",5.51950718685832,167,0,"DEATH"
"61-70",3,">=65",2,"Australia/South America",4,"South America",3,1,3,1,"1",2,165,">150-175",5,81.2,">75-100",3,1.85,">1.75-2.0",4,33400,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"DEATH",2,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",13,9,NA,"Died",2,3,1.37987679671458,"<=3",1,1.37987679671458,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"","","Y","","","Y","Unknown","BODY OF PANCREAS","T2","N0","30","21-30",3,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",0.492813141683778,14,0,"DEATH",0.492813141683778,14,0,"DEATH",0.492813141683778,14,0,"DEATH",0.492813141683778,14,0,"DEATH"
"51-60",2,"<65",1,"Australia/South America",4,"South America",3,0,3,0,"0",1,169,">150-175",5,86,">75-100",3,1.9,">1.75-2.0",4,8520,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",367,335,368,"Died",2,1,0.591375770020534,"<=3",1,0.591375770020534,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","","","Y","","Y","Unknown","TAIL OF PANCREAS","Tx","Nx","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",5.5523613963039,168,0,"DOCUMENTED PROGRESSION",12.0574948665298,366,0,"DEATH",12.0574948665298,366,0,"DEATH",12.0574948665298,366,0,"DEATH"
"51-60",2,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,177.5,">175",6,73.8,">50-75",2,1.91,">1.75-2.0",4,1600,">20xULN-50xULN",6,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",536,469,541,"Died",2,2,1.21560574948665,"<=3",1,1.21560574948665,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T2","N0","70","61-70",7,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",7.19507186858316,218,0,"DOCUMENTED PROGRESSION",17.6427104722793,536,0,"DEATH",17.6427104722793,536,0,"DEATH",17.6427104722793,536,0,"DEATH"
"51-60",2,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,189,">175",6,86.9,">75-100",3,2.14,">2.0",5,965000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",97,85,85,"Died",2,2,1.54414784394251,"<=3",1,1.54414784394251,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","Y","","","G2 - Moderately differentiated","TAIL OF PANCREAS","T3","N1","30","21-30",3,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.67556468172485,50,0,"DOCUMENTED PROGRESSION",3.21971252566735,97,0,"DEATH",3.21971252566735,97,0,"DEATH",3.21971252566735,97,0,"DEATH"
"51-60",2,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,167,">150-175",5,56,">50-75",2,1.62,">1.50-1.75",3,NA,"",NA,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",48,0,47,"Died",2,1,1.57700205338809,"<=3",1,1.57700205338809,"<=3",1,0.0328542094455852,"Y","Y",4,"4",4,"Y","Y","Y","","","Y","G2 - Moderately differentiated","TAIL OF PANCREAS","Tx","Nx","90","81-90",9,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.57700205338809,47,0,"DEATH",1.57700205338809,47,0,"DEATH",1.57700205338809,47,0,"DEATH",1.57700205338809,47,0,"DEATH"
"61-70",3,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,168,">150-175",5,90.8,">75-100",3,2.01,">2.0",5,15800,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",104,75,75,"Died",2,2,1.87268993839836,"<=3",1,1.87268993839836,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","Tx","Nx","70","61-70",7,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.67556468172485,50,0,"DOCUMENTED PROGRESSION",3.44969199178645,104,0,"DEATH",3.44969199178645,104,0,"DEATH",3.44969199178645,104,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,163.2,">150-175",5,55,">50-75",2,1.6,">1.50-1.75",3,4310,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROTOCOL VIOLATION",4,"PROTOCOL VIOLATION","Y","DISEASE PROGRESSION",120,94,94,"Died",2,2,1.28131416837782,"<=3",1,1.28131416837782,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"","","Y","Y","","","Unknown","BODY OF PANCREAS","Unknown","Unknown","50","41-50",5,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.97535934291581,120,0,"DEATH",3.97535934291581,120,0,"DEATH",3.97535934291581,120,0,"DEATH",3.97535934291581,120,0,"DEATH"
"<=50",1,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,163,">150-175",5,71.8,">50-75",2,1.79,">1.75-2.0",4,492000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",113,99,99,"Died",2,2,1.41273100616016,"<=3",1,1.41273100616016,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","Y","","","","Unknown","BODY OF PANCREAS","Unknown","Unknown","30","21-30",3,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",2.0041067761807,60,0,"DOCUMENTED PROGRESSION",3.74537987679671,113,0,"DEATH",3.74537987679671,113,0,"DEATH",3.74537987679671,113,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,173,">150-175",5,80.8,">75-100",3,1.95,">1.75-2.0",4,NA,"",NA,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"WITHDRAWAL BY SUBJECT",5,"WITHDREW CONSENT","Y","DISEASE PROGRESSION",229,218,218,"Died",2,2,1.28131416837782,"<=3",1,1.28131416837782,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","BODY OF PANCREAS","Unknown","Unknown","20","11-20",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",7.5564681724846,229,0,"DEATH",7.5564681724846,229,0,"DEATH",7.5564681724846,229,0,"DEATH",7.5564681724846,229,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,164,">150-175",5,78.3,">75-100",3,1.86,">1.75-2.0",4,95200,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"DEATH",2,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",31,14,NA,"Died",2,1,2.92402464065708,"<=3",1,1.64271047227926,"<=3",1,1.31416837782341,"Y","Y",2,"2",2,"","Y","Y","","","","G2 - Moderately differentiated","BODY OF PANCREAS","Tx","Nx","60","51-60",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.01848049281314,30,0,"DEATH",1.01848049281314,30,0,"DEATH",1.01848049281314,30,0,"DEATH",1.01848049281314,30,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,186,">175",6,85.8,">75-100",3,2.12,">2.0",5,12300,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"ADVERSE EVENT",3,"ADVERSE EVENT","","",NA,290,290,"Alive",1,2,1.37987679671458,"<=3",1,1.1170431211499,"<=3",1,0.295687885010267,"Y","Y",1,"1",1,"Y","","","","","","Unknown","HEAD OF PANCREAS","","Unknown","15","11-20",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.93839835728953,58,1,"CENSORED AT TIME OF LAST ASSESSMENT",9.5605749486653,290,1,"CENSORED AT TIME OF LAST FOLLOW-UP",9.5605749486653,290,1,"CENSORED AT TIME OF LAST FOLLOW-UP",9.5605749486653,290,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"61-70",3,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,175,">150-175",5,72.8,">50-75",2,1.9,">1.75-2.0",4,793,">20xULN-50xULN",6,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",79,64,NA,"Died",2,2,2.43121149897331,"<=3",1,2.43121149897331,"<=3",1,0.0328542094455852,"Y","Y",5,">=5",5,"Y","Y","Y","","","Y","Unknown","BODY OF PANCREAS","Unknown","Unknown","90","81-90",9,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.90554414784394,57,0,"DOCUMENTED PROGRESSION",2.62833675564682,79,0,"DEATH",2.62833675564682,79,0,"DEATH",2.62833675564682,79,0,"DEATH"
"61-70",3,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,156,">150-175",5,61.8,">50-75",2,1.59,">1.50-1.75",3,171000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",95,59,NA,"Died",2,2,1.34702258726899,"<=3",1,1.34702258726899,"<=3",1,0.0328542094455852,"Y","Y",5,">=5",5,"Y","","","","","Y","Unknown","TAIL OF PANCREAS","Unknown","Unknown","10","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.15400410677618,95,0,"DEATH",3.15400410677618,95,0,"DEATH",3.15400410677618,95,0,"DEATH",3.15400410677618,95,0,"DEATH"
"61-70",3,">=65",2,"Australia/South America",4,"South America",3,0,3,0,"0",1,168,">150-175",5,68.5,">50-75",2,1.78,">1.75-2.0",4,NA,"",NA,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",199,177,NA,"Died",2,2,0.887063655030801,"<=3",1,0.887063655030801,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G2 - Moderately differentiated","TAIL OF PANCREAS","T1","Nx","N/A","",NA,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.51950718685832,167,0,"DOCUMENTED PROGRESSION",6.57084188911704,199,0,"DEATH",6.57084188911704,199,0,"DEATH",6.57084188911704,199,0,"DEATH"
"<=50",1,"<65",1,"Australia/South America",4,"US/Western Europe/Australia",1,0,1,0,"0",1,167.6,">150-175",5,107,">100-125",4,2.2,">2.0",5,1520,">20xULN-50xULN",6,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",451,441,441,"Died",2,1,0.394250513347023,"<=3",1,0.394250513347023,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","Unknown","BODY OF PANCREAS","T4","Nx","30","21-30",3,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",11.7618069815195,357,0,"DOCUMENTED PROGRESSION",14.8172484599589,450,0,"DEATH",14.8172484599589,450,0,"DEATH",14.8172484599589,450,0,"DEATH"
"51-60",2,"<65",1,"Australia/South America",4,"US/Western Europe/Australia",1,1,1,1,"1",2,170.5,">150-175",5,55.9,">50-75",2,1.62,">1.50-1.75",3,24700,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",112,94,NA,"Died",2,1,1.74127310061602,"<=3",1,1.74127310061602,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G3 - Poorly differentiated","BODY OF PANCREAS","Unknown","Unknown","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.1211498973306,94,0,"DOCUMENTED PROGRESSION",3.67967145790554,111,0,"DEATH",3.67967145790554,111,0,"DEATH",3.67967145790554,111,0,"DEATH"
"<=50",1,"<65",1,"Australia/South America",4,"US/Western Europe/Australia",1,1,1,1,"1",2,168.5,">150-175",5,137.1,">125-150",5,2.5,">2.0",5,9160,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","Other",247,231,231,"Died",2,2,0.82135523613963,"<=3",1,0.82135523613963,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T4","Nx","80","71-80",8,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.71252566735113,112,0,"DOCUMENTED PROGRESSION",8.14784394250513,247,0,"DEATH",8.14784394250513,247,0,"DEATH",8.14784394250513,247,0,"DEATH"
"<=50",1,"<65",1,"Australia/South America",4,"South America",3,1,3,1,"1",2,162,">150-175",5,55.5,">50-75",2,1.55,">1.50-1.75",3,44.8,">ULN-2xULN",2,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",200,178,202,"Died",2,2,1.67556468172485,"<=3",1,1.54414784394251,"<=3",1,0.164271047227926,"Y","Y",2,"2",2,"Y","","","","","Y","Unknown","HEAD OF PANCREAS","Tx","Nx","95","91-100",10,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.93839835728953,58,0,"DOCUMENTED PROGRESSION",6.60369609856263,200,0,"DEATH",6.60369609856263,200,0,"DEATH",6.60369609856263,200,0,"DEATH"
"61-70",3,"<65",1,"Australia/South America",4,"South America",3,1,3,1,"1",2,156,">150-175",5,53,">50-75",2,1.51,">1.50-1.75",3,125000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"OTHER",8,"INVESTIGATOR DECISION","Y","DISEASE PROGRESSION",73,56,85,"Died",2,2,2.85831622176591,"<=3",1,2.85831622176591,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","Tx","Nx","60","51-60",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",0.985626283367556,29,0,"DOCUMENTED PROGRESSION",2.43121149897331,73,0,"DEATH",2.43121149897331,73,0,"DEATH",2.43121149897331,73,0,"DEATH"
"51-60",2,"<65",1,"Australia/South America",4,"South America",3,1,3,1,"1",2,160,">150-175",5,56,">50-75",2,1.57,">1.50-1.75",3,NA,"",NA,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","Other",106,88,NA,"Died",2,1,1.60985626283368,"<=3",1,1.60985626283368,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","","","Y","Unknown","HEAD OF PANCREAS","T4","N0","50","41-50",5,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",2.13552361396304,64,0,"DOCUMENTED PROGRESSION",3.48254620123203,105,0,"DEATH",3.48254620123203,105,0,"DEATH",3.48254620123203,105,0,"DEATH"
"61-70",3,">=65",2,"Australia/South America",4,"South America",3,1,3,1,"1",2,155,">150-175",5,50,"<=50",1,1.47,">1.25-1.50",2,17800,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","Other",79,64,94,"Died",2,2,6.20944558521561,">6-12",3,1.31416837782341,"<=3",1,4.92813141683778,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","Unknown","Unknown","80","71-80",8,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",2.62833675564682,79,0,"DEATH",2.62833675564682,79,0,"DEATH",2.62833675564682,79,0,"DEATH",2.62833675564682,79,0,"DEATH"
"<=50",1,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,180,">175",6,65.2,">50-75",2,1.83,">1.75-2.0",4,1.4,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","Other",78,70,NA,"Died",2,1,0.82135523613963,"<=3",1,0.75564681724846,"<=3",1,0.0985626283367557,"Y","Y",1,"1",1,"Y","","","","","","G2 - Moderately differentiated","TAIL OF PANCREAS","T4","N1","90","81-90",9,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",2.0041067761807,60,0,"DOCUMENTED PROGRESSION",2.56262833675565,77,0,"DEATH",2.56262833675565,77,0,"DEATH",2.56262833675565,77,0,"DEATH"
"<=50",1,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,164,">150-175",5,50,"<=50",1,1.53,">1.50-1.75",3,1380,">20xULN-50xULN",6,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",370,352,352,"Died",2,1,0.591375770020534,"<=3",1,0.591375770020534,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G3 - Poorly differentiated","TAIL OF PANCREAS","T3","N0","70","61-70",7,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",7.39219712525667,224,0,"DOCUMENTED PROGRESSION",12.1560574948665,369,0,"DEATH",12.1560574948665,369,0,"DEATH",12.1560574948665,369,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,161,">150-175",5,65,">50-75",2,1.68,">1.50-1.75",3,1120,">20xULN-50xULN",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",104,93,93,"Died",2,2,0.394250513347023,"<=3",1,0.394250513347023,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T4","N1","60","51-60",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.90554414784394,57,0,"DOCUMENTED PROGRESSION",3.44969199178645,104,0,"DEATH",3.44969199178645,104,0,"DEATH",3.44969199178645,104,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,182,">175",6,80,">75-100",3,2.01,">2.0",5,28.8,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"DEATH",2,"SUBDURAL HEMATOMA","Y","Other",408,387,NA,"Died",2,2,2.29979466119096,"<=3",1,2.10266940451745,"<=3",1,0.229979466119097,"Y","Y",1,"1",1,"","Y","","","","","G1 - Well differentiated","HEAD OF PANCREAS","T3","N1","30","21-30",3,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",13.4373716632444,408,0,"DEATH",13.4373716632444,408,0,"DEATH",13.4373716632444,408,0,"DEATH",13.4373716632444,408,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,170,">150-175",5,60,">50-75",2,1.69,">1.50-1.75",3,720,">10xULN-20xULN",5,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",96,77,96,"Died",2,2,0.985626283367556,"<=3",1,0.985626283367556,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G3 - Poorly differentiated","TAIL OF PANCREAS","T2","N1","90","81-90",9,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.87268993839836,56,0,"DOCUMENTED PROGRESSION",3.18685831622177,96,0,"DEATH",3.18685831622177,96,0,"DEATH",3.18685831622177,96,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,184,">175",6,92.4,">75-100",3,2.15,">2.0",5,2170,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",185,179,185,"Died",2,2,0.985626283367556,"<=3",1,0.788501026694045,"<=3",1,0.229979466119097,"Y","Y",2,"2",2,"Y","Y","","","","","G3 - Poorly differentiated","BODY OF PANCREAS","T3","N1","40","31-40",4,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",6.11088295687885,185,0,"DEATH",6.11088295687885,185,0,"DEATH",6.11088295687885,185,0,"DEATH",6.11088295687885,185,0,"DEATH"
"<=50",1,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,184,">175",6,72,">50-75",2,1.94,">1.75-2.0",4,3.6,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"WITHDRAWAL BY SUBJECT",5,"WITHDREW CONSENT","Y","Other",185,70,NA,"Died",2,1,2.26694045174538,"<=3",1,2.26694045174538,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T3","N0","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",6.07802874743327,184,0,"DEATH",6.07802874743327,184,0,"DEATH",6.07802874743327,184,0,"DEATH",6.07802874743327,184,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,164,">150-175",5,52,">50-75",2,1.55,">1.50-1.75",3,46200,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",139,121,NA,"Died",2,3,1.57700205338809,"<=3",1,1.64271047227926,"<=3",1,-0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","Unknown","TAIL OF PANCREAS","T3","N0","15","11-20",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.7782340862423,114,0,"DOCUMENTED PROGRESSION",4.63244353182752,140,0,"DEATH",4.63244353182752,140,0,"DEATH",4.63244353182752,140,0,"DEATH"
"51-60",2,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,184,">175",6,76,">75-100",3,1.99,">1.75-2.0",4,455,">10xULN-20xULN",5,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",75,41,NA,"Died",2,3,0.722792607802875,"<=3",1,0.68993839835729,"<=3",1,0.0657084188911704,"Y","Y",2,"2",2,"Y","Y","","","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T3","N1","85","81-90",9,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.18275154004107,35,0,"DOCUMENTED PROGRESSION",2.52977412731006,76,0,"DEATH",2.52977412731006,76,0,"DEATH",2.52977412731006,76,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,180,">175",6,90,">75-100",3,2,">1.75-2.0",4,NA,"",NA,"Gemcitabine",2,"Gemcitabine",2,"OTHER",8,"WORSENING OF GENERAL HEALTH","Y","DISEASE PROGRESSION",154,181,156,"Died",2,2,0.788501026694045,"<=3",1,0.788501026694045,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T3","N1","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.09240246406571,154,0,"DEATH",5.09240246406571,154,0,"DEATH",5.09240246406571,154,0,"DEATH",5.09240246406571,154,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,181,">175",6,67.5,">50-75",2,1.86,">1.75-2.0",4,NA,"",NA,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","Other",327,292,327,"Died",2,2,4.0082135523614,">3-6",2,3.44969199178645,">3-6",2,0.591375770020534,"Y","Y",3,"3",3,"Y","Y","","Y","","","Unknown","HEAD OF PANCREAS","Unknown","N1","70","61-70",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",2.26694045174538,68,0,"DOCUMENTED PROGRESSION",10.776180698152,327,0,"DEATH",10.776180698152,327,0,"DEATH",10.776180698152,327,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,183,">175",6,55,">50-75",2,1.72,">1.50-1.75",3,41600,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"DEATH",2,"PULMONARY EMBOLISM","Y","Other",60,60,NA,"Died",2,2,1.57700205338809,"<=3",1,0.854209445585216,"<=3",1,0.75564681724846,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","BODY OF PANCREAS","Tx","Nx","10","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",2.0041067761807,60,0,"DEATH",2.0041067761807,60,0,"DEATH",2.0041067761807,60,0,"DEATH",2.0041067761807,60,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,170,">150-175",5,72,">50-75",2,1.92,">1.75-2.0",4,6200,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",385,363,405,"Died",2,2,0.985626283367556,"<=3",1,0.985626283367556,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","OTHER","Tx","Nx","20","11-20",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.87268993839836,56,0,"DOCUMENTED PROGRESSION",12.6817248459959,385,0,"DEATH",12.6817248459959,385,0,"DEATH",12.6817248459959,385,0,"DEATH"
"<=50",1,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,164,">150-175",5,72,">50-75",2,1.78,">1.75-2.0",4,1450,">20xULN-50xULN",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,609,609,"Alive",1,4,2.06981519507187,"<=3",1,0.459958932238193,"<=3",1,1.64271047227926,"Y","Y",2,"2",2,"Y","","","Y","","","G3 - Poorly differentiated","TAIL OF PANCREAS","T3","N0","70","61-70",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.7741273100616,53,0,"DOCUMENTED PROGRESSION",20.041067761807,609,1,"CENSORED AT TIME OF LAST FOLLOW-UP",20.041067761807,609,1,"CENSORED AT TIME OF LAST FOLLOW-UP",20.041067761807,609,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"<=50",1,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,162,">150-175",5,69.7,">50-75",2,1.74,">1.50-1.75",3,3010,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"OTHER",8,"INVESTIGATOR DECISION","Y","DISEASE PROGRESSION",216,201,226,"Died",2,12,0.68993839835729,"<=3",1,0.68993839835729,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"","Y","Y","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","Tx","Nx","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",7.45790554414784,226,0,"DEATH",7.45790554414784,226,0,"DEATH",7.45790554414784,226,0,"DEATH",7.45790554414784,226,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,166,">150-175",5,72.8,">50-75",2,1.81,">1.75-2.0",4,26.8,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","DISEASE PROGRESSION",344,323,344,"Died",2,2,35.5482546201232,">24",5,0.75564681724846,"<=3",1,34.8254620123203,"Y","Y",2,"2",2,"","Y","","Y","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T3","N0","30","21-30",3,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",11.3347022587269,344,0,"DEATH",11.3347022587269,344,0,"DEATH",11.3347022587269,344,0,"DEATH",11.3347022587269,344,0,"DEATH"
"51-60",2,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,168,">150-175",5,60,">50-75",2,1.68,">1.50-1.75",3,3150,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"WITHDRAWAL BY SUBJECT",5,"WITHDREW CONSENT","","",NA,330,330,"Alive",1,3,1.7741273100616,"<=3",1,1.37987679671458,"<=3",1,0.427104722792608,"Y","Y",3,"3",3,"Y","Y","","","","Y","G2 - Moderately differentiated","BODY OF PANCREAS","T4","N1","10","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",0.0328542094455852,0,1,"CENSORED AT TIME OF RANDOMIZATION",10.8747433264887,330,1,"CENSORED AT TIME OF LAST FOLLOW-UP",10.8747433264887,330,1,"CENSORED AT TIME OF LAST FOLLOW-UP",10.8747433264887,330,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"51-60",2,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,186,">175",6,95,">75-100",3,2.2,">2.0",5,60000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",50,49,51,"Died",2,3,1.34702258726899,"<=3",1,0.459958932238193,"<=3",1,0.919917864476386,"Y","Y",4,"4",4,"Y","","Y","","","Y","G2 - Moderately differentiated","BODY OF PANCREAS","Unknown","Unknown","30","21-30",3,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",0.722792607802875,21,0,"DOCUMENTED PROGRESSION",1.70841889117043,51,0,"DEATH",1.70841889117043,51,0,"DEATH",1.70841889117043,51,0,"DEATH"
"51-60",2,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,165,">150-175",5,58,">50-75",2,1.64,">1.50-1.75",3,1190,">20xULN-50xULN",6,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,323,323,"Alive",1,3,34.4640657084189,">24",5,0.657084188911704,"<=3",1,33.8398357289528,"Y","Y",1,"1",1,"Y","","","","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T0","N0","15","11-20",2,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.70841889117043,51,0,"DOCUMENTED PROGRESSION",10.6447638603696,323,1,"CENSORED AT TIME OF LAST FOLLOW-UP",10.6447638603696,323,1,"CENSORED AT TIME OF LAST FOLLOW-UP",10.6447638603696,323,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,158,">150-175",5,73,">50-75",2,1.75,">1.50-1.75",3,47600,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",100,100,101,"Died",2,3,0.919917864476386,"<=3",1,0.919917864476386,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","Unknown","HEAD OF PANCREAS","Tx","Nx","10","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.35112936344969,101,0,"DEATH",3.35112936344969,101,0,"DEATH",3.35112936344969,101,0,"DEATH",3.35112936344969,101,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,NA,"",NA,NA,"",NA,NA,"",NA,NA,"",NA,"Gemcitabine Elaidate",1,"",NA,"WITHDRAWAL BY SUBJECT",5,"WITHDREW CONSENT","Y","DISEASE PROGRESSION",NA,62,135,"Died",2,NA,1.90554414784394,"<=3",1,1.90554414784394,"<=3",1,0.0328542094455852,"N","Y",1,"1",1,"","","","","","Y","G2 - Moderately differentiated","BODY OF PANCREAS","Tx","Nx","20","11-20",2,"Gemcitabine Elaidate",1,"",NA,"Progression Free Survival (months)","PFS",2.26694045174538,68,0,"DEATH",2.26694045174538,68,0,"DEATH",2.26694045174538,68,0,"DEATH",2.26694045174538,68,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,174,">150-175",5,80.1,">75-100",3,1.94,">1.75-2.0",4,1800,">20xULN-50xULN",6,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",465,447,447,"Died",2,1,0.558521560574949,"<=3",1,0.558521560574949,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","HEAD OF PANCREAS","T3","N0","50","41-50",5,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",9.00205338809035,273,0,"DOCUMENTED PROGRESSION",15.2772073921971,464,0,"DEATH",15.2772073921971,464,0,"DEATH",15.2772073921971,464,0,"DEATH"
"61-70",3,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,160,">150-175",5,72.5,">50-75",2,1.74,">1.50-1.75",3,9,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",113,71,NA,"Died",2,2,0.75564681724846,"<=3",1,0.75564681724846,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","Unknown","BODY OF PANCREAS","T3","N0","20","11-20",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.74537987679671,113,0,"DEATH",3.74537987679671,113,0,"DEATH",3.74537987679671,113,0,"DEATH",3.74537987679671,113,0,"DEATH"
"<=50",1,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,166,">150-175",5,51.1,">50-75",2,1.54,">1.50-1.75",3,1240,">20xULN-50xULN",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",132,125,125,"Died",2,3,0.82135523613963,"<=3",1,0.82135523613963,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","Y","","","","Unknown","HEAD OF PANCREAS","T4","N1","80","71-80",8,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.70841889117043,51,0,"DOCUMENTED PROGRESSION",4.40246406570842,133,0,"DEATH",4.40246406570842,133,0,"DEATH",4.40246406570842,133,0,"DEATH"
"<=50",1,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,183,">175",6,84.3,">75-100",3,2.06,">2.0",5,0,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,736,736,"Alive",1,4,2.59548254620123,"<=3",1,0.427104722792608,"<=3",1,2.20123203285421,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","HEAD OF PANCREAS","T3","Nx","40","31-40",4,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.71252566735113,112,0,"DOCUMENTED PROGRESSION",24.2135523613963,736,1,"CENSORED AT TIME OF LAST FOLLOW-UP",24.2135523613963,736,1,"CENSORED AT TIME OF LAST FOLLOW-UP",24.2135523613963,736,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"<=50",1,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,158.5,">150-175",5,53,">50-75",2,1.52,">1.50-1.75",3,188000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",101,85,85,"Died",2,2,0.887063655030801,"<=3",1,0.887063655030801,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","Unknown","TAIL OF PANCREAS","T4","N0","20","11-20",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.67556468172485,50,0,"DOCUMENTED PROGRESSION",3.35112936344969,101,0,"DEATH",3.35112936344969,101,0,"DEATH",3.35112936344969,101,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,171,">150-175",5,83,">75-100",3,1.96,">1.75-2.0",4,2070,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",211,199,199,"Died",2,4,0.887063655030801,"<=3",1,0.887063655030801,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","Y","","","G3 - Poorly differentiated","BODY OF PANCREAS","T4","Unknown","100","91-100",10,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.74127310061602,52,0,"DOCUMENTED PROGRESSION",7.03080082135524,213,0,"DEATH",7.03080082135524,213,0,"DEATH",7.03080082135524,213,0,"DEATH"
"61-70",3,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,196,">175",6,103,">100-125",4,2.4,">2.0",5,492000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","Other",148,127,127,"Died",2,3,1.31416837782341,"<=3",1,1.31416837782341,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","","","Y","","","Unknown","TAIL OF PANCREAS","T3","Nx","40","31-40",4,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.67556468172485,50,0,"DOCUMENTED PROGRESSION",4.92813141683778,149,0,"DEATH",4.92813141683778,149,0,"DEATH",4.92813141683778,149,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,186,">175",6,84,">75-100",3,2.08,">2.0",5,87100,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","Other",124,27,NA,"Died",2,3,1.34702258726899,"<=3",1,1.34702258726899,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","BODY OF PANCREAS","T3","Unknown","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",4.13963039014374,125,0,"DEATH",4.13963039014374,125,0,"DEATH",4.13963039014374,125,0,"DEATH",4.13963039014374,125,0,"DEATH"
"51-60",2,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,160,">150-175",5,54,">50-75",2,1.55,">1.50-1.75",3,NA,"",NA,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",163,385,132,"Died",2,3,1.87268993839836,"<=3",1,1.87268993839836,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","","","","","Y","G1 - Well differentiated","TAIL OF PANCREAS","T3","N0","30","21-30",3,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.67556468172485,50,0,"DOCUMENTED PROGRESSION",5.42094455852156,164,0,"DEATH",5.42094455852156,164,0,"DEATH",5.42094455852156,164,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,164,">150-175",5,63,">50-75",2,1.68,">1.50-1.75",3,101000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",125,110,110,"Died",2,3,2.13552361396304,"<=3",1,2.13552361396304,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","HEAD OF PANCREAS","Tx","N1","10","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",2.03696098562628,61,0,"DOCUMENTED PROGRESSION",4.17248459958932,126,0,"DEATH",4.17248459958932,126,0,"DEATH",4.17248459958932,126,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,172,">150-175",5,72,">50-75",2,1.83,">1.75-2.0",4,55.1,">ULN-2xULN",2,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","Other",348,328,328,"Died",2,2,2.06981519507187,"<=3",1,1.05133470225873,"<=3",1,1.05133470225873,"Y","Y",2,"2",2,"","Y","","Y","","","Unknown","HEAD OF PANCREAS","T4","N1","7","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",6.50513347022587,197,0,"DOCUMENTED PROGRESSION",11.4661190965092,348,0,"DEATH",11.4661190965092,348,0,"DEATH",11.4661190965092,348,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,173.5,">150-175",5,87.5,">75-100",3,2,">1.75-2.0",4,1050,">20xULN-50xULN",6,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",164,126,163,"Died",2,1,0.952772073921971,"<=3",1,0.558521560574949,"<=3",1,0.427104722792608,"Y","Y",1,"1",1,"Y","","","","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T3","N0","60","51-60",6,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.64271047227926,49,0,"DOCUMENTED PROGRESSION",5.38809034907598,163,0,"DEATH",5.38809034907598,163,0,"DEATH",5.38809034907598,163,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,148,">125-150",4,39.5,"<=50",1,1.26,">1.25-1.50",2,NA,"",NA,"Gemcitabine",2,"Gemcitabine",2,"WITHDRAWAL BY SUBJECT",5,"WITHDREW CONSENT","Y","DISEASE PROGRESSION",367,356,356,"Died",2,2,1.18275154004107,"<=3",1,0.75564681724846,"<=3",1,0.459958932238193,"Y","Y",3,"3",3,"Y","Y","","Y","","","G3 - Poorly differentiated","HEAD OF PANCREAS","Unknown","Unknown","30","21-30",3,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",12.0903490759754,367,0,"DEATH",12.0903490759754,367,0,"DEATH",12.0903490759754,367,0,"DEATH",12.0903490759754,367,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,147,">125-150",4,40.2,"<=50",1,1.27,">1.25-1.50",2,965000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",174,147,180,"Died",2,4,1.24845995893224,"<=3",1,0.82135523613963,"<=3",1,0.459958932238193,"Y","Y",3,"3",3,"Y","Y","","Y","","","Unknown","BODY OF PANCREAS","T4","N0","40","31-40",4,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.81519507186858,176,0,"DEATH",5.81519507186858,176,0,"DEATH",5.81519507186858,176,0,"DEATH",5.81519507186858,176,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,154.5,">150-175",5,45.5,"<=50",1,1.38,">1.25-1.50",2,819,">20xULN-50xULN",6,"Gemcitabine",2,"Gemcitabine",2,"DEATH",2,"PERITONITIS","Y","Other",10,2,NA,"Died",2,3,2.29979466119096,"<=3",1,0.887063655030801,"<=3",1,1.44558521560575,"Y","Y",3,"3",3,"Y","Y","","Y","","","G3 - Poorly differentiated","OTHER","T3","N1","90","81-90",9,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",0.394250513347023,11,0,"DEATH",0.394250513347023,11,0,"DEATH",0.394250513347023,11,0,"DEATH",0.394250513347023,11,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,151,">150-175",5,51,">50-75",2,1.46,">1.25-1.50",2,NA,"",NA,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",118,115,115,"Died",2,2,0.492813141683778,"<=3",1,0.492813141683778,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","GX - Grade cannot be assessed","BODY OF PANCREAS","Tx","Nx","50","41-50",5,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.70841889117043,51,0,"DOCUMENTED PROGRESSION",3.90965092402464,118,0,"DEATH",3.90965092402464,118,0,"DEATH",3.90965092402464,118,0,"DEATH"
"81-90",5,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,151,">150-175",5,59,">50-75",2,1.53,">1.50-1.75",3,4390,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"WITHDRAWAL BY SUBJECT",5,"WITHDREW CONSENT","","",NA,219,219,"Alive",1,2,0.722792607802875,"<=3",1,0.722792607802875,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","BODY OF PANCREAS","Tx","Nx","80","71-80",8,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",5.58521560574949,169,1,"CENSORED AT TIME OF LAST ASSESSMENT",7.22792607802875,219,1,"CENSORED AT TIME OF LAST FOLLOW-UP",7.22792607802875,219,1,"CENSORED AT TIME OF LAST FOLLOW-UP",7.22792607802875,219,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,162.5,">150-175",5,58.2,">50-75",2,1.6,">1.50-1.75",3,28700,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",21,6,51,"Died",2,7,1.57700205338809,"<=3",1,1.54414784394251,"<=3",1,0.0657084188911704,"Y","Y",1,"1",1,"Y","","","","","","Unknown","BODY OF PANCREAS","Tx","N0","70","61-70",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",0.887063655030801,26,0,"DEATH",0.887063655030801,26,0,"DEATH",0.887063655030801,26,0,"DEATH",0.887063655030801,26,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,175.5,">175",6,57,">50-75",2,1.7,">1.50-1.75",3,3850,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"WITHDRAWAL BY SUBJECT",5,"WITHDREW CONSENT","Y","Other",77,71,71,"Died",2,2,0.82135523613963,"<=3",1,0.82135523613963,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","Unknown","HEAD OF PANCREAS","T4","N0","70","61-70",7,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",2.56262833675565,77,0,"DEATH",2.56262833675565,77,0,"DEATH",2.56262833675565,77,0,"DEATH",2.56262833675565,77,0,"DEATH"
"51-60",2,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,173.4,">150-175",5,64.9,">50-75",2,1.78,">1.75-2.0",4,65200,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","DISEASE PROGRESSION",157,149,149,"Died",2,1,1.18275154004107,"<=3",1,1.18275154004107,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T4","N1","5","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",5.15811088295688,156,0,"DEATH",5.15811088295688,156,0,"DEATH",5.15811088295688,156,0,"DEATH",5.15811088295688,156,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,159.4,">150-175",5,46.3,"<=50",1,1.44,">1.25-1.50",2,13400,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"",NA,"","","",NA,339,NA,"",NA,4,3.58110882956879,">3-6",2,0.722792607802875,"<=3",1,2.8911704312115,"Y","Y",3,"3",3,"Y","Y","Y","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T4","N0","98","91-100",10,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",6.47227926078029,196,1,"CENSORED AT TIME OF LAST ASSESSMENT",11.170431211499,339,1,"CENSORED AT TIME OF LAST VISIT",11.170431211499,339,1,"CENSORED AT TIME OF LAST VISIT",11.170431211499,339,1,"CENSORED AT TIME OF LAST VISIT"
"<=50",1,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,177,">175",6,104,">100-125",4,2.18,">2.0",5,17200,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","Other",218,185,NA,"Died",2,4,1.24845995893224,"<=3",1,1.24845995893224,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","BODY OF PANCREAS","T4","N1","80","71-80",8,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",7.26078028747433,220,0,"DEATH",7.26078028747433,220,0,"DEATH",7.26078028747433,220,0,"DEATH",7.26078028747433,220,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,166,">150-175",5,54.3,">50-75",2,1.61,">1.50-1.75",3,NA,"",NA,"Gemcitabine",2,"Gemcitabine",2,"OTHER",8,"PATIENT WISHED TO CONTINUE TREATMENT AT LOCAL HOSPITAL AS SHE HAD BEEN RANDOMISED TO STANDARD TREATMENT.","Y","DISEASE PROGRESSION",106,77,77,"Died",2,4,0.328542094455852,"<=3",1,0.328542094455852,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","","","Y","","","G3 - Poorly differentiated","BODY OF PANCREAS","T4","Unknown","90","81-90",9,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.58110882956879,108,0,"DEATH",3.58110882956879,108,0,"DEATH",3.58110882956879,108,0,"DEATH",3.58110882956879,108,0,"DEATH"
"51-60",2,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,177.4,">175",6,58.5,">50-75",2,1.71,">1.50-1.75",3,965,">20xULN-50xULN",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",218,195,195,"Died",2,2,1.1170431211499,"<=3",1,0.229979466119097,"<=3",1,0.919917864476386,"Y","Y",3,"3",3,"Y","Y","","Y","","","G4 - Undifferentiated","HEAD OF PANCREAS","T4","N0","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",5.65092402464066,171,0,"DOCUMENTED PROGRESSION",7.19507186858316,218,0,"DEATH",7.19507186858316,218,0,"DEATH",7.19507186858316,218,0,"DEATH"
"61-70",3,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,181,">175",6,75.4,">75-100",3,1.97,">1.75-2.0",4,12100,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","Other",NA,74,74,"Died",2,3,1.57700205338809,"<=3",1,0.427104722792608,"<=3",1,1.18275154004107,"Y","Y",1,"1",1,"Y","","","","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T4","Unknown","70","61-70",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",2.46406570841889,74,0,"DEATH",2.46406570841889,74,0,"DEATH",2.46406570841889,74,0,"DEATH",2.46406570841889,74,0,"DEATH"
"51-60",2,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,174,">150-175",5,61.4,">50-75",2,1.72,">1.50-1.75",3,1.4,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"PROTOCOL VIOLATION",4,"PROTOCOL VIOLATION","","",NA,229,229,"Alive",1,4,29.6016427104723,">24",5,0.164271047227926,"<=3",1,29.4702258726899,"Y","Y",3,"3",3,"Y","Y","Y","","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T4","N1","10","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.48665297741273,166,1,"CENSORED AT TIME OF LAST ASSESSMENT",7.5564681724846,229,1,"CENSORED AT TIME OF LAST FOLLOW-UP",7.5564681724846,229,1,"CENSORED AT TIME OF LAST FOLLOW-UP",7.5564681724846,229,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,180.4,">175",6,78.5,">75-100",3,1.97,">1.75-2.0",4,965000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","Other",27,14,NA,"Died",2,2,0.427104722792608,"<=3",1,0.427104722792608,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","Y","","","","Unknown","BODY OF PANCREAS","T4","N1","45","41-50",5,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",0.919917864476386,27,0,"DEATH",0.919917864476386,27,0,"DEATH",0.919917864476386,27,0,"DEATH",0.919917864476386,27,0,"DEATH"
"71-80",4,">=65",2,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,172.7,">150-175",5,51.3,">50-75",2,1.6,">1.50-1.75",3,109000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","Other",88,85,90,"Died",2,3,0.854209445585216,"<=3",1,0.854209445585216,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G3 - Poorly differentiated","OTHER","T4","N1","30","21-30",3,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",2.95687885010267,89,0,"DEATH",2.95687885010267,89,0,"DEATH",2.95687885010267,89,0,"DEATH",2.95687885010267,89,0,"DEATH"
"61-70",3,">=65",2,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,180.3,">175",6,83.9,">75-100",3,2,">1.75-2.0",4,18300,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","DISEASE PROGRESSION",37,34,38,"Died",2,1,0.788501026694045,"<=3",1,0.788501026694045,"<=3",1,0.0328542094455852,"Y","Y",5,">=5",5,"Y","Y","","Y","Y","Y","Unknown","TAIL OF PANCREAS","T4","N1","70","61-70",7,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.21560574948665,36,0,"DEATH",1.21560574948665,36,0,"DEATH",1.21560574948665,36,0,"DEATH",1.21560574948665,36,0,"DEATH"
"71-80",4,">=65",2,"North America",1,"US/Western Europe/Australia",1,0,1,0,"0",1,157.5,">150-175",5,57.5,">50-75",2,1.58,">1.50-1.75",3,78.8,">2xULN-3xULN",3,"Gemcitabine",2,"Gemcitabine",2,"OTHER",8,"PATIENT DISCHARGE FROM HOSPITAL TO HOSPICE","Y","Other",511,485,511,"Died",2,2,1.34702258726899,"<=3",1,0.68993839835729,"<=3",1,0.68993839835729,"Y","Y",1,"1",1,"","Y","","","","","G1 - Well differentiated","TAIL OF PANCREAS","Unknown","Unknown","40","31-40",4,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",16.8213552361396,511,0,"DEATH",16.8213552361396,511,0,"DEATH",16.8213552361396,511,0,"DEATH",16.8213552361396,511,0,"DEATH"
"51-60",2,"<65",1,"North America",1,"US/Western Europe/Australia",1,0,1,0,"0",1,165.1,">150-175",5,74.4,">50-75",2,1.82,">1.75-2.0",4,35900,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","Other",303,269,269,"Died",2,4,0.394250513347023,"<=3",1,0.394250513347023,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","","","","","Y","Unknown","HEAD OF PANCREAS","Unknown","Unknown","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.64681724845996,110,0,"DOCUMENTED PROGRESSION",10.0533880903491,305,0,"DEATH",10.0533880903491,305,0,"DEATH",10.0533880903491,305,0,"DEATH"
"71-80",4,">=65",2,"North America",1,"US/Western Europe/Australia",1,0,1,0,"0",1,160.5,">150-175",5,84.2,">75-100",3,1.88,">1.75-2.0",4,32600,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"DEATH",2,"METASTATIC PANCREATIC ADENOCARCINOMA","Y","Other",159,154,NA,"Died",2,1,0.75564681724846,"<=3",1,0.75564681724846,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G2 - Moderately differentiated","TAIL OF PANCREAS","Unknown","Unknown","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.22381930184805,158,0,"DEATH",5.22381930184805,158,0,"DEATH",5.22381930184805,158,0,"DEATH",5.22381930184805,158,0,"DEATH"
"61-70",3,"<65",1,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,182.9,">175",6,126.2,">125-150",5,2.4,">2.0",5,263000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",300,269,300,"Died",2,2,0.591375770020534,"<=3",1,0.591375770020534,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","","","Y","","","Unknown","TAIL OF PANCREAS","T3","","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.48254620123203,105,0,"DOCUMENTED PROGRESSION",9.88911704312115,300,0,"DEATH",9.88911704312115,300,0,"DEATH",9.88911704312115,300,0,"DEATH"
"51-60",2,"<65",1,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,167.6,">150-175",5,89.8,">75-100",3,1.99,">1.75-2.0",4,1630,">20xULN-50xULN",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",268,255,270,"Died",2,4,0.591375770020534,"<=3",1,0.591375770020534,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","HEAD OF PANCREAS","T4","N1","20","11-20",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",5.5523613963039,168,0,"DOCUMENTED PROGRESSION",8.90349075975359,270,0,"DEATH",8.90349075975359,270,0,"DEATH",8.90349075975359,270,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,170,">150-175",5,83,">75-100",3,1.98,">1.75-2.0",4,23800,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",122,109,124,"Died",2,1,1.97125256673511,"<=3",1,1.97125256673511,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","BODY OF PANCREAS","T3","Nx","10","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.60985626283368,48,0,"DOCUMENTED PROGRESSION",4.0082135523614,121,0,"DEATH",4.0082135523614,121,0,"DEATH",4.0082135523614,121,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,156,">150-175",5,53,">50-75",2,1.52,">1.50-1.75",3,71.2,">ULN-2xULN",2,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",75,64,83,"Died",2,3,3.05544147843943,">3-6",2,1.60985626283368,"<=3",1,1.47843942505133,"Y","Y",1,"1",1,"Y","","","","","","Unknown","HEAD OF PANCREAS","T3","Nx","90","81-90",9,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.83983572895277,55,0,"DOCUMENTED PROGRESSION",2.52977412731006,76,0,"DEATH",2.52977412731006,76,0,"DEATH",2.52977412731006,76,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,168,">150-175",5,73,">50-75",2,1.85,">1.75-2.0",4,NA,"",NA,"Gemcitabine",2,"Gemcitabine",2,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","Other",276,249,283,"Died",2,3,2.0041067761807,"<=3",1,1.28131416837782,"<=3",1,0.75564681724846,"Y","Y",3,"3",3,"Y","Y","","Y","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T3","Nx","10","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",9.13347022587269,277,0,"DEATH",9.13347022587269,277,0,"DEATH",9.13347022587269,277,0,"DEATH",9.13347022587269,277,0,"DEATH"
"61-70",3,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,170,">150-175",5,60,">50-75",2,1.68,">1.50-1.75",3,10900,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",95,67,98,"Died",2,4,0.558521560574949,"<=3",1,0.558521560574949,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","G3 - Poorly differentiated","BODY OF PANCREAS","T4","Nx","90","81-90",9,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.97125256673511,59,0,"DOCUMENTED PROGRESSION",3.21971252566735,97,0,"DEATH",3.21971252566735,97,0,"DEATH",3.21971252566735,97,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,160,">150-175",5,63,">50-75",2,1.67,">1.50-1.75",3,3370,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","Other",208,201,211,"Died",2,1,16.2299794661191,">12-24",4,0.295687885010267,"<=3",1,15.9671457905544,"Y","Y",1,"1",1,"Y","","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T3","N0","70","61-70",7,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.3223819301848,161,0,"DOCUMENTED PROGRESSION",6.83367556468172,207,0,"DEATH",6.83367556468172,207,0,"DEATH",6.83367556468172,207,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,182,">175",6,79,">75-100",3,1.99,">1.75-2.0",4,214000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",88,84,98,"Died",2,1,1.18275154004107,"<=3",1,1.18275154004107,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","","","Y","G2 - Moderately differentiated","HEAD OF PANCREAS","Tx","Nx","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",2.75975359342916,83,0,"DOCUMENTED PROGRESSION",2.8911704312115,87,0,"DEATH",2.8911704312115,87,0,"DEATH",2.8911704312115,87,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,147,">125-150",4,47.5,"<=50",1,1.39,">1.25-1.50",2,4140,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",100,83,83,"Died",2,2,1.7741273100616,"<=3",1,0.82135523613963,"<=3",1,0.985626283367556,"Y","Y",1,"1",1,"Y","","","","","","G3 - Poorly differentiated","BODY OF PANCREAS","T4","Nx","5","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.67556468172485,50,0,"DOCUMENTED PROGRESSION",3.31827515400411,100,0,"DEATH",3.31827515400411,100,0,"DEATH",3.31827515400411,100,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,176,">175",6,70,">50-75",2,1.85,">1.75-2.0",4,148,">3xULN-10xULN",4,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",170,154,186,"Died",2,2,0.722792607802875,"<=3",1,0.459958932238193,"<=3",1,0.295687885010267,"Y","Y",1,"1",1,"Y","","","","","","G2 - Moderately differentiated","BODY OF PANCREAS","T4","N0","30","21-30",3,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.67556468172485,50,0,"DOCUMENTED PROGRESSION",5.61806981519507,170,0,"DEATH",5.61806981519507,170,0,"DEATH",5.61806981519507,170,0,"DEATH"
"71-80",4,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,167,">150-175",5,71,">50-75",2,1.81,">1.75-2.0",4,1480,">20xULN-50xULN",6,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,240,240,"Alive",1,1,1.05133470225873,"<=3",1,1.05133470225873,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","Y","","","G3 - Poorly differentiated","BODY OF PANCREAS","T4","N1","35","31-40",4,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.35523613963039,162,0,"DOCUMENTED PROGRESSION",7.91786447638604,240,1,"CENSORED AT TIME OF LAST FOLLOW-UP",7.91786447638604,240,1,"CENSORED AT TIME OF LAST FOLLOW-UP",7.91786447638604,240,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,165,">150-175",5,51.7,">50-75",2,1.54,">1.50-1.75",3,777,">20xULN-50xULN",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",133,128,162,"Died",2,2,6.47227926078029,">6-12",3,1.41273100616016,"<=3",1,5.09240246406571,"Y","Y",1,"1",1,"","","Y","","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T3","N0","35","31-40",4,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",4.40246406570842,133,0,"DEATH",4.40246406570842,133,0,"DEATH",4.40246406570842,133,0,"DEATH",4.40246406570842,133,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,170,">150-175",5,75,">50-75",2,1.88,">1.75-2.0",4,450,">10xULN-20xULN",5,"Gemcitabine",2,"Gemcitabine",2,"",NA,"","","",NA,205,NA,"",NA,2,1.14989733059548,"<=3",1,0.262833675564682,"<=3",1,0.919917864476386,"Y","Y",1,"1",1,"Y","","","","","","G1 - Well differentiated","OTHER","T3","Nx","100","91-100",10,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.38809034907598,163,1,"CENSORED AT TIME OF LAST ASSESSMENT",6.76796714579055,205,1,"CENSORED AT TIME OF LAST VISIT",6.76796714579055,205,1,"CENSORED AT TIME OF LAST VISIT",6.76796714579055,205,1,"CENSORED AT TIME OF LAST VISIT"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,180,">175",6,62,">50-75",2,1.76,">1.75-2.0",4,1670,">20xULN-50xULN",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",125,111,139,"Died",2,1,1.93839835728953,"<=3",1,1.93839835728953,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","HEAD OF PANCREAS","T4","N1","98","91-100",10,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.83983572895277,55,0,"DOCUMENTED PROGRESSION",4.10677618069815,124,0,"DEATH",4.10677618069815,124,0,"DEATH",4.10677618069815,124,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,174,">150-175",5,52,">50-75",2,1.59,">1.50-1.75",3,29100,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",190,174,174,"Died",2,1,0.854209445585216,"<=3",1,0.854209445585216,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","Unknown","OTHER","T3","Nx","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",2.79260780287474,84,0,"DOCUMENTED PROGRESSION",6.24229979466119,189,0,"DEATH",6.24229979466119,189,0,"DEATH",6.24229979466119,189,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,153,">150-175",5,57,">50-75",2,1.56,">1.50-1.75",3,1200,">20xULN-50xULN",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",277,265,283,"Died",2,4,1.18275154004107,"<=3",1,1.18275154004107,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"","","Y","","","Y","G1 - Well differentiated","BODY OF PANCREAS","T4","Nx","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",5.68377823408624,172,0,"DOCUMENTED PROGRESSION",9.19917864476386,279,0,"DEATH",9.19917864476386,279,0,"DEATH",9.19917864476386,279,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,170,">150-175",5,90,">75-100",3,2.06,">2.0",5,272000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",379,366,393,"Died",2,1,1.05133470225873,"<=3",1,1.05133470225873,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","Y","","","G4 - Undifferentiated","TAIL OF PANCREAS","T4","Nx","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",8.04928131416838,244,0,"DOCUMENTED PROGRESSION",12.4517453798768,378,0,"DEATH",12.4517453798768,378,0,"DEATH",12.4517453798768,378,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,177,">175",6,75,">50-75",2,1.92,">1.75-2.0",4,243,">3xULN-10xULN",4,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",294,267,297,"Died",2,1,2.92402464065708,"<=3",1,2.92402464065708,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","G3 - Poorly differentiated","OTHER","T4","Nx","5","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",5.5523613963039,168,0,"DOCUMENTED PROGRESSION",9.65913757700205,293,0,"DEATH",9.65913757700205,293,0,"DEATH",9.65913757700205,293,0,"DEATH"
"71-80",4,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,176,">175",6,75,">50-75",2,1.91,">1.75-2.0",4,NA,"",NA,"Gemcitabine",2,"Gemcitabine",2,"DEATH",2,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",50,41,NA,"Died",2,1,1.34702258726899,"<=3",1,0.887063655030801,"<=3",1,0.492813141683778,"Y","Y",2,"2",2,"Y","","Y","","","","G3 - Poorly differentiated","OTHER","T4","Nx","30","21-30",3,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.64271047227926,49,0,"DEATH",1.64271047227926,49,0,"DEATH",1.64271047227926,49,0,"DEATH",1.64271047227926,49,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,170,">150-175",5,79,">75-100",3,1.93,">1.75-2.0",4,1.4,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"DEATH",2,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",16,13,NA,"Died",2,1,1.47843942505133,"<=3",1,1.47843942505133,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","Y","","","","G3 - Poorly differentiated","BODY OF PANCREAS","T4","Nx","50","41-50",5,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",0.525667351129363,15,0,"DEATH",0.525667351129363,15,0,"DEATH",0.525667351129363,15,0,"DEATH",0.525667351129363,15,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,173,">150-175",5,82,">75-100",3,1.98,">1.75-2.0",4,197000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROTOCOL VIOLATION",4,"PROTOCOL VIOLATION","Y","DISEASE PROGRESSION",62,22,NA,"Died",2,1,2.56262833675565,"<=3",1,2.56262833675565,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","GX - Grade cannot be assessed","BODY OF PANCREAS","T3","Nx","10","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",2.03696098562628,61,0,"DEATH",2.03696098562628,61,0,"DEATH",2.03696098562628,61,0,"DEATH",2.03696098562628,61,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,178,">175",6,79,">75-100",3,1.98,">1.75-2.0",4,66.4,">ULN-2xULN",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"DEATH",2,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",24,11,NA,"Died",2,4,2.92402464065708,"<=3",1,2.92402464065708,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","Y","","","G3 - Poorly differentiated","OTHER","T4","Nx","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",0.887063655030801,26,0,"DEATH",0.887063655030801,26,0,"DEATH",0.887063655030801,26,0,"DEATH",0.887063655030801,26,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,176,">175",6,62,">50-75",2,1.74,">1.50-1.75",3,7.2,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"ADVERSE EVENT",3,"ADVERSE EVENT","","",NA,553,553,"Alive",1,4,7.39219712525667,">6-12",3,7.03080082135524,">6-12",3,0.394250513347023,"Y","Y",1,"1",1,"Y","","","","","","G3 - Poorly differentiated","TAIL OF PANCREAS","T4","N0","1","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",7.49075975359343,227,1,"CENSORED AT TIME OF LAST ASSESSMENT",18.2012320328542,553,1,"CENSORED AT TIME OF LAST FOLLOW-UP",18.2012320328542,553,1,"CENSORED AT TIME OF LAST FOLLOW-UP",18.2012320328542,553,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,168,">150-175",5,75,">50-75",2,1.87,">1.75-2.0",4,500,">10xULN-20xULN",5,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"DEATH",2,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",90,84,NA,"Died",2,1,3.48254620123203,">3-6",2,1.47843942505133,"<=3",1,2.03696098562628,"Y","Y",2,"2",2,"Y","","","Y","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T3","Nx","15","11-20",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",2.95687885010267,89,0,"DEATH",2.95687885010267,89,0,"DEATH",2.95687885010267,89,0,"DEATH",2.95687885010267,89,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,161,">150-175",5,95,">75-100",3,2.06,">2.0",5,1.4,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",461,453,484,"Died",2,2,0.952772073921971,"<=3",1,0.887063655030801,"<=3",1,0.0985626283367557,"Y","Y",2,"2",2,"Y","Y","","","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T4","Nx","50","41-50",5,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",11.1047227926078,337,0,"DOCUMENTED PROGRESSION",15.1786447638604,461,0,"DEATH",15.1786447638604,461,0,"DEATH",15.1786447638604,461,0,"DEATH"
"61-70",3,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,163,">150-175",5,60,">50-75",2,1.65,">1.50-1.75",3,43.8,">ULN-2xULN",2,"Gemcitabine",2,"Gemcitabine",2,"DEATH",2,"PULMONARY ARTERY THROMBOEMBOLISM","Y","Other",19,15,NA,"Died",2,2,0.887063655030801,"<=3",1,0.657084188911704,"<=3",1,0.262833675564682,"Y","Y",4,"4",4,"Y","Y","Y","","","Y","G2 - Moderately differentiated","BODY OF PANCREAS","T4","Nx","5","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",0.657084188911704,19,0,"DEATH",0.657084188911704,19,0,"DEATH",0.657084188911704,19,0,"DEATH",0.657084188911704,19,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,175,">150-175",5,71,">50-75",2,1.86,">1.75-2.0",4,686,">10xULN-20xULN",5,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",127,114,NA,"Died",2,1,0.722792607802875,"<=3",1,0.722792607802875,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","","","Y","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T3","Nx","30","21-30",3,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.5482546201232,107,0,"DOCUMENTED PROGRESSION",4.17248459958932,126,0,"DEATH",4.17248459958932,126,0,"DEATH",4.17248459958932,126,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,170,">150-175",5,72,">50-75",2,1.84,">1.75-2.0",4,5490,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",197,169,NA,"Died",2,2,0.68993839835729,"<=3",1,0.68993839835729,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","Unknown","OTHER","T4","Nx","5","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.58521560574949,169,0,"DOCUMENTED PROGRESSION",6.50513347022587,197,0,"DEATH",6.50513347022587,197,0,"DEATH",6.50513347022587,197,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,183,">175",6,97,">75-100",3,2.24,">2.0",5,NA,"",NA,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",101,98,NA,"Died",2,1,1.1170431211499,"<=3",1,1.1170431211499,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","","","Y","G3 - Poorly differentiated","HEAD OF PANCREAS","T3","Nx","5","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.31827515400411,100,0,"DEATH",3.31827515400411,100,0,"DEATH",3.31827515400411,100,0,"DEATH",3.31827515400411,100,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,168,">150-175",5,56,">50-75",2,1.62,">1.50-1.75",3,19000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",260,226,264,"Died",2,2,1.80698151950719,"<=3",1,1.80698151950719,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","","","Y","G2 - Moderately differentiated","OTHER","T4","N1","20","11-20",2,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.58521560574949,169,0,"DOCUMENTED PROGRESSION",8.57494866529774,260,0,"DEATH",8.57494866529774,260,0,"DEATH",8.57494866529774,260,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,164,">150-175",5,77,">75-100",3,1.87,">1.75-2.0",4,1710,">20xULN-50xULN",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,423,423,"Alive",1,2,0.427104722792608,"<=3",1,0.427104722792608,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"","Y","","","","","Unknown","HEAD OF PANCREAS","T4","N1","10","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",7.39219712525667,224,0,"DOCUMENTED PROGRESSION",13.9301848049281,423,1,"CENSORED AT TIME OF LAST FOLLOW-UP",13.9301848049281,423,1,"CENSORED AT TIME OF LAST FOLLOW-UP",13.9301848049281,423,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,161,">150-175",5,44.1,"<=50",1,1.4,">1.25-1.50",2,29.5,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,257,257,"Lost to Follow-up",3,2,1.44558521560575,"<=3",1,1.44558521560575,"<=3",1,0.0328542094455852,"Y","Y",4,"4",4,"Y","Y","Y","Y","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T4","N1","10","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.5523613963039,168,0,"DOCUMENTED PROGRESSION",8.47638603696099,257,1,"CENSORED AT TIME OF LAST FOLLOW-UP",8.47638603696099,257,1,"CENSORED AT TIME OF LAST FOLLOW-UP",8.47638603696099,257,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"61-70",3,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,152,">150-175",5,69.7,">50-75",2,1.72,">1.50-1.75",3,2420,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,313,313,"Alive",1,1,0.722792607802875,"<=3",1,0.722792607802875,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"","","Y","","","Y","G2 - Moderately differentiated","BODY OF PANCREAS","T3","Unknown","10","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.67967145790554,111,0,"DOCUMENTED PROGRESSION",10.3162217659138,313,1,"CENSORED AT TIME OF LAST FOLLOW-UP",10.3162217659138,313,1,"CENSORED AT TIME OF LAST FOLLOW-UP",10.3162217659138,313,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,158,">150-175",5,52,">50-75",2,1.51,">1.50-1.75",3,37600,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"DEATH",2,"CAUSE UNKNOWN","Y","Other",9,0,NA,"Died",2,1,1.7741273100616,"<=3",1,1.05133470225873,"<=3",1,0.75564681724846,"Y","Y",2,"2",2,"Y","","","","","Y","G3 - Poorly differentiated","OTHER","T2","Nx","50","41-50",5,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",0.295687885010267,8,0,"DEATH",0.295687885010267,8,0,"DEATH",0.295687885010267,8,0,"DEATH",0.295687885010267,8,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,154,">150-175",5,66,">50-75",2,1.68,">1.50-1.75",3,NA,"",NA,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,283,283,"Alive",1,1,0.887063655030801,"<=3",1,0.854209445585216,"<=3",1,0.0657084188911704,"Y","Y",3,"3",3,"Y","Y","","Y","","","G3 - Poorly differentiated","BODY OF PANCREAS","T4","N1","50","41-50",5,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",7.49075975359343,227,0,"DOCUMENTED PROGRESSION",9.3305954825462,283,1,"CENSORED AT TIME OF LAST FOLLOW-UP",9.3305954825462,283,1,"CENSORED AT TIME OF LAST FOLLOW-UP",9.3305954825462,283,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,158,">150-175",5,55,">50-75",2,1.55,">1.50-1.75",3,23600,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"DEATH",2,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",26,22,NA,"Died",2,1,1.14989733059548,"<=3",1,1.14989733059548,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"","Y","","","","Y","G3 - Poorly differentiated","HEAD OF PANCREAS","T4","N1","80","71-80",8,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",0.854209445585216,25,0,"DEATH",0.854209445585216,25,0,"DEATH",0.854209445585216,25,0,"DEATH",0.854209445585216,25,0,"DEATH"
"61-70",3,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,146,">125-150",4,51,">50-75",2,1.44,">1.25-1.50",2,2710,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",117,104,133,"Died",2,4,1.47843942505133,"<=3",1,1.01848049281314,"<=3",1,0.492813141683778,"Y","Y",2,"2",2,"","Y","Y","","","","GX - Grade cannot be assessed","BODY OF PANCREAS","T3","N1","90","81-90",9,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.83983572895277,55,0,"DOCUMENTED PROGRESSION",3.94250513347023,119,0,"DEATH",3.94250513347023,119,0,"DEATH",3.94250513347023,119,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,162,">150-175",5,58,">50-75",2,1.62,">1.50-1.75",3,1930,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",427,401,448,"Died",2,4,1.31416837782341,"<=3",1,0.854209445585216,"<=3",1,0.492813141683778,"Y","Y",3,"3",3,"Y","Y","","","","Y","GX - Grade cannot be assessed","BODY OF PANCREAS","T4","N1","80","71-80",8,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.51950718685832,167,0,"DOCUMENTED PROGRESSION",14.1273100616016,429,0,"DEATH",14.1273100616016,429,0,"DEATH",14.1273100616016,429,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,183,">175",6,94,">75-100",3,2.19,">2.0",5,1130,">20xULN-50xULN",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",212,198,225,"Died",2,2,1.37987679671458,"<=3",1,0.985626283367556,"<=3",1,0.427104722792608,"Y","Y",2,"2",2,"Y","Y","","","","","G4 - Undifferentiated","HEAD OF PANCREAS","T1","Nx","60","51-60",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",6.53798767967146,198,0,"DOCUMENTED PROGRESSION",6.99794661190965,212,0,"DEATH",6.99794661190965,212,0,"DEATH",6.99794661190965,212,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,178,">175",6,67,">50-75",2,1.82,">1.75-2.0",4,1390,">20xULN-50xULN",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",189,169,197,"Died",2,2,2.36550308008214,"<=3",1,1.34702258726899,"<=3",1,1.05133470225873,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T4","Nx","70","61-70",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.71252566735113,112,0,"DOCUMENTED PROGRESSION",6.24229979466119,189,0,"DEATH",6.24229979466119,189,0,"DEATH",6.24229979466119,189,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,158,">150-175",5,62,">50-75",2,1.65,">1.50-1.75",3,99.3,">2xULN-3xULN",3,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",169,155,183,"Died",2,2,0.624229979466119,"<=3",1,0.624229979466119,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","","","Y","","","GX - Grade cannot be assessed","HEAD OF PANCREAS","T1","Nx","70","61-70",7,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",0.788501026694045,23,0,"DOCUMENTED PROGRESSION",5.58521560574949,169,0,"DEATH",5.58521560574949,169,0,"DEATH",5.58521560574949,169,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,179,">175",6,80,">75-100",3,1.99,">1.75-2.0",4,17,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",111,84,112,"Died",2,1,2.13552361396304,"<=3",1,0.657084188911704,"<=3",1,1.51129363449692,"Y","Y",2,"2",2,"","Y","Y","","","","G3 - Poorly differentiated","BODY OF PANCREAS","T4","Nx","80","71-80",8,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.83983572895277,55,0,"DOCUMENTED PROGRESSION",3.64681724845996,110,0,"DEATH",3.64681724845996,110,0,"DEATH",3.64681724845996,110,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,161,">150-175",5,48,"<=50",1,1.47,">1.25-1.50",2,17600,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"DEATH",2,"GASTROINTESTINAL HEMORRAGE","Y","Other",35,32,NA,"Died",2,5,4.04106776180698,">3-6",2,1.7741273100616,"<=3",1,2.29979466119096,"Y","Y",2,"2",2,"Y","","","","","Y","GX - Grade cannot be assessed","HEAD OF PANCREAS","T3","Nx","60","51-60",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.28131416837782,38,0,"DEATH",1.28131416837782,38,0,"DEATH",1.28131416837782,38,0,"DEATH",1.28131416837782,38,0,"DEATH"
"61-70",3,">=65",2,"Eastern Europe",3,"Eastern Europe",2,0,2,0,"0",1,160,">150-175",5,55,">50-75",2,1.56,">1.50-1.75",3,35.6,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",122,85,128,"Died",2,1,3.64681724845996,">3-6",2,3.64681724845996,">3-6",2,0.0328542094455852,"Y","Y",3,"3",3,"Y","","Y","Y","","","Unknown","OTHER","T3","Nx","95","91-100",10,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",2.82546201232033,85,0,"DOCUMENTED PROGRESSION",4.0082135523614,121,0,"DEATH",4.0082135523614,121,0,"DEATH",4.0082135523614,121,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,168,">150-175",5,80,">75-100",3,1.9,">1.75-2.0",4,3980,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROTOCOL VIOLATION",4,"PROTOCOL VIOLATION","Y","DISEASE PROGRESSION",90,79,120,"Died",2,1,1.34702258726899,"<=3",1,1.34702258726899,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","HEAD OF PANCREAS","Tx","Nx","5","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",2.95687885010267,89,0,"DEATH",2.95687885010267,89,0,"DEATH",2.95687885010267,89,0,"DEATH",2.95687885010267,89,0,"DEATH"
"61-70",3,">=65",2,"Eastern Europe",3,"Eastern Europe",2,0,2,0,"0",1,170,">150-175",5,112,">100-125",4,2,">1.75-2.0",4,3860,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",275,267,295,"Died",2,2,1.51129363449692,"<=3",1,0.722792607802875,"<=3",1,0.82135523613963,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","HEAD OF PANCREAS","T2","N0","10","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.5523613963039,168,0,"DOCUMENTED PROGRESSION",9.06776180698152,275,0,"DEATH",9.06776180698152,275,0,"DEATH",9.06776180698152,275,0,"DEATH"
"71-80",4,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,160,">150-175",5,70,">50-75",2,1.76,">1.75-2.0",4,636,">10xULN-20xULN",5,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",194,185,185,"Died",2,3,2.52977412731006,"<=3",1,0.525667351129363,"<=3",1,2.03696098562628,"Y","Y",2,"2",2,"Y","","","Y","","","Unknown","BODY OF PANCREAS","Tx","Nx","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",5.61806981519507,170,0,"DOCUMENTED PROGRESSION",6.4394250513347,195,0,"DEATH",6.4394250513347,195,0,"DEATH",6.4394250513347,195,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,175,">150-175",5,59,">50-75",2,1.7,">1.50-1.75",3,47,">ULN-2xULN",2,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",80,56,92,"Died",2,2,3.1211498973306,">3-6",2,1.21560574948665,"<=3",1,1.93839835728953,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","HEAD OF PANCREAS","T4","Nx","100","91-100",10,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",2.6611909650924,80,0,"DEATH",2.6611909650924,80,0,"DEATH",2.6611909650924,80,0,"DEATH",2.6611909650924,80,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,172,">150-175",5,60,">50-75",2,1.7,">1.50-1.75",3,3,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",27,14,39,"Died",2,1,1.37987679671458,"<=3",1,1.37987679671458,"<=3",1,0.0328542094455852,"Y","Y",4,"4",4,"Y","Y","Y","","","Y","Unknown","BODY OF PANCREAS","T3","Nx","30","21-30",3,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",0.887063655030801,26,0,"DEATH",0.887063655030801,26,0,"DEATH",0.887063655030801,26,0,"DEATH",0.887063655030801,26,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,178,">175",6,58,">50-75",2,1.7,">1.50-1.75",3,43200,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",338,320,320,"Died",2,1,1.93839835728953,"<=3",1,0.722792607802875,"<=3",1,1.24845995893224,"Y","Y",3,"3",3,"Y","","Y","Y","","","Unknown","TAIL OF PANCREAS","T3","N0","40","31-40",4,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",9.13347022587269,277,0,"DOCUMENTED PROGRESSION",11.1047227926078,337,0,"DEATH",11.1047227926078,337,0,"DEATH",11.1047227926078,337,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,181,">175",6,80,">75-100",3,2,">1.75-2.0",4,NA,"",NA,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",201,193,202,"Died",2,1,0.82135523613963,"<=3",1,0.82135523613963,"<=3",1,0.0328542094455852,"Y","Y",4,"4",4,"Y","Y","Y","","","Y","Unknown","BODY OF PANCREAS","T3","Unknown","10","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",6.60369609856263,200,0,"DEATH",6.60369609856263,200,0,"DEATH",6.60369609856263,200,0,"DEATH",6.60369609856263,200,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,168,">150-175",5,72,">50-75",2,1.8,">1.75-2.0",4,1.4,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",383,370,402,"Died",2,1,2.8911704312115,"<=3",1,1.21560574948665,"<=3",1,1.70841889117043,"Y","Y",4,"4",4,"Y","Y","Y","Y","","","Unknown","HEAD OF PANCREAS","T3","N1","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.61396303901437,109,0,"DOCUMENTED PROGRESSION",12.5831622176591,382,0,"DEATH",12.5831622176591,382,0,"DEATH",12.5831622176591,382,0,"DEATH"
"71-80",4,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,160,">150-175",5,94,">75-100",3,2,">1.75-2.0",4,1950,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",57,33,60,"Died",2,1,0.722792607802875,"<=3",1,0.985626283367556,"<=3",1,-0.229979466119097,"Y","Y",3,"3",3,"Y","Y","","Y","","","Unknown","HEAD OF PANCREAS","T4","N1","90","81-90",9,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.05133470225873,31,0,"DOCUMENTED PROGRESSION",1.87268993839836,56,0,"DEATH",1.87268993839836,56,0,"DEATH",1.87268993839836,56,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,176,">175",6,70,">50-75",2,1.85,">1.75-2.0",4,9350,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",143,140,170,"Died",2,1,0.919917864476386,"<=3",1,0.657084188911704,"<=3",1,0.295687885010267,"Y","Y",2,"2",2,"Y","","","Y","","","Unknown","BODY OF PANCREAS","T3","Nx","30","21-30",3,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.74127310061602,52,0,"DOCUMENTED PROGRESSION",4.69815195071869,142,0,"DEATH",4.69815195071869,142,0,"DEATH",4.69815195071869,142,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,161,">150-175",5,92,">75-100",3,2,">1.75-2.0",4,13.9,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",258,234,262,"Died",2,1,0.558521560574949,"<=3",1,1.57700205338809,"<=3",1,-0.985626283367556,"Y","Y",1,"1",1,"Y","","","","","","Unknown","OTHER","T3","Nx","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.42094455852156,164,0,"DOCUMENTED PROGRESSION",8.47638603696099,257,0,"DEATH",8.47638603696099,257,0,"DEATH",8.47638603696099,257,0,"DEATH"
"71-80",4,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,170,">150-175",5,71,">50-75",2,1.82,">1.75-2.0",4,38900,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",201,177,227,"Died",2,1,0.624229979466119,"<=3",1,0.624229979466119,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","Y","","","Unknown","BODY OF PANCREAS","T4","N1","80","71-80",8,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",4.04106776180698,122,0,"DOCUMENTED PROGRESSION",6.60369609856263,200,0,"DEATH",6.60369609856263,200,0,"DEATH",6.60369609856263,200,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,175,">150-175",5,114,">100-125",4,2.35,">2.0",5,556000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"OTHER",8,"BAD GENERAL CONDITION.","Y","DISEASE PROGRESSION",191,162,194,"Died",2,1,1.34702258726899,"<=3",1,0.558521560574949,"<=3",1,0.82135523613963,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","TAIL OF PANCREAS","T3","N1","5","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",6.27515400410678,190,0,"DEATH",6.27515400410678,190,0,"DEATH",6.27515400410678,190,0,"DEATH",6.27515400410678,190,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,178,">175",6,62,">50-75",2,1.77,">1.75-2.0",4,240000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",275,212,212,"Died",2,1,1.90554414784394,"<=3",1,1.90554414784394,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","Unknown","TAIL OF PANCREAS","T3","Nx","95","91-100",10,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.67556468172485,50,0,"DOCUMENTED PROGRESSION",9.03490759753593,274,0,"DEATH",9.03490759753593,274,0,"DEATH",9.03490759753593,274,0,"DEATH"
"71-80",4,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,176,">175",6,78,">75-100",3,1.94,">1.75-2.0",4,873,">20xULN-50xULN",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",111,78,122,"Died",2,2,2.29979466119096,"<=3",1,1.08418891170431,"<=3",1,1.24845995893224,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","TAIL OF PANCREAS","T3","N1","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.74127310061602,52,0,"DOCUMENTED PROGRESSION",3.67967145790554,111,0,"DEATH",3.67967145790554,111,0,"DEATH",3.67967145790554,111,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,170,">150-175",5,59,">50-75",2,1.68,">1.50-1.75",3,11700,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",137,70,291,"Died",2,1,3.84394250513347,">3-6",2,3.15400410677618,">3-6",2,0.722792607802875,"Y","Y",2,"2",2,"Y","","","Y","","","Unknown","HEAD OF PANCREAS","T4","N1","95","91-100",10,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",4.50102669404517,136,0,"DEATH",4.50102669404517,136,0,"DEATH",4.50102669404517,136,0,"DEATH",4.50102669404517,136,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,0,2,0,"0",1,168,">150-175",5,115,">100-125",4,2.3,">2.0",5,2860,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",121,91,91,"Died",2,2,0.68993839835729,"<=3",1,0.492813141683778,"<=3",1,0.229979466119097,"Y","Y",1,"1",1,"Y","","","","","","Unknown","BODY OF PANCREAS","T2","Nx","100","91-100",10,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.67556468172485,50,0,"DOCUMENTED PROGRESSION",4.0082135523614,121,0,"DEATH",4.0082135523614,121,0,"DEATH",4.0082135523614,121,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,183,">175",6,85,">75-100",3,2.07,">2.0",5,186,">3xULN-10xULN",4,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"",NA,"","","",NA,295,NA,"",NA,2,2.39835728952772,"<=3",1,1.05133470225873,"<=3",1,1.37987679671458,"Y","Y",1,"1",1,"Y","","","","","","Unknown","BODY OF PANCREAS","T3","N0","70","61-70",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",9.16632443531828,278,1,"CENSORED AT TIME OF LAST ASSESSMENT",9.72484599589322,295,1,"CENSORED AT TIME OF LAST VISIT",9.72484599589322,295,1,"CENSORED AT TIME OF LAST VISIT",9.72484599589322,295,1,"CENSORED AT TIME OF LAST VISIT"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,158,">150-175",5,56,">50-75",2,1.56,">1.50-1.75",3,NA,"",NA,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",138,125,140,"Died",2,1,0.525667351129363,"<=3",1,0.525667351129363,"<=3",1,0.0328542094455852,"Y","Y",4,"4",4,"Y","Y","","Y","","Y","Unknown","HEAD OF PANCREAS","T1","N1","60","51-60",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.44558521560575,43,0,"DOCUMENTED PROGRESSION",4.53388090349076,137,0,"DEATH",4.53388090349076,137,0,"DEATH",4.53388090349076,137,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,162,">150-175",5,73,">50-75",2,1.81,">1.75-2.0",4,1650,">20xULN-50xULN",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",150,146,176,"Died",2,1,1.34702258726899,"<=3",1,0.952772073921971,"<=3",1,0.427104722792608,"Y","Y",4,"4",4,"Y","Y","Y","Y","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T2","N1","30","21-30",3,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.61396303901437,109,0,"DOCUMENTED PROGRESSION",4.92813141683778,149,0,"DEATH",4.92813141683778,149,0,"DEATH",4.92813141683778,149,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,159,">150-175",5,54,">50-75",2,1.54,">1.50-1.75",3,969,">20xULN-50xULN",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",578,550,589,"Died",2,1,1.57700205338809,"<=3",1,0.985626283367556,"<=3",1,0.624229979466119,"Y","Y",3,"3",3,"Y","Y","","Y","","","Unknown","OTHER","T4","N1","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",11.0390143737166,335,0,"DOCUMENTED PROGRESSION",18.9897330595483,577,0,"DEATH",18.9897330595483,577,0,"DEATH",18.9897330595483,577,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,180,">175",6,70,">50-75",2,1.87,">1.75-2.0",4,NA,"",NA,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",245,237,269,"Died",2,1,0.164271047227926,"<=3",1,0.952772073921971,"<=3",1,-0.75564681724846,"Y","Y",3,"3",3,"Y","Y","","","","Y","Unknown","OTHER","T4","N1","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.58110882956879,108,0,"DOCUMENTED PROGRESSION",8.04928131416838,244,0,"DEATH",8.04928131416838,244,0,"DEATH",8.04928131416838,244,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,159,">150-175",5,54,">50-75",2,1.54,">1.50-1.75",3,44200,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",80,74,102,"Died",2,2,0.952772073921971,"<=3",1,0.82135523613963,"<=3",1,0.164271047227926,"Y","Y",3,"3",3,"Y","Y","","","","Y","G2 - Moderately differentiated","OTHER","T4","Nx","85","81-90",9,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.44558521560575,43,0,"DOCUMENTED PROGRESSION",2.6611909650924,80,0,"DEATH",2.6611909650924,80,0,"DEATH",2.6611909650924,80,0,"DEATH"
"61-70",3,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,171,">150-175",5,55,">50-75",2,1.61,">1.50-1.75",3,1.4,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",172,149,NA,"Died",2,3,1.57700205338809,"<=3",1,0.985626283367556,"<=3",1,0.624229979466119,"Y","Y",4,"4",4,"","Y","Y","","","Y","G2 - Moderately differentiated","BODY OF PANCREAS","T4","N0","30","21-30",3,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",5.71663244353183,173,0,"DEATH",5.71663244353183,173,0,"DEATH",5.71663244353183,173,0,"DEATH",5.71663244353183,173,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,155,">150-175",5,45,"<=50",1,1.4,">1.25-1.50",2,3030,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",130,104,134,"Died",2,3,3.90965092402464,">3-6",2,1.18275154004107,"<=3",1,2.75975359342916,"Y","Y",3,"3",3,"Y","Y","","Y","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T4","N1","30","21-30",3,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.87268993839836,56,0,"DOCUMENTED PROGRESSION",4.33675564681725,131,0,"DEATH",4.33675564681725,131,0,"DEATH",4.33675564681725,131,0,"DEATH"
"61-70",3,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,154,">150-175",5,68,">50-75",2,1.7,">1.50-1.75",3,8370,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",203,195,227,"Died",2,3,2.03696098562628,"<=3",1,2.36550308008214,"<=3",1,-0.295687885010267,"Y","Y",4,"4",4,"Y","Y","","Y","","Y","G3 - Poorly differentiated","HEAD OF PANCREAS","T2","Nx","70","61-70",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",5.5523613963039,168,0,"DOCUMENTED PROGRESSION",6.73511293634497,204,0,"DEATH",6.73511293634497,204,0,"DEATH",6.73511293634497,204,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,174,">150-175",5,54,">50-75",2,1.62,">1.50-1.75",3,1.4,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"DEATH",2,"GASTRORRHAGIA","Y","Other",5,1,NA,"Died",2,2,2.10266940451745,"<=3",1,4.0082135523614,">3-6",2,-1.87268993839836,"Y","Y",1,"1",1,"Y","","","","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T4","Nx","10","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",0.197125256673511,5,0,"DEATH",0.197125256673511,5,0,"DEATH",0.197125256673511,5,0,"DEATH",0.197125256673511,5,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,174,">150-175",5,91,">75-100",3,2,">1.75-2.0",4,959,">20xULN-50xULN",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,272,272,"Alive",1,2,2.49691991786448,"<=3",1,1.47843942505133,"<=3",1,1.05133470225873,"Y","Y",1,"1",1,"Y","","","","","","Unknown","HEAD OF PANCREAS","Tx","Nx","40","31-40",4,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.83983572895277,55,0,"DOCUMENTED PROGRESSION",8.96919917864476,272,1,"CENSORED AT TIME OF LAST FOLLOW-UP",8.96919917864476,272,1,"CENSORED AT TIME OF LAST FOLLOW-UP",8.96919917864476,272,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,156,">150-175",5,70,">50-75",2,1.74,">1.50-1.75",3,38600,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",33,33,91,"Died",2,3,1.14989733059548,"<=3",1,1.14989733059548,"<=3",1,0.0328542094455852,"Y","Y",4,"4",4,"Y","","Y","","","Y","G1 - Well differentiated","OTHER","Tx","Nx","65","61-70",7,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",0.985626283367556,29,0,"DOCUMENTED PROGRESSION",1.14989733059548,34,0,"DEATH",1.14989733059548,34,0,"DEATH",1.14989733059548,34,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,180,">175",6,66,">50-75",2,1.82,">1.75-2.0",4,24400,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",119,107,137,"Died",2,4,2.98973305954825,"<=3",1,2.98973305954825,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T3","Nx","15","11-20",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",2.0041067761807,60,0,"DOCUMENTED PROGRESSION",4.0082135523614,121,0,"DEATH",4.0082135523614,121,0,"DEATH",4.0082135523614,121,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,167,">150-175",5,52,">50-75",2,1.55,">1.50-1.75",3,25000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROTOCOL VIOLATION",4,"PROTOCOL VIOLATION","Y","DISEASE PROGRESSION",79,77,106,"Died",2,1,1.01848049281314,"<=3",1,1.01848049281314,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","BODY OF PANCREAS","T4","N1","10","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",2.59548254620123,78,0,"DEATH",2.59548254620123,78,0,"DEATH",2.59548254620123,78,0,"DEATH",2.59548254620123,78,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,176,">175",6,112,">100-125",4,2.34,">2.0",5,17700,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"DEATH",2,"ACUTE CARDIOVASCULAR FAILURE","Y","Other",196,190,NA,"Died",2,2,1.24845995893224,"<=3",1,0.952772073921971,"<=3",1,0.328542094455852,"Y","Y",2,"2",2,"","","Y","","","Y","G2 - Moderately differentiated","OTHER","T4","Nx","30","21-30",3,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",6.47227926078029,196,0,"DEATH",6.47227926078029,196,0,"DEATH",6.47227926078029,196,0,"DEATH",6.47227926078029,196,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,185,">175",6,76,">75-100",3,1.98,">1.75-2.0",4,776,">20xULN-50xULN",6,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",129,107,139,"Died",2,3,0.525667351129363,"<=3",1,0.525667351129363,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G3 - Poorly differentiated","TAIL OF PANCREAS","T2","Nx","45","41-50",5,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.87268993839836,56,0,"DOCUMENTED PROGRESSION",4.30390143737166,130,0,"DEATH",4.30390143737166,130,0,"DEATH",4.30390143737166,130,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,0,2,0,"0",1,153,">150-175",5,74,">50-75",2,1.77,">1.75-2.0",4,NA,"",NA,"Gemcitabine",2,"Gemcitabine",2,"",NA,"","","",NA,225,NA,"",NA,3,0.985626283367556,"<=3",1,0.492813141683778,"<=3",1,0.525667351129363,"Y","Y",4,"4",4,"Y","Y","","Y","","Y","Unknown","TAIL OF PANCREAS","T3","Nx","2","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.61806981519507,170,1,"CENSORED AT TIME OF LAST ASSESSMENT",7.42505133470226,225,1,"CENSORED AT TIME OF LAST VISIT",7.42505133470226,225,1,"CENSORED AT TIME OF LAST VISIT",7.42505133470226,225,1,"CENSORED AT TIME OF LAST VISIT"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,185,">175",6,87,">75-100",3,2.11,">2.0",5,21700,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",34,7,37,"Died",2,2,1.64271047227926,"<=3",1,1.14989733059548,"<=3",1,0.525667351129363,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T4","N1","30","21-30",3,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.14989733059548,34,0,"DEATH",1.14989733059548,34,0,"DEATH",1.14989733059548,34,0,"DEATH",1.14989733059548,34,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,164,">150-175",5,65,">50-75",2,1.72,">1.50-1.75",3,31.1,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",116,87,118,"Died",2,2,2.75975359342916,"<=3",1,1.44558521560575,"<=3",1,1.34702258726899,"Y","Y",1,"1",1,"Y","","","","","","GX - Grade cannot be assessed","HEAD OF PANCREAS","T4","N0","10","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.67556468172485,50,0,"DOCUMENTED PROGRESSION",3.84394250513347,116,0,"DEATH",3.84394250513347,116,0,"DEATH",3.84394250513347,116,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,170,">150-175",5,53.2,">50-75",2,1.58,">1.50-1.75",3,4290,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",150,125,158,"Died",2,8,1.51129363449692,"<=3",1,0.131416837782341,"<=3",1,1.41273100616016,"Y","Y",2,"2",2,"Y","","","Y","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T4","N1","50","41-50",5,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.90554414784394,57,0,"DOCUMENTED PROGRESSION",5.15811088295688,156,0,"DEATH",5.15811088295688,156,0,"DEATH",5.15811088295688,156,0,"DEATH"
"61-70",3,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,155,">150-175",5,42,"<=50",1,1.34,">1.25-1.50",2,28700,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","DISEASE PROGRESSION",80,77,86,"Died",2,3,2.49691991786448,"<=3",1,2.49691991786448,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G3 - Poorly differentiated","TAIL OF PANCREAS","T3","Nx","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",2.69404517453799,81,0,"DEATH",2.69404517453799,81,0,"DEATH",2.69404517453799,81,0,"DEATH",2.69404517453799,81,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,157,">150-175",5,79,">75-100",3,1.86,">1.75-2.0",4,8.5,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"DEATH",2,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",22,22,NA,"Died",2,2,13.0102669404517,">12-24",4,13.0102669404517,">12-24",4,0.0328542094455852,"Y","Y",4,"4",4,"Y","Y","","Y","","Y","G3 - Poorly differentiated","BODY OF PANCREAS","T3","N1","70","61-70",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",0.75564681724846,22,0,"DEATH",0.75564681724846,22,0,"DEATH",0.75564681724846,22,0,"DEATH",0.75564681724846,22,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,163,">150-175",5,67,">50-75",2,1.74,">1.50-1.75",3,6.3,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",188,175,188,"Died",2,1,2.06981519507187,"<=3",1,2.06981519507187,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G3 - Poorly differentiated","OTHER","T4","N1","10","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.782340862423,175,0,"DOCUMENTED PROGRESSION",6.17659137577002,187,0,"DEATH",6.17659137577002,187,0,"DEATH",6.17659137577002,187,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,161,">150-175",5,51,">50-75",2,1.51,">1.50-1.75",3,3610,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",136,63,414,"Died",2,1,1.1170431211499,"<=3",1,1.1170431211499,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","","","","Y","","G3 - Poorly differentiated","HEAD OF PANCREAS","T4","N1","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.87268993839836,56,0,"DOCUMENTED PROGRESSION",4.46817248459959,135,0,"DEATH",4.46817248459959,135,0,"DEATH",4.46817248459959,135,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,172,">150-175",5,110,">100-125",4,2.29,">2.0",5,1570,">20xULN-50xULN",6,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",271,253,253,"Died",2,2,8.83778234086242,">6-12",3,8.83778234086242,">6-12",3,0.0328542094455852,"Y","Y",3,"3",3,"","Y","Y","Y","","","G2 - Moderately differentiated","BODY OF PANCREAS","T4","N1","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.5523613963039,168,0,"DOCUMENTED PROGRESSION",8.93634496919918,271,0,"DEATH",8.93634496919918,271,0,"DEATH",8.93634496919918,271,0,"DEATH"
"71-80",4,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,173,">150-175",5,49,"<=50",1,1.53,">1.50-1.75",3,2740,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",311,302,302,"Died",2,3,3.21971252566735,">3-6",2,1.37987679671458,"<=3",1,1.87268993839836,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","BODY OF PANCREAS","T4","N1","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",9.69199178644764,294,0,"DOCUMENTED PROGRESSION",10.2833675564682,312,0,"DEATH",10.2833675564682,312,0,"DEATH",10.2833675564682,312,0,"DEATH"
"71-80",4,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,170,">150-175",5,68.2,">50-75",2,1.79,">1.75-2.0",4,927,">20xULN-50xULN",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",112,98,NA,"Died",2,1,0.985626283367556,"<=3",1,0.985626283367556,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","","","Y","","","Unknown","HEAD OF PANCREAS","T2","N0","90","81-90",9,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.67967145790554,111,0,"DEATH",3.67967145790554,111,0,"DEATH",3.67967145790554,111,0,"DEATH",3.67967145790554,111,0,"DEATH"
"61-70",3,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,161,">150-175",5,45.2,"<=50",1,1.42,">1.25-1.50",2,5310,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",107,91,NA,"Died",2,1,1.41273100616016,"<=3",1,1.41273100616016,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","","","Y","","Y","GX - Grade cannot be assessed","BODY OF PANCREAS","T3","N1","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.51540041067762,106,0,"DEATH",3.51540041067762,106,0,"DEATH",3.51540041067762,106,0,"DEATH",3.51540041067762,106,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,165,">150-175",5,70.8,">50-75",2,1.8,">1.75-2.0",4,46000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",259,250,266,"Died",2,1,0.68993839835729,"<=3",1,0.68993839835729,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","Y","","","GX - Grade cannot be assessed","BODY OF PANCREAS","T3","N1","100","91-100",10,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",7.22792607802875,219,0,"DOCUMENTED PROGRESSION",8.50924024640657,258,0,"DEATH",8.50924024640657,258,0,"DEATH",8.50924024640657,258,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,170,">150-175",5,77,">75-100",3,1.9,">1.75-2.0",4,8,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","DISEASE PROGRESSION",458,448,503,"Died",2,2,1.18275154004107,"<=3",1,1.18275154004107,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","","","","","Y","G3 - Poorly differentiated","TAIL OF PANCREAS","T3","N1","80","71-80",8,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",15.0800821355236,458,0,"DEATH",15.0800821355236,458,0,"DEATH",15.0800821355236,458,0,"DEATH",15.0800821355236,458,0,"DEATH"
"61-70",3,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,167,">150-175",5,73.2,">50-75",2,1.84,">1.75-2.0",4,3,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",24,16,NA,"Died",2,3,13.1416837782341,">12-24",4,2.46406570841889,"<=3",1,10.7104722792608,"Y","Y",3,"3",3,"","","Y","Y","","Y","GX - Grade cannot be assessed","HEAD OF PANCREAS","T3","N0","60","51-60",6,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",0.854209445585216,25,0,"DEATH",0.854209445585216,25,0,"DEATH",0.854209445585216,25,0,"DEATH",0.854209445585216,25,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,178,">175",6,76,">75-100",3,1.94,">1.75-2.0",4,8660,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",234,233,NA,"Died",2,2,1.01848049281314,"<=3",1,1.01848049281314,"<=3",1,0.0328542094455852,"Y","Y",4,"4",4,"Y","Y","","","","Y","G2 - Moderately differentiated","BODY OF PANCREAS","T3","N1","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",7.68788501026694,233,0,"DOCUMENTED PROGRESSION",7.72073921971253,234,0,"DEATH",7.72073921971253,234,0,"DEATH",7.72073921971253,234,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,175,">150-175",5,67.4,">50-75",2,1.81,">1.75-2.0",4,1930,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",346,316,413,"Died",2,1,1.18275154004107,"<=3",1,1.18275154004107,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T3","N0","2","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",7.49075975359343,227,0,"DOCUMENTED PROGRESSION",11.3675564681725,345,0,"DEATH",11.3675564681725,345,0,"DEATH",11.3675564681725,345,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,162,">150-175",5,57.5,">50-75",2,1.61,">1.50-1.75",3,1640,">20xULN-50xULN",6,"Gemcitabine",2,"Gemcitabine",2,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","Other",184,41,277,"Died",2,1,3.5482546201232,">3-6",2,3.5482546201232,">3-6",2,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","","","Y","Unknown","BODY OF PANCREAS","T4","N1","45","41-50",5,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",6.04517453798768,183,0,"DEATH",6.04517453798768,183,0,"DEATH",6.04517453798768,183,0,"DEATH",6.04517453798768,183,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,180,">175",6,80,">75-100",3,2,">1.75-2.0",4,11.2,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",404,390,427,"Died",2,1,0.985626283367556,"<=3",1,0.985626283367556,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","GX - Grade cannot be assessed","BODY OF PANCREAS","T3","N1","30","21-30",3,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",12.8131416837782,389,0,"DOCUMENTED PROGRESSION",13.2731006160164,403,0,"DEATH",13.2731006160164,403,0,"DEATH",13.2731006160164,403,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,185,">175",6,84,">75-100",3,2.07,">2.0",5,922,">20xULN-50xULN",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"",NA,"","","",NA,462,NA,"",NA,1,9.72484599589322,">6-12",3,1.67556468172485,"<=3",1,8.08213552361396,"Y","Y",3,"3",3,"Y","Y","","","","Y","G2 - Moderately differentiated","TAIL OF PANCREAS","T3","N0","80","71-80",8,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",14.4887063655031,440,1,"CENSORED AT TIME OF LAST ASSESSMENT",15.211498973306,462,1,"CENSORED AT TIME OF LAST VISIT",15.211498973306,462,1,"CENSORED AT TIME OF LAST VISIT",15.211498973306,462,1,"CENSORED AT TIME OF LAST VISIT"
"61-70",3,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,176,">175",6,76,">75-100",3,1.93,">1.75-2.0",4,NA,"",NA,"Gemcitabine",2,"Gemcitabine",2,"DEATH",2,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",338,329,NA,"Died",2,1,0.558521560574949,"<=3",1,0.558521560574949,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G1 - Well differentiated","OTHER","T4","N0","20","11-20",2,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",11.1047227926078,337,0,"DEATH",11.1047227926078,337,0,"DEATH",11.1047227926078,337,0,"DEATH",11.1047227926078,337,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,165,">150-175",5,55,">50-75",2,1.59,">1.50-1.75",3,1.4,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROTOCOL VIOLATION",4,"PROTOCOL VIOLATION","Y","Other",16,15,99,"Died",2,2,0.722792607802875,"<=3",1,0.722792607802875,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","","Y","","","Y","Unknown","HEAD OF PANCREAS","T3","N0","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",0.558521560574949,16,0,"DEATH",0.558521560574949,16,0,"DEATH",0.558521560574949,16,0,"DEATH",0.558521560574949,16,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,164,">150-175",5,80,">75-100",3,1.9,">1.75-2.0",4,461,">10xULN-20xULN",5,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"DEATH",2,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",79,71,NA,"Died",2,2,5.45379876796715,">3-6",2,5.45379876796715,">3-6",2,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","","","Y","Unknown","HEAD OF PANCREAS","T2","N1","20","11-20",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",2.62833675564682,79,0,"DEATH",2.62833675564682,79,0,"DEATH",2.62833675564682,79,0,"DEATH",2.62833675564682,79,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,179,">175",6,92,">75-100",3,2.14,">2.0",5,66600,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","Other",113,112,NA,"Died",2,2,0.919917864476386,"<=3",1,0.919917864476386,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","","","Y","G2 - Moderately differentiated","TAIL OF PANCREAS","T2","N1","60","51-60",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.74537987679671,113,0,"DEATH",3.74537987679671,113,0,"DEATH",3.74537987679671,113,0,"DEATH",3.74537987679671,113,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,162,">150-175",5,58,">50-75",2,1.62,">1.50-1.75",3,3.2,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"",NA,"","","",NA,365,NA,"",NA,2,0.722792607802875,"<=3",1,0.722792607802875,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T2","N1","40","31-40",4,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",11.0718685831622,336,1,"CENSORED AT TIME OF LAST ASSESSMENT",12.0246406570842,365,1,"CENSORED AT TIME OF LAST VISIT",12.0246406570842,365,1,"CENSORED AT TIME OF LAST VISIT",12.0246406570842,365,1,"CENSORED AT TIME OF LAST VISIT"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,180,">175",6,79,">75-100",3,1.99,">1.75-2.0",4,73000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",233,218,NA,"Died",2,2,11.8275154004107,">6-12",3,0.952772073921971,"<=3",1,10.9075975359343,"Y","Y",2,"2",2,"Y","","","","","Y","Unknown","HEAD OF PANCREAS","T3","N1","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",7.19507186858316,218,0,"DOCUMENTED PROGRESSION",7.68788501026694,233,0,"DEATH",7.68788501026694,233,0,"DEATH",7.68788501026694,233,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,177,">175",6,79,">75-100",3,1.98,">1.75-2.0",4,93000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"DEATH",2,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",37,22,NA,"Died",2,2,1.18275154004107,"<=3",1,1.18275154004107,"<=3",1,0.0328542094455852,"Y","Y",4,"4",4,"Y","Y","Y","Y","","","Unknown","TAIL OF PANCREAS","T4","N1","30","21-30",3,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.24845995893224,37,0,"DEATH",1.24845995893224,37,0,"DEATH",1.24845995893224,37,0,"DEATH",1.24845995893224,37,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,160,">150-175",5,56,">50-75",2,1.58,">1.50-1.75",3,2030,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"DEATH",2,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",12,1,NA,"Died",2,2,0.722792607802875,"<=3",1,0.722792607802875,"<=3",1,0.0328542094455852,"Y","Y",4,"4",4,"Y","Y","Y","Y","","","Unknown","HEAD OF PANCREAS","T3","N1","85","81-90",9,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",0.427104722792608,12,0,"DEATH",0.427104722792608,12,0,"DEATH",0.427104722792608,12,0,"DEATH",0.427104722792608,12,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,178,">175",6,73,">50-75",2,1.9,">1.75-2.0",4,422,">10xULN-20xULN",5,"Gemcitabine",2,"Gemcitabine",2,"",NA,"","","",NA,308,NA,"",NA,1,3.81108829568789,">3-6",2,0.82135523613963,"<=3",1,3.02258726899384,"Y","Y",2,"2",2,"Y","","","","","Y","G4 - Undifferentiated","HEAD OF PANCREAS","T4","N0","N/A","",NA,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",9.26488706365503,281,1,"CENSORED AT TIME OF LAST ASSESSMENT",10.1519507186858,308,1,"CENSORED AT TIME OF LAST VISIT",10.1519507186858,308,1,"CENSORED AT TIME OF LAST VISIT",10.1519507186858,308,1,"CENSORED AT TIME OF LAST VISIT"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,173,">150-175",5,71,">50-75",2,1.85,">1.75-2.0",4,17.8,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",163,163,NA,"Died",2,3,1.41273100616016,"<=3",1,0.68993839835729,"<=3",1,0.75564681724846,"Y","Y",2,"2",2,"Y","","","","","Y","GX - Grade cannot be assessed","OTHER","T3","N0","1","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",5.38809034907598,163,0,"DOCUMENTED PROGRESSION",5.42094455852156,164,0,"DEATH",5.42094455852156,164,0,"DEATH",5.42094455852156,164,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,152,">150-175",5,76.2,">75-100",3,1.79,">1.75-2.0",4,NA,"",NA,"Gemcitabine",2,"Gemcitabine",2,"DEATH",2,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",45,35,NA,"Died",2,1,0.75564681724846,"<=3",1,0.75564681724846,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","G3 - Poorly differentiated","OTHER","T4","N1","30","21-30",3,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.47843942505133,44,0,"DEATH",1.47843942505133,44,0,"DEATH",1.47843942505133,44,0,"DEATH",1.47843942505133,44,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,164,">150-175",5,61,">50-75",2,1.67,">1.50-1.75",3,304,">3xULN-10xULN",4,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",584,573,606,"Died",2,5,0.919917864476386,"<=3",1,0.919917864476386,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","Unknown","OTHER","Tx","N0","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",16.7227926078029,508,0,"DOCUMENTED PROGRESSION",19.3182751540041,587,0,"DEATH",19.3182751540041,587,0,"DEATH",19.3182751540041,587,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,150,">125-150",4,54,">50-75",2,1.5,">1.25-1.50",2,25.6,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",253,232,260,"Died",2,2,1.37987679671458,"<=3",1,1.37987679671458,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"","Y","","Y","Y","","Unknown","BODY OF PANCREAS","T3","N1","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.58521560574949,169,0,"DOCUMENTED PROGRESSION",8.34496919917864,253,0,"DEATH",8.34496919917864,253,0,"DEATH",8.34496919917864,253,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,182,">175",6,96,">75-100",3,2.2,">2.0",5,2260,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",365,345,367,"Died",2,2,0.985626283367556,"<=3",1,0.459958932238193,"<=3",1,0.558521560574949,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T2","N1","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",7.19507186858316,218,0,"DOCUMENTED PROGRESSION",12.0246406570842,365,0,"DEATH",12.0246406570842,365,0,"DEATH",12.0246406570842,365,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,162,">150-175",5,54,">50-75",2,1.56,">1.50-1.75",3,25.3,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",595,587,623,"Died",2,2,7.12936344969199,">6-12",3,0.952772073921971,"<=3",1,6.20944558521561,"Y","Y",1,"1",1,"Y","","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T4","Nx","70","61-70",7,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",9.03490759753593,274,0,"DOCUMENTED PROGRESSION",19.5811088295688,595,0,"DEATH",19.5811088295688,595,0,"DEATH",19.5811088295688,595,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,174,">150-175",5,60,">50-75",2,1.7,">1.50-1.75",3,126,">3xULN-10xULN",4,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",209,206,NA,"Died",2,4,1.18275154004107,"<=3",1,1.18275154004107,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","","","","","Y","G3 - Poorly differentiated","HEAD OF PANCREAS","T4","N0","20","11-20",2,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",6.80082135523614,206,0,"DOCUMENTED PROGRESSION",6.96509240246407,211,0,"DEATH",6.96509240246407,211,0,"DEATH",6.96509240246407,211,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,158,">150-175",5,56,">50-75",2,1.57,">1.50-1.75",3,5,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",257,232,264,"Died",2,2,0.919917864476386,"<=3",1,0.919917864476386,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","","","Y","","","G3 - Poorly differentiated","OTHER","T4","N1","80","71-80",8,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",6.47227926078029,196,0,"DOCUMENTED PROGRESSION",8.47638603696099,257,0,"DEATH",8.47638603696099,257,0,"DEATH",8.47638603696099,257,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,163,">150-175",5,74,">50-75",2,1.83,">1.75-2.0",4,1.4,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,524,524,"Alive",1,2,0.722792607802875,"<=3",1,0.722792607802875,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T3","N1","5","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",14.5215605749487,441,0,"DOCUMENTED PROGRESSION",17.2484599589322,524,1,"CENSORED AT TIME OF LAST FOLLOW-UP",17.2484599589322,524,1,"CENSORED AT TIME OF LAST FOLLOW-UP",17.2484599589322,524,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,176,">175",6,67,">50-75",2,1.81,">1.75-2.0",4,48700,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",89,50,96,"Died",2,2,0.985626283367556,"<=3",1,0.985626283367556,"<=3",1,0.0328542094455852,"Y","Y",5,">=5",5,"Y","Y","Y","","","Y","G2 - Moderately differentiated","OTHER","T4","N1","50","41-50",5,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.67556468172485,50,0,"DOCUMENTED PROGRESSION",2.95687885010267,89,0,"DEATH",2.95687885010267,89,0,"DEATH",2.95687885010267,89,0,"DEATH"
"81-90",5,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,149,">125-150",4,49.1,"<=50",1,1.42,">1.25-1.50",2,28600,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",116,106,134,"Died",2,2,0.459958932238193,"<=3",1,0.459958932238193,"<=3",1,0.0328542094455852,"Y","Y",4,"4",4,"Y","","","","","Y","G2 - Moderately differentiated","TAIL OF PANCREAS","T4","N0","70","61-70",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.28542094455852,99,0,"DOCUMENTED PROGRESSION",3.84394250513347,116,0,"DEATH",3.84394250513347,116,0,"DEATH",3.84394250513347,116,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,161,">150-175",5,63,">50-75",2,1.68,">1.50-1.75",3,2830,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",107,105,135,"Died",2,2,1.34702258726899,"<=3",1,1.34702258726899,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","","","Y","G2 - Moderately differentiated","HEAD OF PANCREAS","T1","N1","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.44558521560575,43,0,"DOCUMENTED PROGRESSION",3.5482546201232,107,0,"DEATH",3.5482546201232,107,0,"DEATH",3.5482546201232,107,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,175,">150-175",5,84,">75-100",3,2.02,">2.0",5,106000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",119,102,123,"Died",2,4,1.24845995893224,"<=3",1,0.952772073921971,"<=3",1,0.328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T3","N0","50","41-50",5,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.38398357289528,102,0,"DOCUMENTED PROGRESSION",4.0082135523614,121,0,"DEATH",4.0082135523614,121,0,"DEATH",4.0082135523614,121,0,"DEATH"
"71-80",4,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,155,">150-175",5,56,">50-75",2,1.55,">1.50-1.75",3,3350,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",290,272,301,"Died",2,4,9.10061601642711,">6-12",3,1.7741273100616,"<=3",1,7.35934291581109,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","OTHER","T4","N1","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.68377823408624,172,0,"DOCUMENTED PROGRESSION",9.62628336755647,292,0,"DEATH",9.62628336755647,292,0,"DEATH",9.62628336755647,292,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,165,">150-175",5,53,">50-75",2,1.56,">1.50-1.75",3,3920,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",236,233,233,"Died",2,2,1.70841889117043,"<=3",1,1.70841889117043,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T3","N0","5","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",6.70225872689938,203,0,"DOCUMENTED PROGRESSION",7.7864476386037,236,0,"DEATH",7.7864476386037,236,0,"DEATH",7.7864476386037,236,0,"DEATH"
"61-70",3,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,165,">150-175",5,87,">75-100",3,2,">1.75-2.0",4,9490,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","Other",96,92,96,"Died",2,2,0.68993839835729,"<=3",1,0.68993839835729,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","Y","","","G3 - Poorly differentiated","OTHER","T3","Nx","20","11-20",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.05544147843943,92,0,"DOCUMENTED PROGRESSION",3.18685831622177,96,0,"DEATH",3.18685831622177,96,0,"DEATH",3.18685831622177,96,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,161,">150-175",5,69.1,">50-75",2,1.76,">1.75-2.0",4,71100,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",58,24,62,"Died",2,4,7.72073921971253,">6-12",3,0.75564681724846,"<=3",1,6.99794661190965,"Y","Y",2,"2",2,"Y","","","Y","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T2","Nx","20","11-20",2,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",0.82135523613963,24,0,"DOCUMENTED PROGRESSION",2.0041067761807,60,0,"DEATH",2.0041067761807,60,0,"DEATH",2.0041067761807,60,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,181,">175",6,67,">50-75",2,1.84,">1.75-2.0",4,134,">3xULN-10xULN",4,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",253,231,253,"Died",2,2,0.68993839835729,"<=3",1,0.68993839835729,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"","Y","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T2","N1","90","81-90",9,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.3223819301848,161,0,"DOCUMENTED PROGRESSION",8.34496919917864,253,0,"DEATH",8.34496919917864,253,0,"DEATH",8.34496919917864,253,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,180,">175",6,68.5,">50-75",2,1.85,">1.75-2.0",4,7730,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",177,163,195,"Died",2,2,0.492813141683778,"<=3",1,0.492813141683778,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","Unknown","OTHER","T3","N0","1","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",4.435318275154,134,0,"DOCUMENTED PROGRESSION",5.84804928131417,177,0,"DEATH",5.84804928131417,177,0,"DEATH",5.84804928131417,177,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,164,">150-175",5,76,">75-100",3,1.86,">1.75-2.0",4,72800,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",97,70,NA,"Died",2,2,1.21560574948665,"<=3",1,1.21560574948665,"<=3",1,0.0328542094455852,"Y","Y",4,"4",4,"Y","Y","","Y","","Y","G3 - Poorly differentiated","OTHER","T4","N1","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",2.33264887063655,70,0,"DOCUMENTED PROGRESSION",3.21971252566735,97,0,"DEATH",3.21971252566735,97,0,"DEATH",3.21971252566735,97,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,167,">150-175",5,61,">50-75",2,1.68,">1.50-1.75",3,494,">10xULN-20xULN",5,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",143,140,172,"Died",2,1,1.01848049281314,"<=3",1,1.01848049281314,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","","","Y","G2 - Moderately differentiated","BODY OF PANCREAS","T4","N1","5","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.38398357289528,102,0,"DOCUMENTED PROGRESSION",4.69815195071869,142,0,"DEATH",4.69815195071869,142,0,"DEATH",4.69815195071869,142,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,169,">150-175",5,65.1,">50-75",2,1.75,">1.50-1.75",3,1.4,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"WITHDRAWAL BY SUBJECT",5,"WITHDREW CONSENT","Y","DISEASE PROGRESSION",57,36,80,"Died",2,2,0.82135523613963,"<=3",1,0.82135523613963,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T2","N1","30","21-30",3,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.90554414784394,57,0,"DEATH",1.90554414784394,57,0,"DEATH",1.90554414784394,57,0,"DEATH",1.90554414784394,57,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,180,">175",6,92.1,">75-100",3,2.14,">2.0",5,1500,">20xULN-50xULN",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",265,260,265,"Died",2,2,10.8418891170431,">6-12",3,10.8418891170431,">6-12",3,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","Y","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T3","N0","20","11-20",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",6.30800821355236,191,0,"DOCUMENTED PROGRESSION",8.73921971252567,265,0,"DEATH",8.73921971252567,265,0,"DEATH",8.73921971252567,265,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,158,">150-175",5,40,"<=50",1,1.32,">1.25-1.50",2,NA,"",NA,"Gemcitabine",2,"Gemcitabine",2,"DEATH",2,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",6,0,NA,"Died",2,1,0.919917864476386,"<=3",1,0.919917864476386,"<=3",1,0.0328542094455852,"Y","Y",5,">=5",5,"Y","Y","Y","Y","","Y","G3 - Poorly differentiated","OTHER","T2","N1","5","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",0.197125256673511,5,0,"DEATH",0.197125256673511,5,0,"DEATH",0.197125256673511,5,0,"DEATH",0.197125256673511,5,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,168,">150-175",5,74.1,">50-75",2,1.86,">1.75-2.0",4,45.9,">ULN-2xULN",2,"Gemcitabine",2,"Gemcitabine",2,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","DISEASE PROGRESSION",80,64,95,"Died",2,1,0.492813141683778,"<=3",1,0.492813141683778,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","","","Y","G2 - Moderately differentiated","HEAD OF PANCREAS","T4","N1","100","91-100",10,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",2.62833675564682,79,0,"DEATH",2.62833675564682,79,0,"DEATH",2.62833675564682,79,0,"DEATH",2.62833675564682,79,0,"DEATH"
"61-70",3,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,162,">150-175",5,90.1,">75-100",3,2.01,">2.0",5,16,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",136,119,137,"Died",2,1,4.73100616016427,">3-6",2,-7.29363449691992,"",NA,12.0574948665298,"Y","Y",4,"4",4,"Y","Y","Y","","","Y","G2 - Moderately differentiated","HEAD OF PANCREAS","T4","N0","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.64271047227926,49,0,"DOCUMENTED PROGRESSION",4.46817248459959,135,0,"DEATH",4.46817248459959,135,0,"DEATH",4.46817248459959,135,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,155,">150-175",5,61.1,">50-75",2,1.62,">1.50-1.75",3,470,">10xULN-20xULN",5,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",184,173,204,"Died",2,1,0.919917864476386,"<=3",1,0.919917864476386,"<=3",1,0.0328542094455852,"Y","Y",4,"4",4,"Y","","Y","Y","","Y","G2 - Moderately differentiated","BODY OF PANCREAS","T4","N0","30","21-30",3,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.48254620123203,105,0,"DOCUMENTED PROGRESSION",6.04517453798768,183,0,"DEATH",6.04517453798768,183,0,"DEATH",6.04517453798768,183,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,176,">175",6,58,">50-75",2,1.68,">1.50-1.75",3,107,">2xULN-3xULN",3,"Gemcitabine",2,"Gemcitabine",2,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","DISEASE PROGRESSION",148,148,174,"Died",2,6,0.722792607802875,"<=3",1,0.722792607802875,"<=3",1,0.0328542094455852,"Y","Y",4,"4",4,"Y","Y","","Y","","Y","G2 - Moderately differentiated","OTHER","T3","Nx","10","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.02669404517454,152,0,"DEATH",5.02669404517454,152,0,"DEATH",5.02669404517454,152,0,"DEATH",5.02669404517454,152,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,165,">150-175",5,65.2,">50-75",2,1.73,">1.50-1.75",3,1040,">20xULN-50xULN",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",114,90,153,"Died",2,2,0.919917864476386,"<=3",1,0.919917864476386,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","","","","","Y","Unknown","HEAD OF PANCREAS","T2","N0","15","11-20",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",2.6611909650924,80,0,"DOCUMENTED PROGRESSION",3.7782340862423,114,0,"DEATH",3.7782340862423,114,0,"DEATH",3.7782340862423,114,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,174,">150-175",5,76,">75-100",3,1.92,">1.75-2.0",4,11.6,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",193,178,203,"Died",2,3,0.722792607802875,"<=3",1,0.722792607802875,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G2 - Moderately differentiated","OTHER","T2","N0","75","71-80",8,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",6.40657084188912,194,0,"DEATH",6.40657084188912,194,0,"DEATH",6.40657084188912,194,0,"DEATH",6.40657084188912,194,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,175,">150-175",5,64,">50-75",2,1.78,">1.75-2.0",4,17,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",177,168,192,"Died",2,1,1.67556468172485,"<=3",1,1.60985626283368,"<=3",1,0.0985626283367557,"Y","Y",2,"2",2,"Y","Y","","","","","G3 - Poorly differentiated","TAIL OF PANCREAS","T3","N0","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.70841889117043,51,0,"DOCUMENTED PROGRESSION",5.81519507186858,176,0,"DEATH",5.81519507186858,176,0,"DEATH",5.81519507186858,176,0,"DEATH"
"61-70",3,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,158,">150-175",5,67,">50-75",2,1.71,">1.50-1.75",3,310,">3xULN-10xULN",4,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",352,353,383,"Died",2,4,1.47843942505133,"<=3",1,1.47843942505133,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","Y","","","G2 - Moderately differentiated","TAIL OF PANCREAS","T3","N1","70","61-70",7,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.81108829568789,115,0,"DOCUMENTED PROGRESSION",11.6632443531828,354,0,"DEATH",11.6632443531828,354,0,"DEATH",11.6632443531828,354,0,"DEATH"
"61-70",3,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,156,">150-175",5,60,">50-75",2,1.59,">1.50-1.75",3,63.2,">ULN-2xULN",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","DISEASE PROGRESSION",323,305,305,"Died",2,2,3.21971252566735,">3-6",2,3.08829568788501,">3-6",2,0.164271047227926,"Y","Y",4,"4",4,"Y","Y","","Y","","Y","G2 - Moderately differentiated","BODY OF PANCREAS","T3","N1","40","31-40",4,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",10.6447638603696,323,0,"DEATH",10.6447638603696,323,0,"DEATH",10.6447638603696,323,0,"DEATH",10.6447638603696,323,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,174,">150-175",5,64,">50-75",2,1.77,">1.75-2.0",4,18800,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",42,32,NA,"Died",2,1,1.37987679671458,"<=3",1,1.24845995893224,"<=3",1,0.164271047227926,"Y","Y",3,"3",3,"Y","Y","","Y","","","G2 - Moderately differentiated","BODY OF PANCREAS","T3","Nx","10","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",0.952772073921971,28,0,"DOCUMENTED PROGRESSION",1.37987679671458,41,0,"DEATH",1.37987679671458,41,0,"DEATH",1.37987679671458,41,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,155,">150-175",5,48,"<=50",1,1.44,">1.25-1.50",2,965000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",111,106,NA,"Died",2,1,1.83983572895277,"<=3",1,1.34702258726899,"<=3",1,0.525667351129363,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","BODY OF PANCREAS","T3","Nx","20","11-20",2,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.48254620123203,105,0,"DOCUMENTED PROGRESSION",3.64681724845996,110,0,"DEATH",3.64681724845996,110,0,"DEATH",3.64681724845996,110,0,"DEATH"
"61-70",3,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,176,">175",6,84,">75-100",3,2.01,">2.0",5,15000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",83,59,NA,"Died",2,4,1.05133470225873,"<=3",1,0.591375770020534,"<=3",1,0.492813141683778,"Y","Y",4,"4",4,"Y","Y","Y","Y","","","G2 - Moderately differentiated","BODY OF PANCREAS","T3","N1","60","51-60",6,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.74127310061602,52,0,"DOCUMENTED PROGRESSION",2.82546201232033,85,0,"DEATH",2.82546201232033,85,0,"DEATH",2.82546201232033,85,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,165,">150-175",5,49,"<=50",1,1.52,">1.50-1.75",3,7520,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,292,292,"Alive",1,1,1.34702258726899,"<=3",1,1.14989733059548,"<=3",1,0.229979466119097,"Y","Y",2,"2",2,"Y","Y","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T3","N1","40","31-40",4,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",8.60780287474333,261,0,"DOCUMENTED PROGRESSION",9.62628336755647,292,1,"CENSORED AT TIME OF LAST FOLLOW-UP",9.62628336755647,292,1,"CENSORED AT TIME OF LAST FOLLOW-UP",9.62628336755647,292,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,170,">150-175",5,75,">50-75",2,1.77,">1.75-2.0",4,748,">20xULN-50xULN",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",195,101,377,"Died",2,4,4.40246406570842,">3-6",2,3.05544147843943,">3-6",2,1.37987679671458,"Y","Y",1,"1",1,"Y","","","","","","Unknown","BODY OF PANCREAS","T4","Nx","5","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.93839835728953,58,0,"DOCUMENTED PROGRESSION",6.50513347022587,197,0,"DEATH",6.50513347022587,197,0,"DEATH",6.50513347022587,197,0,"DEATH"
"61-70",3,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,172,">150-175",5,73,">50-75",2,1.86,">1.75-2.0",4,116000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"DEATH",2,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",38,33,NA,"Died",2,4,2.13552361396304,"<=3",1,2.0041067761807,"<=3",1,0.164271047227926,"Y","Y",1,"1",1,"Y","","","","","","G3 - Poorly differentiated","BODY OF PANCREAS","T4","N1","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.34702258726899,40,0,"DEATH",1.34702258726899,40,0,"DEATH",1.34702258726899,40,0,"DEATH",1.34702258726899,40,0,"DEATH"
"61-70",3,">=65",2,"Eastern Europe",3,"Eastern Europe",2,0,2,0,"0",1,167,">150-175",5,89,">75-100",3,2.03,">2.0",5,163,">3xULN-10xULN",4,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"ADVERSE EVENT",3,"ADVERSE EVENT","","",NA,412,412,"Lost to Follow-up",3,4,3.28542094455852,">3-6",2,2.92402464065708,"<=3",1,0.394250513347023,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","HEAD OF PANCREAS","T4","N1","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",0.0328542094455852,0,1,"CENSORED AT TIME OF RANDOMIZATION",13.5687885010267,412,1,"CENSORED AT TIME OF LAST FOLLOW-UP",13.5687885010267,412,1,"CENSORED AT TIME OF LAST FOLLOW-UP",13.5687885010267,412,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"71-80",4,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,163,">150-175",5,86,">75-100",3,1.97,">1.75-2.0",4,569000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",97,85,85,"Died",2,1,0.919917864476386,"<=3",1,0.919917864476386,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","G3 - Poorly differentiated","OTHER","T4","N1","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.70841889117043,51,0,"DOCUMENTED PROGRESSION",3.18685831622177,96,0,"DEATH",3.18685831622177,96,0,"DEATH",3.18685831622177,96,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,169,">150-175",5,71,">50-75",2,1.83,">1.75-2.0",4,1.4,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",62,42,82,"Died",2,1,0.657084188911704,"<=3",1,0.952772073921971,"<=3",1,-0.262833675564682,"Y","Y",4,"4",4,"Y","Y","","Y","","Y","G4 - Undifferentiated","OTHER","T3","N1","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",2.03696098562628,61,0,"DEATH",2.03696098562628,61,0,"DEATH",2.03696098562628,61,0,"DEATH",2.03696098562628,61,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,166,">150-175",5,47,"<=50",1,1.47,">1.25-1.50",2,16600,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",207,195,223,"Died",2,1,0.887063655030801,"<=3",1,1.1170431211499,"<=3",1,-0.197125256673511,"Y","Y",5,">=5",5,"Y","Y","","Y","","Y","Unknown","OTHER","T4","N1","15","11-20",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.44969199178645,104,0,"DOCUMENTED PROGRESSION",6.80082135523614,206,0,"DEATH",6.80082135523614,206,0,"DEATH",6.80082135523614,206,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,179,">175",6,70,">50-75",2,1.87,">1.75-2.0",4,10200,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",66,56,84,"Died",2,1,1.41273100616016,"<=3",1,2.46406570841889,"<=3",1,-1.01848049281314,"Y","Y",5,">=5",5,"Y","Y","","Y","","Y","G3 - Poorly differentiated","OTHER","T4","N1","50","41-50",5,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.70841889117043,51,0,"DOCUMENTED PROGRESSION",2.16837782340862,65,0,"DEATH",2.16837782340862,65,0,"DEATH",2.16837782340862,65,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,172,">150-175",5,72,">50-75",2,1.86,">1.75-2.0",4,15.7,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",136,127,155,"Died",2,2,0.722792607802875,"<=3",1,0.722792607802875,"<=3",1,0.0328542094455852,"Y","Y",5,">=5",5,"Y","Y","","Y","","Y","GX - Grade cannot be assessed","BODY OF PANCREAS","T4","N1","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",2.13552361396304,64,0,"DOCUMENTED PROGRESSION",4.50102669404517,136,0,"DEATH",4.50102669404517,136,0,"DEATH",4.50102669404517,136,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,163,">150-175",5,67,">50-75",2,1.74,">1.50-1.75",3,1.4,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",84,78,106,"Died",2,16,0.854209445585216,"<=3",1,0.854209445585216,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"","Y","Y","","","Y","GX - Grade cannot be assessed","OTHER","T4","N1","40","31-40",4,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",2.59548254620123,78,0,"DOCUMENTED PROGRESSION",3.25256673511294,98,0,"DEATH",3.25256673511294,98,0,"DEATH",3.25256673511294,98,0,"DEATH"
"61-70",3,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,170,">150-175",5,69,">50-75",2,1.81,">1.75-2.0",4,41900,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",68,57,87,"Died",2,2,0.624229979466119,"<=3",1,0.68993839835729,"<=3",1,-0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","G3 - Poorly differentiated","OTHER","T3","N1","5","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.67556468172485,50,0,"DOCUMENTED PROGRESSION",2.26694045174538,68,0,"DEATH",2.26694045174538,68,0,"DEATH",2.26694045174538,68,0,"DEATH"
"61-70",3,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,178,">175",6,74,">50-75",2,1.9,">1.75-2.0",4,34.2,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,316,316,"Alive",1,2,0.68993839835729,"<=3",1,0.68993839835729,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","GX - Grade cannot be assessed","HEAD OF PANCREAS","T3","N1","60","51-60",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",5.42094455852156,164,0,"DOCUMENTED PROGRESSION",10.4147843942505,316,1,"CENSORED AT TIME OF LAST FOLLOW-UP",10.4147843942505,316,1,"CENSORED AT TIME OF LAST FOLLOW-UP",10.4147843942505,316,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"71-80",4,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,169,">150-175",5,75,">50-75",2,1.88,">1.75-2.0",4,18400,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",27,14,35,"Died",2,2,1.70841889117043,"<=3",1,1.70841889117043,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","","Y","","","","G2 - Moderately differentiated","OTHER","T4","N1","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",0.919917864476386,27,0,"DEATH",0.919917864476386,27,0,"DEATH",0.919917864476386,27,0,"DEATH",0.919917864476386,27,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,159,">150-175",5,73,">50-75",2,1.8,">1.75-2.0",4,29700,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,240,240,"Alive",1,2,0.952772073921971,"<=3",1,0.492813141683778,"<=3",1,0.492813141683778,"Y","Y",2,"2",2,"Y","Y","","","","","G3 - Poorly differentiated","OTHER","T4","Nx","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.67556468172485,50,0,"DOCUMENTED PROGRESSION",7.91786447638604,240,1,"CENSORED AT TIME OF LAST FOLLOW-UP",7.91786447638604,240,1,"CENSORED AT TIME OF LAST FOLLOW-UP",7.91786447638604,240,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,162,">150-175",5,54,">50-75",2,1.6,">1.50-1.75",3,8.3,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"WITHDRAWAL BY SUBJECT",5,"WITHDREW CONSENT","Y","DISEASE PROGRESSION",156,134,162,"Died",2,2,0.919917864476386,"<=3",1,0.459958932238193,"<=3",1,0.492813141683778,"Y","Y",2,"2",2,"Y","","","","","Y","G3 - Poorly differentiated","BODY OF PANCREAS","T3","Nx","85","81-90",9,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.15811088295688,156,0,"DEATH",5.15811088295688,156,0,"DEATH",5.15811088295688,156,0,"DEATH",5.15811088295688,156,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,180,">175",6,63.4,">50-75",2,1.78,">1.75-2.0",4,1070,">20xULN-50xULN",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",432,417,417,"Died",2,2,1.67556468172485,"<=3",1,0.952772073921971,"<=3",1,0.75564681724846,"Y","Y",2,"2",2,"Y","","Y","","","","GX - Grade cannot be assessed","BODY OF PANCREAS","T2","Nx","40","31-40",4,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",12.7474332648871,387,0,"DOCUMENTED PROGRESSION",14.2258726899384,432,0,"DEATH",14.2258726899384,432,0,"DEATH",14.2258726899384,432,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,183,">175",6,102,">100-125",4,2.27,">2.0",5,39000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",89,63,94,"Died",2,1,1.24845995893224,"<=3",1,1.24845995893224,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","GX - Grade cannot be assessed","TAIL OF PANCREAS","T3","Nx","30","21-30",3,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.87268993839836,56,0,"DOCUMENTED PROGRESSION",2.92402464065708,88,0,"DEATH",2.92402464065708,88,0,"DEATH",2.92402464065708,88,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,162,">150-175",5,49.4,"<=50",1,1.49,">1.25-1.50",2,798000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"DEATH",2,"PROGRESSION OF METASTATIC PANCREATIC ADENOCARCINOMA","Y","Other",54,50,NA,"Died",2,2,1.31416837782341,"<=3",1,0.887063655030801,"<=3",1,0.459958932238193,"Y","Y",4,"4",4,"Y","Y","Y","","","Y","GX - Grade cannot be assessed","OTHER","T2","Nx","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.80698151950719,54,0,"DEATH",1.80698151950719,54,0,"DEATH",1.80698151950719,54,0,"DEATH",1.80698151950719,54,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,166,">150-175",5,68.3,">50-75",2,1.77,">1.75-2.0",4,34300,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",170,150,181,"Died",2,2,0.887063655030801,"<=3",1,0.887063655030801,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G2 - Moderately differentiated","OTHER","T3","Nx","60","51-60",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",4.96098562628337,150,0,"DOCUMENTED PROGRESSION",5.61806981519507,170,0,"DEATH",5.61806981519507,170,0,"DEATH",5.61806981519507,170,0,"DEATH"
"71-80",4,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,152,">150-175",5,57.2,">50-75",2,1.55,">1.50-1.75",3,1.4,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,309,309,"Alive",1,3,1.60985626283368,"<=3",1,1.60985626283368,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"","","Y","","","Y","GX - Grade cannot be assessed","TAIL OF PANCREAS","T4","Nx","40","31-40",4,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",7.45790554414784,226,0,"DOCUMENTED PROGRESSION",10.1848049281314,309,1,"CENSORED AT TIME OF LAST FOLLOW-UP",10.1848049281314,309,1,"CENSORED AT TIME OF LAST FOLLOW-UP",10.1848049281314,309,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"71-80",4,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,168,">150-175",5,60.4,">50-75",2,1.68,">1.50-1.75",3,87.9,">2xULN-3xULN",3,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",126,95,95,"Died",2,3,2.92402464065708,"<=3",1,2.92402464065708,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","Y","","","","GX - Grade cannot be assessed","HEAD OF PANCREAS","T3","Nx","2","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",4.20533880903491,127,0,"DEATH",4.20533880903491,127,0,"DEATH",4.20533880903491,127,0,"DEATH",4.20533880903491,127,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,164,">150-175",5,58.3,">50-75",2,1.63,">1.50-1.75",3,9.4,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","DISEASE PROGRESSION",170,167,197,"Died",2,3,0.919917864476386,"<=3",1,0.919917864476386,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","","Y","","","","G3 - Poorly differentiated","OTHER","T4","Nx","N/A","",NA,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",5.65092402464066,171,0,"DEATH",5.65092402464066,171,0,"DEATH",5.65092402464066,171,0,"DEATH",5.65092402464066,171,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,174,">150-175",5,68.3,">50-75",2,1.82,">1.75-2.0",4,NA,"",NA,"Gemcitabine",2,"Gemcitabine",2,"",NA,"","","",NA,268,NA,"",NA,3,1.7741273100616,"<=3",1,1.31416837782341,"<=3",1,0.492813141683778,"Y","Y",1,"1",1,"","","Y","","","","G2 - Moderately differentiated","BODY OF PANCREAS","T4","Nx","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",7.45790554414784,226,1,"CENSORED AT TIME OF LAST ASSESSMENT",8.83778234086242,268,1,"CENSORED AT TIME OF LAST VISIT",8.83778234086242,268,1,"CENSORED AT TIME OF LAST VISIT",8.83778234086242,268,1,"CENSORED AT TIME OF LAST VISIT"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,172,">150-175",5,63.4,">50-75",2,1.74,">1.50-1.75",3,24800,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"ADVERSE EVENT",3,"ADVERSE EVENT","","",NA,46,46,"Lost to Follow-up",3,3,7.5564681724846,">6-12",3,5.91375770020534,">3-6",2,1.67556468172485,"Y","Y",3,"3",3,"Y","Y","","","","Y","Unknown","BODY OF PANCREAS","T4","Nx","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",0.0328542094455852,0,1,"CENSORED AT TIME OF RANDOMIZATION",1.54414784394251,46,1,"CENSORED AT TIME OF LAST FOLLOW-UP",1.54414784394251,46,1,"CENSORED AT TIME OF LAST FOLLOW-UP",1.54414784394251,46,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,174,">150-175",5,69,">50-75",2,1.83,">1.75-2.0",4,95400,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",120,111,NA,"Died",2,5,2.85831622176591,"<=3",1,2.85831622176591,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","","","Y","GX - Grade cannot be assessed","TAIL OF PANCREAS","T3","N0","60","51-60",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",2.10266940451745,63,0,"DOCUMENTED PROGRESSION",4.07392197125257,123,0,"DEATH",4.07392197125257,123,0,"DEATH",4.07392197125257,123,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,177,">175",6,76,">75-100",3,1.93,">1.75-2.0",4,NA,"",NA,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",451,442,453,"Died",2,2,1.54414784394251,"<=3",1,1.54414784394251,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","","","Y","Unknown","TAIL OF PANCREAS","T3","N0","30","21-30",3,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",12.911704312115,392,0,"DOCUMENTED PROGRESSION",14.8501026694045,451,0,"DEATH",14.8501026694045,451,0,"DEATH",14.8501026694045,451,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,0,2,0,"0",1,168,">150-175",5,81,">75-100",3,1.8,">1.75-2.0",4,4970,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",93,78,78,"Died",2,1,0.558521560574949,"<=3",1,0.558521560574949,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","BODY OF PANCREAS","T4","N1","15","11-20",2,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.67556468172485,50,0,"DOCUMENTED PROGRESSION",3.05544147843943,92,0,"DEATH",3.05544147843943,92,0,"DEATH",3.05544147843943,92,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,0,2,0,"0",1,188,">175",6,127,">125-150",5,2.4,">2.0",5,442,">10xULN-20xULN",5,"Gemcitabine",2,"Gemcitabine",2,"DEATH",2,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",11,7,NA,"Died",2,1,0.788501026694045,"<=3",1,0.788501026694045,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","","Y","","","","G4 - Undifferentiated","BODY OF PANCREAS","T4","N0","30","21-30",3,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",0.361396303901437,10,0,"DEATH",0.361396303901437,10,0,"DEATH",0.361396303901437,10,0,"DEATH",0.361396303901437,10,0,"DEATH"
"51-60",2,"<65",1,"Eastern Europe",3,"Eastern Europe",2,0,2,0,"0",1,174,">150-175",5,69,">50-75",2,1.83,">1.75-2.0",4,60.6,">ULN-2xULN",2,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",178,173,182,"Died",2,2,1.28131416837782,"<=3",1,1.28131416837782,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","BODY OF PANCREAS","T4","N1","30","21-30",3,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.87268993839836,56,0,"DOCUMENTED PROGRESSION",5.88090349075975,178,0,"DEATH",5.88090349075975,178,0,"DEATH",5.88090349075975,178,0,"DEATH"
"61-70",3,"<65",1,"Eastern Europe",3,"Eastern Europe",2,0,2,0,"0",1,180,">175",6,63,">50-75",2,1.77,">1.75-2.0",4,105000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",43,42,NA,"Died",2,1,0.722792607802875,"<=3",1,0.722792607802875,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","","Y","","","G3 - Poorly differentiated","BODY OF PANCREAS","T4","N1","50","41-50",5,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.41273100616016,42,0,"DEATH",1.41273100616016,42,0,"DEATH",1.41273100616016,42,0,"DEATH",1.41273100616016,42,0,"DEATH"
"71-80",4,">=65",2,"Eastern Europe",3,"Eastern Europe",2,1,2,1,"1",2,165,">150-175",5,51,">50-75",2,1.55,">1.50-1.75",3,2250,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",190,185,212,"Died",2,1,1.54414784394251,"<=3",1,1.54414784394251,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","","","","","Y","Unknown","HEAD OF PANCREAS","T4","N0","60","51-60",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.7782340862423,114,0,"DOCUMENTED PROGRESSION",6.24229979466119,189,0,"DEATH",6.24229979466119,189,0,"DEATH",6.24229979466119,189,0,"DEATH"
"<=50",1,"<65",1,"Eastern Europe",3,"Eastern Europe",2,0,2,0,"0",1,173,">150-175",5,50,"<=50",1,1.55,">1.50-1.75",3,1.4,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",152,141,170,"Died",2,1,1.18275154004107,"<=3",1,0.952772073921971,"<=3",1,0.262833675564682,"Y","Y",1,"1",1,"Y","","","","","","GX - Grade cannot be assessed","BODY OF PANCREAS","T4","N1","60","51-60",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.48254620123203,105,0,"DOCUMENTED PROGRESSION",4.99383983572895,151,0,"DEATH",4.99383983572895,151,0,"DEATH",4.99383983572895,151,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,156,">150-175",5,57.5,">50-75",2,1.56,">1.50-1.75",3,2970,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",246,226,226,"Died",2,2,5.22381930184805,">3-6",2,1.34702258726899,"<=3",1,3.90965092402464,"Y","Y",3,"3",3,"Y","","Y","Y","","","G2 - Moderately differentiated","BODY OF PANCREAS","T1","N0","5","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.90554414784394,57,0,"DOCUMENTED PROGRESSION",8.11498973305955,246,0,"DEATH",8.11498973305955,246,0,"DEATH",8.11498973305955,246,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,167,">150-175",5,64,">50-75",2,1.74,">1.50-1.75",3,53000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",170,168,168,"Died",2,2,1.97125256673511,"<=3",1,1.28131416837782,"<=3",1,0.722792607802875,"Y","Y",4,"4",4,"Y","Y","Y","Y","","","Unknown","OTHER","Tx","Nx","60","51-60",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.51540041067762,106,0,"DOCUMENTED PROGRESSION",5.61806981519507,170,0,"DEATH",5.61806981519507,170,0,"DEATH",5.61806981519507,170,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,158,">150-175",5,52,">50-75",2,1.51,">1.50-1.75",3,1.4,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","Other",26,21,NA,"Died",2,2,1.24845995893224,"<=3",1,1.14989733059548,"<=3",1,0.131416837782341,"Y","Y",1,"1",1,"Y","","","","","","Unknown","HEAD OF PANCREAS","T4","Unknown","5","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",0.722792607802875,21,0,"DOCUMENTED PROGRESSION",0.887063655030801,26,0,"DEATH",0.887063655030801,26,0,"DEATH",0.887063655030801,26,0,"DEATH"
"81-90",5,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,169,">150-175",5,65,">50-75",2,1.79,">1.75-2.0",4,1.4,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",246,231,245,"Died",2,1,1.37987679671458,"<=3",1,0.657084188911704,"<=3",1,0.75564681724846,"Y","Y",1,"1",1,"Y","","","","","","Unknown","BODY OF PANCREAS","Tx","Nx","45","41-50",5,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",5.3223819301848,161,0,"DOCUMENTED PROGRESSION",8.08213552361396,245,0,"DEATH",8.08213552361396,245,0,"DEATH",8.08213552361396,245,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,162,">150-175",5,59,">50-75",2,1.61,">1.50-1.75",3,NA,"",NA,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",389,363,389,"Died",2,2,0.952772073921971,"<=3",1,0.525667351129363,"<=3",1,0.459958932238193,"Y","Y",2,"2",2,"Y","","","Y","","","Unknown","OTHER","Tx","Nx","30","21-30",3,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.44969199178645,104,0,"DOCUMENTED PROGRESSION",12.8131416837782,389,0,"DEATH",12.8131416837782,389,0,"DEATH",12.8131416837782,389,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,153,">150-175",5,52,">50-75",2,1.46,">1.25-1.50",2,NA,"",NA,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,456,456,"Alive",1,2,0.722792607802875,"<=3",1,0.427104722792608,"<=3",1,0.328542094455852,"Y","Y",1,"1",1,"Y","","","","","","Unknown","HEAD OF PANCREAS","Tx","Nx","10","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.08829568788501,93,0,"DOCUMENTED PROGRESSION",15.0143737166324,456,1,"CENSORED AT TIME OF LAST FOLLOW-UP",15.0143737166324,456,1,"CENSORED AT TIME OF LAST FOLLOW-UP",15.0143737166324,456,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,157,">150-175",5,50,"<=50",1,1.48,">1.25-1.50",2,177000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",78,69,69,"Died",2,2,1.83983572895277,"<=3",1,0.492813141683778,"<=3",1,1.37987679671458,"Y","Y",2,"2",2,"Y","","Y","","","","G3 - Poorly differentiated","OTHER","T4","Nx","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.41273100616016,42,0,"DOCUMENTED PROGRESSION",2.59548254620123,78,0,"DEATH",2.59548254620123,78,0,"DEATH",2.59548254620123,78,0,"DEATH"
"51-60",2,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,168,">150-175",5,94,">75-100",3,2.05,">2.0",5,10800,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,337,337,"Alive",1,2,1.1170431211499,"<=3",1,0.919917864476386,"<=3",1,0.229979466119097,"Y","Y",2,"2",2,"Y","","","","","Y","Unknown","OTHER","Tx","Nx","20","11-20",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.83983572895277,55,0,"DOCUMENTED PROGRESSION",11.1047227926078,337,1,"CENSORED AT TIME OF LAST FOLLOW-UP",11.1047227926078,337,1,"CENSORED AT TIME OF LAST FOLLOW-UP",11.1047227926078,337,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"61-70",3,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,170,">150-175",5,67,">50-75",2,1.77,">1.75-2.0",4,559,">10xULN-20xULN",5,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,302,302,"Alive",1,3,13.9958932238193,">12-24",4,0.854209445585216,"<=3",1,13.1745379876797,"Y","Y",2,"2",2,"Y","Y","","","","","G1 - Well differentiated","HEAD OF PANCREAS","T3","N0","15","11-20",2,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.5523613963039,168,1,"CENSORED AT TIME OF LAST ASSESSMENT",9.95482546201232,302,1,"CENSORED AT TIME OF LAST FOLLOW-UP",9.95482546201232,302,1,"CENSORED AT TIME OF LAST FOLLOW-UP",9.95482546201232,302,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,159,">150-175",5,50,"<=50",1,1.51,">1.50-1.75",3,1.4,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",260,237,265,"Died",2,7,5.782340862423,">3-6",2,1.44558521560575,"<=3",1,4.36960985626283,"Y","Y",3,"3",3,"Y","","Y","Y","","","Unknown","HEAD OF PANCREAS","T3","N1","40","31-40",4,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",5.58521560574949,169,0,"DOCUMENTED PROGRESSION",8.73921971252567,265,0,"DEATH",8.73921971252567,265,0,"DEATH",8.73921971252567,265,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,170,">150-175",5,68,">50-75",2,1.79,">1.75-2.0",4,7600,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","DISEASE PROGRESSION",313,301,301,"Died",2,1,1.21560574948665,"<=3",1,1.21560574948665,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","OTHER","T3","N1","40","31-40",4,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",10.2833675564682,312,0,"DEATH",10.2833675564682,312,0,"DEATH",10.2833675564682,312,0,"DEATH",10.2833675564682,312,0,"DEATH"
"61-70",3,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,160,">150-175",5,55,">50-75",2,1.56,">1.50-1.75",3,20.6,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",158,148,148,"Died",2,2,0.919917864476386,"<=3",1,0.394250513347023,"<=3",1,0.558521560574949,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","HEAD OF PANCREAS","T3","N1","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.70841889117043,51,0,"DOCUMENTED PROGRESSION",5.22381930184805,158,0,"DEATH",5.22381930184805,158,0,"DEATH",5.22381930184805,158,0,"DEATH"
"<=50",1,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,164,">150-175",5,62,">50-75",2,1.67,">1.50-1.75",3,47200,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",462,446,461,"Died",2,1,1.18275154004107,"<=3",1,1.14989733059548,"<=3",1,0.0657084188911704,"Y","Y",1,"1",1,"Y","","","","","","Unknown","HEAD OF PANCREAS","T3","N0","60","51-60",6,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.67556468172485,50,0,"DOCUMENTED PROGRESSION",15.1786447638604,461,0,"DEATH",15.1786447638604,461,0,"DEATH",15.1786447638604,461,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,1,1,1,"1",2,172,">150-175",5,78.5,">75-100",3,1.93,">1.75-2.0",4,629,">10xULN-20xULN",5,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","Other",93,76,NA,"Died",2,1,0.952772073921971,"<=3",1,0.75564681724846,"<=3",1,0.229979466119097,"Y","Y",1,"1",1,"Y","","","","","","G2 - Moderately differentiated","TAIL OF PANCREAS","Unknown","N0","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",2.03696098562628,61,0,"DOCUMENTED PROGRESSION",3.05544147843943,92,0,"DEATH",3.05544147843943,92,0,"DEATH",3.05544147843943,92,0,"DEATH"
"61-70",3,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,176,">175",6,72.5,">50-75",2,1.8,">1.75-2.0",4,145000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","Other",392,379,379,"Died",2,3,2.10266940451745,"<=3",1,2.10266940451745,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G3 - Poorly differentiated","BODY OF PANCREAS","T2","N0","30","21-30",3,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",10.9733059548255,333,0,"DOCUMENTED PROGRESSION",12.9445585215606,393,0,"DEATH",12.9445585215606,393,0,"DEATH",12.9445585215606,393,0,"DEATH"
"61-70",3,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,172,">150-175",5,74.9,">50-75",2,1.87,">1.75-2.0",4,6810,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",409,392,419,"Died",2,3,0.75564681724846,"<=3",1,0.75564681724846,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T2","N0","5","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.51950718685832,167,0,"DOCUMENTED PROGRESSION",13.5030800821355,410,0,"DEATH",13.5030800821355,410,0,"DEATH",13.5030800821355,410,0,"DEATH"
"51-60",2,"<65",1,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,183,">175",6,85.5,">75-100",3,2.1,">2.0",5,2060000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",169,160,160,"Died",2,4,1.05133470225873,"<=3",1,0.82135523613963,"<=3",1,0.262833675564682,"Y","Y",4,"4",4,"Y","Y","","","","Y","Unknown","HEAD OF PANCREAS","T4","N1","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.67967145790554,111,0,"DOCUMENTED PROGRESSION",5.65092402464066,171,0,"DEATH",5.65092402464066,171,0,"DEATH",5.65092402464066,171,0,"DEATH"
"61-70",3,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,181,">175",6,102,">100-125",4,2.23,">2.0",5,49.4,">ULN-2xULN",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"DEATH",2,"SUDDEN HEART DEATH","Y","Other",357,352,NA,"Died",2,2,1.51129363449692,"<=3",1,1.51129363449692,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","HEAD OF PANCREAS","T2","N1","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",11.7618069815195,357,0,"DEATH",11.7618069815195,357,0,"DEATH",11.7618069815195,357,0,"DEATH",11.7618069815195,357,0,"DEATH"
"71-80",4,">=65",2,"Western Europe",2,"US/Western Europe/Australia",1,0,1,0,"0",1,152,">150-175",5,51.7,">50-75",2,1.45,">1.25-1.50",2,27500,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",142,127,127,"Died",2,3,1.08418891170431,"<=3",1,1.08418891170431,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","Unknown","HEAD OF PANCREAS","T2","N0","N/A","",NA,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.74127310061602,52,0,"DOCUMENTED PROGRESSION",4.73100616016427,143,0,"DEATH",4.73100616016427,143,0,"DEATH",4.73100616016427,143,0,"DEATH"
"61-70",3,">=65",2,"North America",1,"US/Western Europe/Australia",1,0,1,0,"0",1,171.5,">150-175",5,72.6,">50-75",2,1.84,">1.75-2.0",4,10,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"",NA,"","","",NA,718,NA,"",NA,4,2.0041067761807,"<=3",1,2.0041067761807,"<=3",1,0.0328542094455852,"Y","Y",5,">=5",5,"Y","","Y","Y","Y","Y","Unknown","TAIL OF PANCREAS","T3","Unknown","20","11-20",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",22.0780287474333,671,1,"CENSORED AT TIME OF LAST ASSESSMENT",23.6221765913758,718,1,"CENSORED AT TIME OF LAST VISIT",23.6221765913758,718,1,"CENSORED AT TIME OF LAST VISIT",23.6221765913758,718,1,"CENSORED AT TIME OF LAST VISIT"
"71-80",4,">=65",2,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,177.8,">175",6,96.6,">75-100",3,2.14,">2.0",5,1920,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",287,273,273,"Died",2,4,0.624229979466119,"<=3",1,0.624229979466119,"<=3",1,0.0328542094455852,"Y","Y",4,"4",4,"Y","Y","","Y","","Y","G2 - Moderately differentiated","BODY OF PANCREAS","T4","N1","80","71-80",8,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.45379876796715,165,0,"DOCUMENTED PROGRESSION",9.52772073921971,289,0,"DEATH",9.52772073921971,289,0,"DEATH",9.52772073921971,289,0,"DEATH"
"71-80",4,">=65",2,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,170.2,">150-175",5,103,">100-125",4,2.13,">2.0",5,9810,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","Other",72,62,75,"Died",2,3,0.68993839835729,"<=3",1,0.68993839835729,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","","","Y","Y","","G2 - Moderately differentiated","BODY OF PANCREAS","Unknown","Unknown","20","11-20",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.70841889117043,51,0,"DOCUMENTED PROGRESSION",2.43121149897331,73,0,"DEATH",2.43121149897331,73,0,"DEATH",2.43121149897331,73,0,"DEATH"
"71-80",4,">=65",2,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,162.1,">150-175",5,65.4,">50-75",2,1.7,">1.50-1.75",3,55900,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","DISEASE PROGRESSION",189,167,167,"Died",2,4,0.722792607802875,"<=3",1,0.722792607802875,"<=3",1,0.0328542094455852,"Y","Y",7,">=5",5,"Y","Y","Y","Y","","Y","G1 - Well differentiated","TAIL OF PANCREAS","Unknown","Unknown","30","21-30",3,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",6.30800821355236,191,0,"DEATH",6.30800821355236,191,0,"DEATH",6.30800821355236,191,0,"DEATH",6.30800821355236,191,0,"DEATH"
"51-60",2,"<65",1,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,171.5,">150-175",5,88.9,">75-100",3,2.02,">2.0",5,51.3,">ULN-2xULN",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",153,141,141,"Died",2,2,1.21560574948665,"<=3",1,0.919917864476386,"<=3",1,0.328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","G3 - Poorly differentiated","BODY OF PANCREAS","T4","N1","60","51-60",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.61396303901437,109,0,"DOCUMENTED PROGRESSION",5.05954825462012,153,0,"DEATH",5.05954825462012,153,0,"DEATH",5.05954825462012,153,0,"DEATH"
"71-80",4,">=65",2,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,183.1,">175",6,90.1,">75-100",3,2.13,">2.0",5,64400,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","DISEASE PROGRESSION",148,147,147,"Died",2,4,0.492813141683778,"<=3",1,0.492813141683778,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G2 - Moderately differentiated","BODY OF PANCREAS","Unknown","Unknown","10","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",2.23408624229979,67,0,"DOCUMENTED PROGRESSION",4.96098562628337,150,0,"DEATH",4.96098562628337,150,0,"DEATH",4.96098562628337,150,0,"DEATH"
"81-90",5,">=65",2,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,168.9,">150-175",5,55.6,">50-75",2,1.62,">1.50-1.75",3,6010,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",259,227,262,"Died",2,4,12.2546201232033,">12-24",4,6.53798767967146,">6-12",3,5.74948665297741,"Y","Y",2,"2",2,"Y","Y","","","","","GX - Grade cannot be assessed","HEAD OF PANCREAS","T2","N1","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",7.26078028747433,220,0,"DOCUMENTED PROGRESSION",8.60780287474333,261,0,"DEATH",8.60780287474333,261,0,"DEATH",8.60780287474333,261,0,"DEATH"
"61-70",3,"<65",1,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,166.4,">150-175",5,55,">50-75",2,1.64,">1.50-1.75",3,44000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",29,27,NA,"Died",2,3,0.75564681724846,"<=3",1,0.427104722792608,"<=3",1,0.361396303901437,"Y","Y",2,"2",2,"","","Y","","","Y","Unknown","BODY OF PANCREAS","T2","Nx","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.01848049281314,30,0,"DEATH",1.01848049281314,30,0,"DEATH",1.01848049281314,30,0,"DEATH",1.01848049281314,30,0,"DEATH"
"61-70",3,"<65",1,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,150,">125-150",4,56.4,">50-75",2,1.52,">1.50-1.75",3,167,">3xULN-10xULN",4,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",143,112,144,"Died",2,2,1.41273100616016,"<=3",1,0.722792607802875,"<=3",1,0.722792607802875,"Y","Y",2,"2",2,"","Y","","Y","","","G1 - Well differentiated","BODY OF PANCREAS","T4","N1","90","81-90",9,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.51540041067762,106,0,"DOCUMENTED PROGRESSION",4.73100616016427,143,0,"DEATH",4.73100616016427,143,0,"DEATH",4.73100616016427,143,0,"DEATH"
"71-80",4,">=65",2,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,170.2,">150-175",5,74.4,">50-75",2,1.88,">1.75-2.0",4,17900,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","Other",22,20,22,"Died",2,2,0.525667351129363,"<=3",1,0.459958932238193,"<=3",1,0.0985626283367557,"Y","Y",1,"1",1,"Y","","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T4","N1","60","51-60",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",0.75564681724846,22,0,"DEATH",0.75564681724846,22,0,"DEATH",0.75564681724846,22,0,"DEATH",0.75564681724846,22,0,"DEATH"
"81-90",5,">=65",2,"North America",1,"US/Western Europe/Australia",1,0,1,0,"0",1,165.1,">150-175",5,64,">50-75",2,1.84,">1.75-2.0",4,1.4,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",376,349,349,"Died",2,2,3.71252566735113,">3-6",2,1.24845995893224,"<=3",1,2.49691991786448,"Y","Y",1,"1",1,"Y","","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","T2","N0","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",12.3860369609856,376,0,"DEATH",12.3860369609856,376,0,"DEATH",12.3860369609856,376,0,"DEATH",12.3860369609856,376,0,"DEATH"
"61-70",3,">=65",2,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,182.9,">175",6,86.6,">75-100",3,2.08,">2.0",5,10100,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",55,51,51,"Died",2,1,0.624229979466119,"<=3",1,0.591375770020534,"<=3",1,0.0657084188911704,"Y","Y",4,"4",4,"Y","Y","","Y","","Y","G3 - Poorly differentiated","TAIL OF PANCREAS","T3","Nx","70","61-70",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.64271047227926,49,0,"DOCUMENTED PROGRESSION",1.80698151950719,54,0,"DEATH",1.80698151950719,54,0,"DEATH",1.80698151950719,54,0,"DEATH"
"81-90",5,">=65",2,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,NA,"",NA,63.5,">50-75",2,1.67,">1.50-1.75",3,NA,"",NA,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",157,154,154,"Died",2,2,0.919917864476386,"<=3",1,0.427104722792608,"<=3",1,0.525667351129363,"Y","Y",2,"2",2,"Y","","","Y","","","G2 - Moderately differentiated","HEAD OF PANCREAS","Unknown","Unknown","20","11-20",2,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.90965092402464,118,0,"DOCUMENTED PROGRESSION",5.19096509240246,157,0,"DEATH",5.19096509240246,157,0,"DEATH",5.19096509240246,157,0,"DEATH"
"61-70",3,">=65",2,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,185.4,">175",6,81.2,">75-100",3,2,">1.75-2.0",4,36.5,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"",NA,"","","",NA,256,NA,"",NA,4,0.75564681724846,"<=3",1,0.75564681724846,"<=3",1,0.0328542094455852,"N","Y",1,"1",1,"","","","","","Y","Unknown","PANCREATIC DUCT","Unknown","Unknown","40","31-40",4,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",0.0328542094455852,0,1,"CENSORED AT TIME OF RANDOMIZATION",8.4435318275154,256,1,"CENSORED AT TIME OF LAST VISIT",8.4435318275154,256,1,"CENSORED AT TIME OF LAST VISIT",8.4435318275154,256,1,"CENSORED AT TIME OF LAST VISIT"
"71-80",4,">=65",2,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,167.6,">150-175",5,58.1,">50-75",2,1.8,">1.75-2.0",4,337,">3xULN-10xULN",4,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",59,35,NA,"Died",2,1,0.427104722792608,"<=3",1,0.427104722792608,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","Unknown","BODY OF PANCREAS","Unknown","Unknown","95","91-100",10,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.93839835728953,58,0,"DEATH",1.93839835728953,58,0,"DEATH",1.93839835728953,58,0,"DEATH",1.93839835728953,58,0,"DEATH"
"61-70",3,">=65",2,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,170,">150-175",5,76.4,">75-100",3,1.88,">1.75-2.0",4,1620,">20xULN-50xULN",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",155,137,137,"Died",2,2,1.57700205338809,"<=3",1,1.57700205338809,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","","Y","","","Y","G2 - Moderately differentiated","BODY OF PANCREAS","T4","N1","50","41-50",5,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",5.12525667351129,155,0,"DEATH",5.12525667351129,155,0,"DEATH",5.12525667351129,155,0,"DEATH",5.12525667351129,155,0,"DEATH"
"61-70",3,">=65",2,"North America",1,"US/Western Europe/Australia",1,0,1,0,"0",1,172,">150-175",5,75.3,">75-100",3,1.88,">1.75-2.0",4,17500,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",312,310,314,"Died",2,4,2.69404517453799,"<=3",1,2.43121149897331,"<=3",1,0.295687885010267,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","HEAD OF PANCREAS","Unknown","Unknown","N/A","",NA,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",8.83778234086242,268,0,"DOCUMENTED PROGRESSION",10.3490759753593,314,0,"DEATH",10.3490759753593,314,0,"DEATH",10.3490759753593,314,0,"DEATH"
"51-60",2,"<65",1,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,162.3,">150-175",5,48.3,"<=50",1,1.48,">1.25-1.50",2,21100,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,56,NA,"Withdrew consent from monthly follow-up",4,2,1.60985626283368,"<=3",1,1.64271047227926,"<=3",1,0,"Y","Y",2,"2",2,"Y","","","Y","","","Unknown","HEAD OF PANCREAS","Unknown","Unknown","90","81-90",9,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.64271047227926,49,0,"DOCUMENTED PROGRESSION",1.87268993839836,56,0,"DEATH",1.87268993839836,56,0,"DEATH",1.87268993839836,56,1,"CENSORED AT TIME OF LAST VISIT"
"61-70",3,">=65",2,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,167.5,">150-175",5,58.4,">50-75",2,1.65,">1.50-1.75",3,1920,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","Other",83,49,NA,"Died",2,2,2.13552361396304,"<=3",1,2.13552361396304,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"","Y","Y","","","","Unknown","TAIL OF PANCREAS","Unknown","Unknown","35","31-40",4,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",2.75975359342916,83,0,"DEATH",2.75975359342916,83,0,"DEATH",2.75975359342916,83,0,"DEATH",2.75975359342916,83,0,"DEATH"
"51-60",2,"<65",1,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,181.7,">175",6,89.1,">75-100",3,2.13,">2.0",5,143000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",211,182,211,"Died",2,2,0.985626283367556,"<=3",1,0.985626283367556,"<=3",1,0.0328542094455852,"Y","Y",4,"4",4,"Y","Y","","Y","","Y","Unknown","OTHER","Unknown","Unknown","50","41-50",5,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",5.35523613963039,162,0,"DOCUMENTED PROGRESSION",6.96509240246407,211,0,"DEATH",6.96509240246407,211,0,"DEATH",6.96509240246407,211,0,"DEATH"
"61-70",3,">=65",2,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,152,">150-175",5,42.4,"<=50",1,1.34,">1.25-1.50",2,1.4,"<=ULN",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",239,243,245,"Died",2,8,2.39835728952772,"<=3",1,1.87268993839836,"<=3",1,0.558521560574949,"Y","Y",1,"1",1,"Y","","","","","","G2 - Moderately differentiated","OTHER","Tx","Nx","60","51-60",6,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.61396303901437,109,0,"DOCUMENTED PROGRESSION",8.08213552361396,245,0,"DEATH",8.08213552361396,245,0,"DEATH",8.08213552361396,245,0,"DEATH"
"51-60",2,"<65",1,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,162.5,">150-175",5,56.4,">50-75",2,1.6,">1.50-1.75",3,1.4,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,252,NA,"",NA,2,2.56262833675565,"<=3",1,0.75564681724846,"<=3",1,1.83983572895277,"Y","Y",2,"2",2,"Y","Y","","","","","Unknown","HEAD OF PANCREAS","Tx","Nx","20","11-20",2,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",7.62217659137577,231,0,"DOCUMENTED PROGRESSION",8.31211498973306,252,1,"CENSORED AT TIME OF LAST VISIT",8.31211498973306,252,1,"CENSORED AT TIME OF LAST VISIT",8.31211498973306,252,1,"CENSORED AT TIME OF LAST VISIT"
"51-60",2,"<65",1,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,160.5,">150-175",5,68.5,">50-75",2,1.76,">1.75-2.0",4,87600,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",190,178,193,"Died",2,5,1.41273100616016,"<=3",1,1.41273100616016,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","Y","","","","GX - Grade cannot be assessed","HEAD OF PANCREAS","Unknown","Unknown","25","21-30",3,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.41273100616016,42,0,"DOCUMENTED PROGRESSION",6.37371663244353,193,0,"DEATH",6.37371663244353,193,0,"DEATH",6.37371663244353,193,0,"DEATH"
"71-80",4,">=65",2,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,175.3,">175",6,77.1,">75-100",3,1.95,">1.75-2.0",4,10400,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",413,379,379,"Died",2,2,0.657084188911704,"<=3",1,0.657084188911704,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"Y","Y","","","","","G4 - Undifferentiated","BODY OF PANCREAS","Unknown","N1","30","21-30",3,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",5.38809034907598,163,0,"DOCUMENTED PROGRESSION",13.6016427104723,413,0,"DEATH",13.6016427104723,413,0,"DEATH",13.6016427104723,413,0,"DEATH"
"61-70",3,">=65",2,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,177.8,">175",6,103.4,">100-125",4,2,">1.75-2.0",4,2950,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"WITHDRAWAL BY SUBJECT",5,"WITHDREW CONSENT","Y","Other",243,239,NA,"Died",2,2,0.68993839835729,"<=3",1,0.295687885010267,"<=3",1,0.427104722792608,"Y","Y",4,"4",4,"Y","","Y","Y","","Y","G2 - Moderately differentiated","HEAD OF PANCREAS","T4","Nx","95","91-100",10,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",8.01642710472279,243,0,"DEATH",8.01642710472279,243,0,"DEATH",8.01642710472279,243,0,"DEATH",8.01642710472279,243,0,"DEATH"
"<=50",1,"<65",1,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,162.6,">150-175",5,97.1,">75-100",3,2.13,">2.0",5,28000,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"WITHDRAWAL BY SUBJECT",5,"WITHDREW CONSENT","Y","Other",111,97,97,"Died",2,10,0.919917864476386,"<=3",1,0.919917864476386,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","Unknown","HEAD OF PANCREAS","Unknown","Unknown","60","51-60",6,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.94250513347023,119,0,"DEATH",3.94250513347023,119,0,"DEATH",3.94250513347023,119,0,"DEATH",3.94250513347023,119,0,"DEATH"
"51-60",2,"<65",1,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,180.3,">175",6,77,">75-100",3,1.96,">1.75-2.0",4,278,">3xULN-10xULN",4,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",171,165,165,"Died",2,5,1.05133470225873,"<=3",1,0.525667351129363,"<=3",1,0.558521560574949,"Y","Y",2,"2",2,"Y","","","","","Y","G3 - Poorly differentiated","HEAD OF PANCREAS","T2","N0","95","91-100",10,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",3.67967145790554,111,0,"DOCUMENTED PROGRESSION",5.74948665297741,174,0,"DEATH",5.74948665297741,174,0,"DEATH",5.74948665297741,174,0,"DEATH"
"61-70",3,">=65",2,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,177.8,">175",6,78,">75-100",3,1.96,">1.75-2.0",4,66.7,">ULN-2xULN",2,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",231,216,216,"Died",2,2,0.788501026694045,"<=3",1,0.262833675564682,"<=3",1,0.558521560574949,"Y","Y",2,"2",2,"","Y","","Y","","","G3 - Poorly differentiated","HEAD OF PANCREAS","Unknown","Unknown","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",1.37987679671458,41,0,"DOCUMENTED PROGRESSION",7.62217659137577,231,0,"DEATH",7.62217659137577,231,0,"DEATH",7.62217659137577,231,0,"DEATH"
"81-90",5,">=65",2,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,152.4,">150-175",5,56.2,">50-75",2,1.52,">1.50-1.75",3,16500,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",133,123,123,"Died",2,2,1.05133470225873,"<=3",1,1.05133470225873,"<=3",1,0.0328542094455852,"Y","Y",4,"4",4,"","","Y","Y","","Y","G3 - Poorly differentiated","OTHER","Tx","Nx","50","41-50",5,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.08418891170431,32,0,"DOCUMENTED PROGRESSION",4.40246406570842,133,0,"DEATH",4.40246406570842,133,0,"DEATH",4.40246406570842,133,0,"DEATH"
"71-80",4,">=65",2,"North America",1,"US/Western Europe/Australia",1,0,1,0,"0",1,177.8,">175",6,73,">50-75",2,1.9,">1.75-2.0",4,9770,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,337,337,"Alive",1,2,1.37987679671458,"<=3",1,0.262833675564682,"<=3",1,1.14989733059548,"Y","Y",1,"1",1,"Y","","","","","","G2 - Moderately differentiated","HEAD OF PANCREAS","Unknown","Unknown","5","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.90554414784394,57,0,"DOCUMENTED PROGRESSION",11.1047227926078,337,1,"CENSORED AT TIME OF LAST FOLLOW-UP",11.1047227926078,337,1,"CENSORED AT TIME OF LAST FOLLOW-UP",11.1047227926078,337,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"61-70",3,">=65",2,"North America",1,"US/Western Europe/Australia",1,0,1,0,"0",1,167.6,">150-175",5,61.7,">50-75",2,1.7,">1.50-1.75",3,15600,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"DEATH",2,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",115,113,NA,"Died",2,2,2.79260780287474,"<=3",1,1.31416837782341,"<=3",1,1.51129363449692,"Y","Y",3,"3",3,"Y","Y","","Y","","","Unknown","BODY OF PANCREAS","Unknown","Unknown","0","0-10",1,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.81108829568789,115,0,"DEATH",3.81108829568789,115,0,"DEATH",3.81108829568789,115,0,"DEATH",3.81108829568789,115,0,"DEATH"
"61-70",3,">=65",2,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,167.6,">150-175",5,56.2,">50-75",2,1.63,">1.50-1.75",3,21000,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",292,284,284,"Died",2,2,1.51129363449692,"<=3",1,1.51129363449692,"<=3",1,0.0328542094455852,"Y","Y",2,"2",2,"","Y","Y","","","","Unknown","BODY OF PANCREAS","T4","N0","0","0-10",1,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",4.27104722792608,129,0,"DOCUMENTED PROGRESSION",9.62628336755647,292,0,"DEATH",9.62628336755647,292,0,"DEATH",9.62628336755647,292,0,"DEATH"
"51-60",2,"<65",1,"North America",1,"US/Western Europe/Australia",1,0,1,0,"0",1,182.9,">175",6,93.4,">75-100",3,2.16,">2.0",5,63100,">50xULN",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","Other",82,54,NA,"Died",2,2,0.427104722792608,"<=3",1,0.427104722792608,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","Y","Y","","","","GX - Grade cannot be assessed","TAIL OF PANCREAS","Tx","N1","70","61-70",7,"Gemcitabine Elaidate",1,"Gemcitabine Elaidate",1,"Progression Free Survival (months)","PFS",2.72689938398357,82,0,"DEATH",2.72689938398357,82,0,"DEATH",2.72689938398357,82,0,"DEATH",2.72689938398357,82,0,"DEATH"
"51-60",2,"<65",1,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,157.5,">150-175",5,54.4,">50-75",2,1.54,">1.50-1.75",3,48.8,">ULN-2xULN",2,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,276,276,"Alive",1,2,1.05133470225873,"<=3",1,1.05133470225873,"<=3",1,0.0328542094455852,"Y","Y",1,"1",1,"Y","","","","","","G3 - Poorly differentiated","HEAD OF PANCREAS","T3","Nx","80","71-80",8,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.71252566735113,112,1,"CENSORED AT TIME OF LAST ASSESSMENT",9.10061601642711,276,1,"CENSORED AT TIME OF LAST FOLLOW-UP",9.10061601642711,276,1,"CENSORED AT TIME OF LAST FOLLOW-UP",9.10061601642711,276,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"71-80",4,">=65",2,"North America",1,"US/Western Europe/Australia",1,0,1,0,"0",1,157,">150-175",5,61.7,">50-75",2,1.62,">1.50-1.75",3,24.4,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","DISEASE PROGRESSION",250,238,238,"Died",2,2,1.14989733059548,"<=3",1,1.57700205338809,"<=3",1,-0.394250513347023,"Y","Y",3,"3",3,"Y","Y","","","","Y","G3 - Poorly differentiated","HEAD OF PANCREAS","T3","N1","60","51-60",6,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",1.70841889117043,51,0,"DOCUMENTED PROGRESSION",8.24640657084189,250,0,"DEATH",8.24640657084189,250,0,"DEATH",8.24640657084189,250,0,"DEATH"
"71-80",4,">=65",2,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,160.8,">150-175",5,61.2,">50-75",2,1.64,">1.50-1.75",3,67600,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"ADVERSE EVENT",3,"ADVERSE EVENT","Y","DISEASE PROGRESSION",21,6,NA,"Died",2,7,1.18275154004107,"<=3",1,1.18275154004107,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"Y","","","Y","","Y","Unknown","HEAD OF PANCREAS","T2","N1","N/A","",NA,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",0.887063655030801,26,0,"DEATH",0.887063655030801,26,0,"DEATH",0.887063655030801,26,0,"DEATH",0.887063655030801,26,0,"DEATH"
"71-80",4,">=65",2,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,162.1,">150-175",5,65.3,">50-75",2,1.7,">1.50-1.75",3,1.4,"<=ULN",1,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","","",NA,239,239,"Alive",1,2,2.0041067761807,"<=3",1,2.0041067761807,"<=3",1,0.0328542094455852,"Y","Y",3,"3",3,"","Y","","Y","","Y","G2 - Moderately differentiated","HEAD OF PANCREAS","T3","N0","N/A","",NA,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",5.42094455852156,164,1,"CENSORED AT TIME OF LAST ASSESSMENT",7.88501026694045,239,1,"CENSORED AT TIME OF LAST FOLLOW-UP",7.88501026694045,239,1,"CENSORED AT TIME OF LAST FOLLOW-UP",7.88501026694045,239,1,"CENSORED AT TIME OF LAST FOLLOW-UP"
"61-70",3,"<65",1,"North America",1,"US/Western Europe/Australia",1,1,1,1,"1",2,175.3,">175",6,74.4,">50-75",2,1.9,">1.75-2.0",4,22600,">50xULN",7,"Gemcitabine",2,"Gemcitabine",2,"PROGRESSIVE DISEASE",1,"DISEASE PROGRESSION","Y","Other",169,136,169,"Died",2,2,0.854209445585216,"<=3",1,0.197125256673511,"<=3",1,0.68993839835729,"Y","Y",4,"4",4,"Y","Y","","Y","","Y","G3 - Poorly differentiated","TAIL OF PANCREAS","T3","Nx","N/A","",NA,"Gemcitabine",2,"Gemcitabine",2,"Progression Free Survival (months)","PFS",3.51540041067762,106,0,"DOCUMENTED PROGRESSION",5.58521560574949,169,0,"DEATH",5.58521560574949,169,0,"DEATH",5.58521560574949,169,0,"DEATH"
